Medications for human use with 2-4 active ingredients

Médicaments à usage humain avec 2-4 ingrédients actifs

Updated | Mise à jour : 2021-09-02
∙ Product Name | Nom du produit;
∙ Active ingredient(s) and concentration | Ingrédient(s) actif(s) et concentration;
∙ Original market date | Date de commercisalisation originale;
∙ Number of active ingredients | Nombre d’ingrédients actifs ;
∙ Route(s) of administration | Voie(s) d’administration;
∙ Dosage form(s) | Forme(s) posologique(s);
∙ AHFS;
∙ Schedule(s) | Annexe(s);
∙ Company | Entreprise;
∙ DIN:
Monograph | Monographie
∙ KIVEXA;
∙ abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
∙ 2005-08-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02269341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75473
∙ APO-ABACAVIR-LAMIVUDINE;
∙ abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
∙ 2016-03-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02399539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88441
∙ TEVA-ABACAVIR/LAMIVUDINE;
∙ abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
∙ 2016-03-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02416662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90124
∙ MYLAN-ABACAVIR/LAMIVUDINE;
∙ abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
∙ 2016-03-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02450682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93683
∙ AURO-ABACAVIR/LAMIVUDINE;
∙ abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
∙ 2016-08-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02454513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94109
∙ PMS-ABACAVIR-LAMIVUDINE;
∙ abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
∙ 2016-10-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.20 – INTERFERONS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02458381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94550
∙ NEOCITRAN ULTRA STRENGTH TOTAL FLU;
∙ acetaminophen 1000 mg / sachet , dextromethorphan hydrobromide 30 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet;
∙ 2014-10-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02404966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88979
∙ CHILDREN’S TYLENOL COLD;
∙ acetaminophen 160 mg / 5 ml , chlorpheniramine maleate 1 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
∙ 1997-08-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02039982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26863
∙ CHILDREN’S TYLENOL COLD AND COUGH NIGHTTIME;
∙ acetaminophen 160 mg / 5 ml , diphenhydramine hydrochloride 6.25 mg / 5 ml , dextromethorphan hydrobromide 5 mg / 5 ml;
∙ 2006-08-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02279150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76469
∙ BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER NIGHTIME;
∙ acetaminophen 160 mg / 5 ml , diphenhydramine hydrochloride 6.25 mg / 5 ml , dextromethorphan hydrobromide 5 mg / 5 ml;
∙ 2008-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02305666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79122
∙ CHILDREN’S TYLENOL COMPLETE COLD, COUGH & FEVER NIGHTTIME;
∙ acetaminophen 160 mg / 5 ml , diphenhydramine hydrochloride 6.25 mg / 5 ml , dextromethorphan hydrobromide 5 mg / 5 ml;
∙ 2014-06-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02416050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90063
∙ CHILDREN’S TYLENOL COLD & STUFFY NOSE;
∙ acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
∙ 1997-10-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02229538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47448
∙ COLD AND SINUS COMPLETE LIQUID GELS;
∙ acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
∙ 2016-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02349523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83481
∙ TEVA-LENOLTEC NO. 2;
∙ acetaminophen 300 mg , caffeine 15 mg , codeine phosphate 15 mg;
∙ 1986-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00653241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6764
∙ TEVA-LENOLTEC NO. 1;
∙ acetaminophen 300 mg , caffeine 15 mg , codeine phosphate 8 mg;
∙ 1986-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00653233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6763
∙ ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS;
∙ acetaminophen 300 mg , caffeine 15 mg , codeine phosphate 8 mg;
∙ 1996-10-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02154234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33917
∙ TEVA-EMTEC-30;
∙ acetaminophen 300 mg , codeine phosphate 30 mg;
∙ 1984-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00608882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5780
∙ TRIATEC-30;
∙ acetaminophen 300 mg , codeine phosphate 30 mg;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ LABORATOIRE RIVA INC.;
∙ DIN: 00789828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9626
∙ TEVA-LENOLTEC NO. 4;
∙ acetaminophen 300 mg , codeine phosphate 60 mg;
∙ 1986-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00621463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6824
∙ ACETAMINOPHEN WITH CODEINE – CAPLET;
∙ acetaminophen 300 mg , codeine phosphate 8 mg , caffeine 15 mg;
∙ 1997-10-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02143933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31568
∙ VICKS DAYQUIL COLD & FLU MULTI-SYMPTOM RELIEF LIQUICAPS;
∙ acetaminophen 325 mg , dextromethorphan hydrobromide 10 mg , phenylephrine hydrochloride 5 mg;
∙ 2006-06-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02272784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75828
∙ MUCINEX MULTI-ACTION CONGESTION, COLD & FLU;
∙ acetaminophen 325 mg , guaifenesin 200 mg , phenylephrine hydrochloride 5 mg;
∙ 2020-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ RB HEALTH (CANADA) INC.;
∙ DIN: 02433451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91782
∙ MUCINEX MULTI-ACTION CONGESTION, COLD & COUGH;
∙ acetaminophen 325 mg , guaifenesin 200 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg;
∙ 2020-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ RB HEALTH (CANADA) INC.;
∙ DIN: 02433435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91781
∙ COMBOGESIC;
∙ acetaminophen 325 mg , ibuprofen 97.5 mg;
∙ 2020-12-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Otc | En Vente Libre;
∙ BIOSYENT PHARMA INC;
∙ DIN: 02488280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97838
∙ ROBAXACET;
∙ acetaminophen 325 mg , methocarbamol 400 mg;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02026805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14509
∙ DILOTAB II;
∙ acetaminophen 325 mg , phenylephrine hydrochloride 5 mg;
∙ 2006-04-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:12.00 – SYMPATHOMIMETIC (ADRENERGIC) AGENTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ ZEE MEDICAL;
∙ DIN: 02266148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75158
∙ DAYQUIL SINUS LIQUICAPS;
∙ acetaminophen 325 mg , phenylephrine hydrochloride 5 mg;
∙ 2006-06-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 12:12.00 – SYMPATHOMIMETIC (ADRENERGIC) AGENTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02273829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75930
∙ COLTALIN COLD & ALLERGY TABLETS;
∙ acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
∙ 2002-01-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ FORTUNE PHARMACAL CO. LTD.;
∙ DIN: 02244263
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68230
∙ VICKS NYQUIL COMPLETE COLD & FLU LIQUICAPS;
∙ acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg , doxylamine succinate 6.25 mg;
∙ 2019-07-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02483351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97379
∙ DAYQUIL COMPLETE + VICKS VAPOCOOL;
∙ acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 200 mg;
∙ 2020-07-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02481936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97240
∙ VICKS DAYQUIL COMPLETE COLD & FLU LIQUICAPS;
∙ acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 200 mg;
∙ 2019-07-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02483378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97380
∙ HISTENOL II;
∙ acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 200 mg;
∙ 2007-03-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ ZEE MEDICAL;
∙ DIN: 02276119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76178
∙ NYQUIL SINUS LIQUICAPS;
∙ acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , doxylamine succinate 6.25 mg;
∙ 2006-06-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02273810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75929
∙ MEDICAMENT POUR LES SINUS, REGULIER;
∙ acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2000-04-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02240562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64134
∙ APO-TRAMADOL/ACET;
∙ acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
∙ 2009-11-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02336790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82241
∙ TEVA-TRAMADOL/ACETAMINOPHEN;
∙ acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
∙ 2012-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02347180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83257
∙ TARO-TRAMADOL/ACET;
∙ acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
∙ 2012-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02388197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87374
∙ JAMP-ACET-TRAMADOL;
∙ acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
∙ 2012-09-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02388308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87385
∙ MAR-TRAMADOL/ACET;
∙ acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
∙ 2012-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02388324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87386
∙ MINT-TRAMADOL/ACET;
∙ acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
∙ 2012-09-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02389800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87528
∙ AURO-TRAMADOL/ACETAMINOPHEN;
∙ acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
∙ 2015-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02439050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92342
∙ BUCKLEY’S COMPLETE PLUS EXTRA STRENGTH MUCUS RELIEF;
∙ acetaminophen 325 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 20 mg / 5 ml;
∙ 2012-10-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02357232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84236
∙ BUCKLEY’S COMPLETE;
∙ acetaminophen 325 mg / 5 ml , menthol 20 mg / 5 ml;
∙ 2006-08-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02279703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76530
∙ MIDOL COMPLETE;
∙ acetaminophen 500 mg , caffeine 60 mg , pyrilamine maleate 15 mg;
∙ 2006-06-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02275201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76086
∙ MENSTRUAL COMPLETE;
∙ acetaminophen 500 mg , caffeine 60 mg , pyrilamine maleate 15 mg;
∙ 2013-07-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.08 – ETHYLENEDIAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02397420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88238
∙ TYLENOL ULTRA RELIEF;
∙ acetaminophen 500 mg , caffeine 65 mg;
∙ 2005-01-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02254468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73935
∙ ULTRA HEADACHE RELIEF;
∙ acetaminophen 500 mg , caffeine 65 mg;
∙ 2005-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02264870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75038
∙ COLDASIDE COLD & FLU EXTRA STRENGTH;
∙ acetaminophen 500 mg , chlorpheniramine maleate 2 mg , dextromethorphan hydrobromide 15 mg;
∙ 2009-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02305216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79071
∙ EXTRA STRENGTH ALLERGY SINUS MEDICATION;
∙ acetaminophen 500 mg , chlorpheniramine maleate 2 mg , pseudoephedrine hydrochloride 30 mg;
∙ 1996-10-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02159546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34150
∙ EXTRA STRENGTH TYLENOL COLD NIGHTTIME;
∙ acetaminophen 500 mg , dextromethorphan hydrobromide 10 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
∙ 2006-07-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02276259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76192
∙ FLU, COUGH & COLD COMPLETE;
∙ acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2012-05-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02380447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86625
∙ EXTRA STRENGTH TYLENOL NIGHTTIME;
∙ acetaminophen 500 mg , diphenhydramine hydrochloride 25 mg;
∙ 2012-10-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02385619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87122
∙ EXTRA STRENGTH TYLENOL BACK PAIN;
∙ acetaminophen 500 mg , methocarbamol 400 mg;
∙ 2009-07-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02290510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77584
∙ PAINAID PMF PREMENSTRUAL FORMULA;
∙ acetaminophen 500 mg , pamabrom 25 mg;
∙ 2004-12-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ ZEE MEDICAL;
∙ DIN: 02246308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70470
∙ MIDOL PMS;
∙ acetaminophen 500 mg , pamabrom 25 mg , pyrilamine maleate 15 mg;
∙ 2006-07-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02275228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76087
∙ BENYLIN EXTRA STRENGTH COLD & SINUS DAY;
∙ acetaminophen 500 mg , phenylephrine hydrochloride 5 mg;
∙ 2006-08-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02273462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75895
∙ EXTRA STRENGTH TYLENOL SINUS DAYTIME;
∙ acetaminophen 500 mg , phenylephrine hydrochloride 5 mg;
∙ 2006-07-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:12.00 – SYMPATHOMIMETIC (ADRENERGIC) AGENTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02276003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76168
∙ EXTRA STRENGTH TYLENOL SINUS NIGHTTIME;
∙ acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
∙ 2006-07-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02276038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76170
∙ BENYLIN EXTRA STRENGTH COLD & SINUS NIGHT;
∙ acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
∙ 2008-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02306409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79195
∙ EXTRA STRENGTH TYLENOL FLU NIGHTTIME;
∙ acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg , dextromethorphan hydrobromide 10 mg;
∙ 2006-07-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02276046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76171
∙ EXTRA STRENGTH TYLENOL FLU DAYTIME;
∙ acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg;
∙ 2006-07-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02275996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76167
∙ EXTRA STRENGTH SINUTAB SINUS DAYTIME;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 01938371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13120
∙ MEDICAMENT POUR LES SINUS, EXTRA-FORT;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2000-04-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02240563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64135
∙ EXTRA STRENGTH TYLENOL COLD & SINUS DAYTIME;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2010-08-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02348071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83343
∙ SINUS MEDICATION DAYTIME RELIEF;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2012-01-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02368854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85382
∙ COLD AND SINUS DAYTIME RELIEF;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2014-07-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02385252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87089
∙ EXTRA STRENGTH SINUTAB SINUS & ALLERGY;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
∙ 1986-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 01986988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17113
∙ EXTRA STRENGTH TYLENOL COLD & SINUS NIGHTTIME;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
∙ 2010-08-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02348098
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83344
∙ BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH NIGHT;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg;
∙ 2005-09-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02256576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74181
∙ EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU NIGHTTIME;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg;
∙ 2011-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02365766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85064
∙ COUGH & COLD RELIEF;
∙ acetaminophen 500 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
∙ 2020-01-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02487004
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97715
∙ NEOCITRAN TOTAL COLD NIGHT;
∙ acetaminophen 500 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
∙ 2017-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02413280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89795
∙ ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH;
∙ acetaminophen 500 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , chlorpheniramine maleate 2 mg / 15 ml;
∙ 2008-08-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02291371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77675
∙ BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU WITH WARMING SENSATION;
∙ acetaminophen 500 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml;
∙ 2009-08-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02321432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80682
∙ NIGHT TIME TOTAL EXTRA STRENGTH;
∙ acetaminophen 650 mg / sachet , chlorpheniramine maleate 4 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet;
∙ 2010-12-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02344548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83004
∙ EXTRA STRENGTH TOTAL SYMPTOM RELIEF SUGAR-FREE;
∙ acetaminophen 650 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
∙ 2014-12-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02420937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90552
∙ COLD STIX SUPER STRENGTH;
∙ acetaminophen 650 mg / sachet , pheniramine maleate 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
∙ 2013-10-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02377888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86368
∙ NEOCITRAN EXTRA STRENGTH TOTAL COLD;
∙ acetaminophen 650 mg / sachet , phenylephrine hydrochloride 10 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet;
∙ 2008-07-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02293994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77936
∙ HOT LEMON RELIEF FOR SYMPTOMS OF COUGH, COLD AND FLU EXTRA STRENGTH;
∙ acetaminophen 650 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet , chlorpheniramine maleate 4 mg / sachet;
∙ 2004-02-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02246848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71050
∙ VICKS NYQUIL COMPLETE COLD & FLU;
∙ acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
∙ 2014-08-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02409542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89423
∙ NYQUIL COMPLETE;
∙ acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
∙ 2021-07-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02503549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99301
∙ VICKS DAYQUIL COMPLETE COLD & FLU LIQUID;
∙ acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
∙ 2014-08-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02409534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89422
∙ DAYTIME COMPLETE;
∙ acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
∙ 2020-01-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02458470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94560
∙ DAYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID;
∙ acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
∙ 2020-07-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02482428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97287
∙ DAYQUIL COMPLETE;
∙ acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
∙ 2021-07-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02503638
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99308
∙ DAYQUIL COLD & FLU;
∙ acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
∙ 2009-08-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02300842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78620
∙ VICKS NYQUIL COLD & FLU NIGHTTIME RELIEF;
∙ acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 30 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
∙ 2012-07-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02374277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85947
∙ ROBITUSSIN TOTAL COUGH, COLD & FLU;
∙ acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 30 mg / 30 ml , pseudoephedrine hydrochloride 30 mg / 30 ml;
∙ 2008-08-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02291363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77674
∙ DAYTIME COLD/FLU MEDICINE;
∙ acetaminophen 650 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml;
∙ 2007-08-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02290863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77628
∙ NYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID;
∙ acetaminophen 650 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
∙ 2020-07-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02482401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97286
∙ ANACIN;
∙ acetylsalicylic acid 325 mg , caffeine 32 mg;
∙ 2011-01-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES , 28:20.32 – Respiratory and CNS Stimulants;
∙ Otc | En Vente Libre;
∙ PALADIN LABS INC.;
∙ DIN: 02332450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81810
∙ TEVA-OXYCODAN;
∙ acetylsalicylic acid 325 mg , oxycodone hydrochloride 5 mg;
∙ 1984-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.04.24 – SALICYLATES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00608157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5777
∙ ALKA-SELTZER FLAVOURED;
∙ acetylsalicylic acid 325 mg , sodium bicarbonate 1700 mg , citric acid 1000 mg;
∙ 2002-09-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet (Effervescent) | Comprimé (Effervescent);
∙ 56:04.00 – ANTACIDS AND ADSORBENTS , 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02245367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69406
∙ ALKA-SELTZER;
∙ acetylsalicylic acid 325 mg / evt , citric acid 1000 mg / evt , sodium bicarbonate 1916 mg / evt;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet (Effervescent) | Comprimé (Effervescent);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02152746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42652
∙ FIORINAL-C 1/4;
∙ acetylsalicylic acid 330 mg , caffeine 40 mg , butalbital 50 mg , codeine phosphate 15 mg;
∙ 1970-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.08 – OPIATE AGONISTS , 28:24.04 – BARBITURATES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ ARALEZ PHARMACEUTICALS CANADA INC;
∙ DIN: 00176192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=872
∙ FIORINAL-C 1/2;
∙ acetylsalicylic acid 330 mg , caffeine 40 mg , codeine phosphate 30 mg , butalbital 50 mg;
∙ 1970-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.08 – OPIATE AGONISTS , 28:24.04 – BARBITURATES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ ARALEZ PHARMACEUTICALS CANADA INC;
∙ DIN: 00176206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=873
∙ DUAKLIR GENUAIR;
∙ aclidinium bromide 400 mcg / act , formoterol fumarate dihydrate 12 mcg / act;
∙ 2015-07-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder (Metered Dose) | Poudre (À Dose Mesurée);
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02439530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92396
∙ XERESE;
∙ acyclovir 5 % / w/w , hydrocortisone 1 % / w/w;
∙ 2013-07-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.06 – ANTIVIRALS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02404044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88879
∙ TACTUPUMP;
∙ adapalene 0.1 % / w/w , benzoyl peroxide 2.5 % / w/w;
∙ 2011-05-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02365871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85075
∙ TARO-ADAPALENE/BENZOYL PEROXIDE;
∙ adapalene 0.1 % / w/w , benzoyl peroxide 2.5 % / w/w;
∙ 2019-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02456923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94404
∙ SANDOZ ADAPALENE / BENZOYL PEROXIDE;
∙ adapalene 0.1 % / w/w , benzoyl peroxide 2.5 % / w/w;
∙ 2019-09-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02489007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97906
∙ TACTUPUMP FORTE;
∙ adapalene 0.3 % / w/w , benzoyl peroxide 2.5 % / w/w;
∙ 2016-01-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02446235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93152
∙ FOSAVANCE;
∙ alendronic acid (alendronate sodium trihydrate) 70 mg , vitamin d3 (cholecalciferol) 2800 unit;
∙ 2006-03-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02276429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76210
∙ FOSAVANCE;
∙ alendronic acid (alendronate sodium trihydrate) 70 mg , vitamin d3 (cholecalciferol) 5600 unit;
∙ 2008-09-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02314940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80047
∙ SANDOZ ALENDRONATE/CHOLECALCIFEROL;
∙ alendronic acid (alendronate sodium trihydrate) 70 mg , vitamin d3 (cholecalciferol) 5600 unit;
∙ 2014-08-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02429160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91361
∙ APO-ALENDRONATE/VITAMIN D3;
∙ alendronic acid (alendronate sodium) 70 mg , vitamin d3 (cholecalciferol) 2800 unit;
∙ 2016-07-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02454467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94104
∙ APO-ALENDRONATE/VITAMIN D3;
∙ alendronic acid (alendronate sodium) 70 mg , vitamin d3 (cholecalciferol) 5600 unit;
∙ 2016-07-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02454475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94105
∙ KAZANO;
∙ alogliptin (alogliptin benzoate) 12.5 mg , metformin hydrochloride 1000 mg;
∙ 2014-04-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02417235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90187
∙ KAZANO;
∙ alogliptin (alogliptin benzoate) 12.5 mg , metformin hydrochloride 500 mg;
∙ 2014-04-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02417219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90185
∙ KAZANO;
∙ alogliptin (alogliptin benzoate) 12.5 mg , metformin hydrochloride 850 mg;
∙ 2014-04-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02417227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90186
∙ PIQRAY;
∙ alpelisib 50 mg , alpelisib 200 mg;
∙ 2020-06-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02497085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98694
∙ ACTIVASE RT-PA;
∙ alteplase 100 mg / kit , water 100 ml / kit;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Liquid , Powder For Solution | Liquide , Poudre Pour Solution;
∙ 20:12.20 – THROMBOLYTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02147440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20105
∙ ACTIVASE RT-PA;
∙ alteplase 50 mg / kit , water 50 ml / kit;
∙ 1998-04-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Liquid , Powder For Solution | Liquide , Poudre Pour Solution;
∙ 20:12.20 – THROMBOLYTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02225689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43443
∙ DIOVOL PLUS SUSPENSION;
∙ aluminum hydroxide (dried aluminum hydroxide gel) 165 mg / 5 ml , magnesium hydroxide 200 mg / 5 ml , simethicone 25 mg / 5 ml;
∙ 1963-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 00116815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=187
∙ ALMAGEL PLUS SUS;
∙ aluminum hydroxide 200 mg / 5 ml , magnesium hydroxide 200 mg / 5 ml , dimethicone 25 mg / 5 ml;
∙ 1997-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 00815527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44552
∙ DIOVOL PLUS TABLETS;
∙ aluminum hydroxide-magnesium carbonate-co dried gel 300 mg , magnesium hydroxide 100 mg , simethicone 25 mg;
∙ 1963-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 00116882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=188
∙ APO-AMLODIPINE-ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
∙ 2013-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02411318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89592
∙ APO-AMLODIPINE-ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
∙ 2013-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02411326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89593
∙ APO-AMLODIPINE-ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
∙ 2013-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02411334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89594
∙ APO-AMLODIPINE-ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
∙ 2013-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02411342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89595
∙ CADUET;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 10 mg;
∙ 2005-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02273284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75877
∙ GD-AMLODIPINE/ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 10 mg;
∙ 2011-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02362791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84779
∙ CADUET;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 20 mg;
∙ 2005-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02273292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75878
∙ GD-AMLODIPINE/ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 20 mg;
∙ 2011-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02362805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84780
∙ CADUET;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 40 mg;
∙ 2005-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02273306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75879
∙ GD-AMLODIPINE/ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 40 mg;
∙ 2011-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02362813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84781
∙ CADUET;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 80 mg;
∙ 2005-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02273314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75880
∙ GD-AMLODIPINE/ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 80 mg;
∙ 2011-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02362821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84782
∙ APO-AMLODIPINE-ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
∙ 2013-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02411253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89588
∙ APO-AMLODIPINE-ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
∙ 2013-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02411261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89589
∙ APO-AMLODIPINE-ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
∙ 2013-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02411288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89590
∙ APO-AMLODIPINE-ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
∙ 2013-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02411296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89591
∙ CADUET;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 10 mg;
∙ 2005-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02273233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75873
∙ GD-AMLODIPINE/ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 10 mg;
∙ 2011-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02362759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84775
∙ CADUET;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 20 mg;
∙ 2005-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02273241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75874
∙ CADUET;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 40 mg;
∙ 2005-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02273268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75875
∙ GD-AMLODIPINE/ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 40 mg;
∙ 2011-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02362775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84777
∙ CADUET;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 80 mg;
∙ 2005-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02273276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75876
∙ GD-AMLODIPINE/ATORVASTATIN;
∙ amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 80 mg;
∙ 2011-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02362783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84778
∙ VIACORAM;
∙ amlodipine (amlodipine besylate) 5 mg , perindopril arginine 7 mg;
∙ 2016-04-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02451549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93783
∙ CLAVULIN 125 F ORAL SUS;
∙ amoxicillin (amoxicillin trihydrate) 125 mg / 5 ml , clavulanic acid (clavulanate potassium) 31.25 mg / 5 ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 01916882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15208
∙ CLAVULIN 200;
∙ amoxicillin (amoxicillin trihydrate) 200 mg / 5 ml , clavulanic acid (clavulanate potassium) 28.5 mg / 5 ml;
∙ 1998-10-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02238831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62269
∙ APO-AMOXI CLAV;
∙ amoxicillin (amoxicillin trihydrate) 250 mg , clavulanic acid (clavulanate potassium) 125 mg;
∙ 2001-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02243350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67257
∙ CLAVULIN 250 F ORAL SUS;
∙ amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml , clavulanic acid (clavulanate potassium) 62.5 mg / 5 ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 01916874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15209
∙ CLAVULIN 500 F TAB;
∙ amoxicillin (amoxicillin trihydrate) 500 mg , clavulanic acid (clavulanate potassium) 125 mg;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 01916858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15903
∙ APO-AMOXI CLAV;
∙ amoxicillin (amoxicillin trihydrate) 500 mg , clavulanic acid (clavulanate potassium) 125 mg;
∙ 2001-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02243351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67258
∙ SANDOZ AMOXI-CLAV TABLET;
∙ amoxicillin (amoxicillin trihydrate) 500 mg , clavulanic acid (clavulanate potassium) 125 mg;
∙ 2019-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02482576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97300
∙ CLAVULIN 875;
∙ amoxicillin (amoxicillin trihydrate) 875 mg , clavulanic acid (clavulanate potassium) 125 mg;
∙ 1998-10-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02238829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62267
∙ APO-AMOXI CLAV;
∙ amoxicillin (amoxicillin trihydrate) 875 mg , clavulanic acid (clavulanate potassium) 125 mg;
∙ 2002-10-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02245623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69723
∙ SANDOZ AMOXI-CLAV TABLET;
∙ amoxicillin (amoxicillin trihydrate) 875 mg , clavulanic acid (clavulanate potassium) 125 mg;
∙ 2019-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02482584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97301
∙ PANCREASE MT 10;
∙ amylase 43750 unit , protease 25000 unit , lipase 10500 unit;
∙ 1988-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ VIVUS INC.;
∙ DIN: 00789437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9513
∙ CEPACOL SENSATIONS;
∙ amylmetacresol 0.6 mg , dichlorobenzyl alcohol 1.2 mg;
∙ 2012-07-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Lozenge | Pastille;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ RB HEALTH (CANADA) INC.;
∙ DIN: 02382938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86872
∙ CEPACOL CHILDREN’S FRUITY STRAWBERRY;
∙ amylmetacresol 0.6 mg , dichlorobenzyl alcohol 1.2 mg;
∙ 2013-08-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Lozenge | Pastille;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ RB HEALTH (CANADA) INC.;
∙ DIN: 02404982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88981
∙ REFRESH EYE ALLERGY RELIEF;
∙ antazoline phosphate 0.51 % , naphazoline hydrochloride 0.051 %;
∙ 2009-02-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02315890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80140
∙ WILATE;
∙ antihemophilic factor (human) 1000 unit / 10 ml , von willebrand factor (human) 1000 unit / 10 ml , human plasma proteins 15 mg / 10 ml;
∙ 2008-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H;
∙ DIN: 02286769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77222
∙ HUMATE-P;
∙ antihemophilic factor (human) 1200 unit / 15 ml , von willebrand factor (human) 3360 unit / 15 ml;
∙ 2004-12-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02261235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74663
∙ HUMATE-P;
∙ antihemophilic factor (human) 300 unit / 5 ml , von willebrand factor (human) 840 unit / 5 ml;
∙ 2004-12-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02261219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74661
∙ WILATE;
∙ antihemophilic factor (human) 500 unit / 5 ml , von willebrand factor (human) 500 unit / 5 ml , human plasma proteins 7.5 mg / 5 ml;
∙ 2008-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H;
∙ DIN: 02286750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77219
∙ HUMATE-P;
∙ antihemophilic factor (human) 600 unit / 10 ml , von willebrand factor (human) 1680 unit / 10 ml;
∙ 2004-12-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02261227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74662
∙ OTEZLA;
∙ apremilast 10 mg , apremilast 20 mg , apremilast 30 mg;
∙ 2014-11-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription | Prescription;
∙ AMGEN CANADA INC;
∙ DIN: 02434318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91864
∙ EMEND TRI-PACK;
∙ aprepitant 125 mg , aprepitant 80 mg;
∙ 2007-09-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Kit , Capsule | Trousse , Capsule;
∙ 56:22.32 – NEUROKININ-1 RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02298813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78412
∙ TISSEEL;
∙ aprotinin (synthetic) 3000 kiu / ml , thrombin (human) 500 unit / ml , calcium chloride 40 mcmol / ml , sealer protein (human) 125 mg / ml;
∙ 2011-06-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ BAXTER CORPORATION;
∙ DIN: 02326175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81151
∙ SEPTANEST N;
∙ articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Liquid | Liquide;
∙ 52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT;
∙ DIN: 02123371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16851
∙ 4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML);
∙ articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
∙ 2004-01-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ DENTSPLY CANADA LIMITED;
∙ DIN: 02248489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72841
∙ POSICAINE N;
∙ articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
∙ 2012-04-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ NOVOCOL PHARMACEUTICAL OF CANADA INC;
∙ DIN: 02381311
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86711
∙ 4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML);
∙ articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
∙ 2004-01-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ DENTSPLY CANADA LIMITED;
∙ DIN: 02248488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72840
∙ POSICAINE SP;
∙ articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
∙ 2012-04-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ NOVOCOL PHARMACEUTICAL OF CANADA INC;
∙ DIN: 02381338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86712
∙ ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION;
∙ articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.009 mg / ml;
∙ 2010-04-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PIERREL PHARMA S.R.L.;
∙ DIN: 02339536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82513
∙ ORABLOC 1:200,000;
∙ articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.009 mg / ml;
∙ 2012-06-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PIERREL PHARMA S.R.L.;
∙ DIN: 02361906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84694
∙ ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION;
∙ articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.018 mg / ml;
∙ 2010-04-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PIERREL PHARMA S.R.L.;
∙ DIN: 02339544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82514
∙ ORABLOC 1:100,000;
∙ articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.018 mg / ml;
∙ 2012-06-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PIERREL PHARMA S.R.L.;
∙ DIN: 02361914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84695
∙ MULTI-12/K1 PEDIATRIC;
∙ ascorbic acid (ascorbic acid) 80 mg / vial , vitamin a 2300 unit / vial , vitamin d 400 unit / vial , vitamin b1 (thiamine hydrochloride) 1.2 mg / vial , vitamin b2 (riboflavin-5-phosphate) 1.4 mg / vial , pyridoxine hydrochloride 1 mg / vial , nicotinamide 17 mg / vial , dexpanthenol 5 mg / vial , vitamin e (dl-alpha tocopheryl acetate) 7 unit / vial , vitamin k1 0.2 mg / vial , biotin 20 mcg / vial , folic acid 140 mcg / vial , vitamin b12 (cyanocobalamin) 1 mcg / vial;
∙ 2000-11-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 13.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 88:28.00 – MULTIVITAMIN PREPARATIONS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02242529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66277
∙ MULTI 12 INJECTION;
∙ ascorbic acid 20 mg / ml , vitamin a 660 unit / ml , vitamin d 40 unit / ml , vitamin b1 (thiamine hydrochloride) 0.6 mg / ml , vitamin b2 (riboflavin-5-phosphate) 0.72 mg / ml , nicotinamide 8 mg / ml , pyridoxine hydrochloride 0.8 mg / ml , dexpanthenol 3 mg / ml , vitamin e 2 unit / ml , biotin 12 mcg / ml , folic acid 80 mcg / ml , vitamin b12 (vitamin b12) 1 mcg / ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 12.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 88:28.00 – MULTIVITAMIN PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02100606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16462
∙ AA-ATENIDONE;
∙ atenolol 100 mg , chlorthalidone 25 mg;
∙ 2004-08-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02248764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73132
∙ AA-ATENIDONE;
∙ atenolol 50 mg , chlorthalidone 25 mg;
∙ 2004-08-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02248763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73131
∙ GD-AMLODIPINE/ATORVASTATIN;
∙ atorvastatin (atorvastatin calcium) 20 mg , amlodipine (amlodipine besylate) 5 mg;
∙ 2011-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02362767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84776
∙ MALARONE;
∙ atovaquone 250 mg , proguanil hydrochloride 100 mg;
∙ 1998-08-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02238151
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61542
∙ TEVA-ATOVAQUONE PROGUANIL;
∙ atovaquone 250 mg , proguanil hydrochloride 100 mg;
∙ 2012-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02380927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86668
∙ MYLAN-ATOVAQUONE/PROGUANIL;
∙ atovaquone 250 mg , proguanil hydrochloride 100 mg;
∙ 2013-10-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02402165
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88703
∙ ATOVAQUONE PROGUANIL;
∙ atovaquone 250 mg , proguanil hydrochloride 100 mg;
∙ 2014-05-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02421429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90605
∙ ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS;
∙ atovaquone 250 mg , proguanil hydrochloride 100 mg;
∙ 2017-10-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
∙ Prescription | Prescription;
∙ GLENMARK PHARMACEUTICALS CANADA INC.;
∙ DIN: 02466783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95514
∙ MALARONE PEDIATRIC;
∙ atovaquone 62.5 mg , proguanil hydrochloride 25.0 mg;
∙ 2005-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02264935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75044
∙ INSTANT BRONZER INSTANTANÉ 4 SPRAY GEL SUNSCREEN;
∙ avobenzone 1 % / w/w , octocrylene 1 % / w/w;
∙ 2020-10-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02502062
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99166
∙ SHEER DAILY MOISTURIZER;
∙ avobenzone 1.5 % / w/w , octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w;
∙ 2018-01-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02462133
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94987
∙ COOLA CLASSIC FACE SPF 50 SUNSCREEN LOTION FRAGRANCE-FREE;
∙ avobenzone 1.75 % / w/w , homosalate 5 % / w/w , octisalate 2 % / w/w , octocrylene 5 % / w/w;
∙ 2021-03-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02510804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100000
∙ REVERSA UV CREME VISAGE ET COU FPS 15;
∙ avobenzone 1.8 % , octinoxate 7.5 % , oxybenzone 4 %;
∙ 2002-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DERMTEK PHARMA INC;
∙ DIN: 02244858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68850
∙ PREVENTAGE FIRMING DEFENSE CRÈME NORMAL/DRY BROAD SPECTRUM SPF 15;
∙ avobenzone 1.9 % / w/w , octocrylene 9.4 % / w/w;
∙ 2013-06-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MERLE NORMAN COSMETICS INC;
∙ DIN: 02403552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88834
∙ PREVENTAGE FIRMING DEFENSE CRÈME NORMAL/OILY BROAD SPECTRUM SPF 15;
∙ avobenzone 1.9 % / w/w , octocrylene 9.4 % / w/w;
∙ 2013-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MERLE NORMAN COSMETICS INC;
∙ DIN: 02403560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88835
∙ SUNSCREEN CONTINUOUS SPRAY NO PUMPING NEEDED;
∙ avobenzone 2 % , homosalate 15 % , octisalate 5 % , oxybenzone 4 %;
∙ 2016-03-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02447525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93311
∙ SPORT SUNSCREEN CONTINUOUS SPRAY SPF 15;
∙ avobenzone 2 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w;
∙ 2020-03-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02491044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98106
∙ 30 SPF;
∙ avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
∙ 2017-02-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EMPACK SPRAYTECH INC;
∙ DIN: 02391155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87652
∙ SUNSCREEN SPORT SPF 30;
∙ avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
∙ 2014-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EMPACK SPRAYTECH INC;
∙ DIN: 02393727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87892
∙ RODAN + FIELDS REDEFINE TRIPLE DEFENSE LOTION;
∙ avobenzone 2 % / w/w , homosalate 6.8 % / w/w , octisalate 3.4 % / w/w , octocrylene 4.4 % / w/w;
∙ 2020-09-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02492830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98283
∙ HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRAY SPF 30;
∙ avobenzone 2 % / w/w , homosalate 7 % / w/w , octocrylene 5 % / w/w;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02454602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94131
∙ VITAMIN E MOISTURE-PROTECT LIP CARE;
∙ avobenzone 2 % / w/w , octisalate 5 % / w/w , octocrylene 3 % / w/w;
∙ 2016-08-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE BODY SHOP CANADA LIMITED;
∙ DIN: 02423952
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90868
∙ SUNSCREEN CONTINUOUS SPRAY;
∙ avobenzone 2 % / w/w , octisalate 5 % / w/w , oxybenzone 3 % / w/w , homosalate 10 % / w/w;
∙ 2016-03-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02447649
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93322
∙ LIFE BRAND SPORT SUNSCREEN BROAD SPECTRUM SPRAY;
∙ avobenzone 2 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w , homosalate 15 % / w/w;
∙ 2016-03-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02447509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93309
∙ DRY BALANCE SUNSCREEN SPRAY SPF 30;
∙ avobenzone 2 % / w/w , octocrylene 1.5 % / w/w , homosalate 7 % / w/w , oxybenzone 3 % / w/w;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02456060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94291
∙ INSTANT BRONZER INSTANTANÉ 15;
∙ avobenzone 2 % / w/w , octocrylene 2 % / w/w , octisalate 5 % / w/w;
∙ 2020-10-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02497344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98717
∙ INSTANT BRONZER INSTANTANÉ 15 CONTINUOUS SPRAY SUNSCREEN;
∙ avobenzone 2 % / w/w , octocrylene 2 % / w/w , octisalate 5 % / w/w;
∙ 2020-10-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02501066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99071
∙ COOLA PINA COLADA SCENT SUNSCREEN SPRAY;
∙ avobenzone 2 % / w/w , octocrylene 7 % / w/w , octinoxate 7.5 % / w/w , octisalate 4 % / w/w;
∙ 2017-07-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02458918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94608
∙ COOLA CITRUS MIMOSA SCENT SUNSCREEN SPRAY;
∙ avobenzone 2 % / w/w , octocrylene 7 % / w/w , octinoxate 7.5 % / w/w , octisalate 4 % / w/w;
∙ 2017-07-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02458950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94610
∙ COOLA MAKEUP SETTING SPRAY GREEN TEA SCENT;
∙ avobenzone 2.1 % / w/w , homosalate 3.5 % / w/w , octinoxate 3.5 % / w/w , octisalate 2.8 % / w/w;
∙ 2017-07-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02458942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94609
∙ DRY BALANCE SUNSCREEN LOTION SPF 30;
∙ avobenzone 2.2 % / w/w , homosalate 7 % / w/w , octocrylene 4.2 % / w/w;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02456052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94290
∙ SPF 30 SPRAY-ON ALCOHOL-FREE SUNSCREEN;
∙ avobenzone 2.5 % , octinoxate 7.5 % , octocrylene 7.5 % , octisalate 5 %;
∙ 2012-01-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ WILC HEALTHCARE INC;
∙ DIN: 02375788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86119
∙ RODAN+FIELDS ESSENTIALS LIP SHIELD;
∙ avobenzone 2.5 % / w/w , homosalate 8.0 % / w/w , octisalate 5.0 % / w/w , octocrylene 2.2 % / w/w;
∙ 2016-04-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02407051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89171
∙ MOISTURE SUN PROTECTOR;
∙ avobenzone 2.5 % / w/w , homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 9 % / w/w;
∙ 2018-07-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMOREPACIFIC CORPORATION;
∙ DIN: 02462931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95082
∙ FOUNDATION PRIMER SUNSCREEN BROAD SPECTRUM SPF 15;
∙ avobenzone 2.5 % / w/w , homosalate 9 % / w/w , octocrylene 3 % / w/w , octisalate 5 % / w/w;
∙ 2021-06-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MARY KAY COSMETICS LTD;
∙ DIN: 02507455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99678
∙ CLE DE PEAU BEAUTE 30 SOIN PROTECTEUR UV POUR LES LEVRES;
∙ avobenzone 2.5 % / w/w , oxybenzone 2 % / w/w , octocrylene 3 % / w/w , octinoxate 4.9 % / w/w;
∙ 2017-02-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02450224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93627
∙ ADAPTASUN CRÈME DE SOIN SOLAIRE MER ET TROPIQUES VISAGE FPS/SPF 25;
∙ avobenzone 2.54 % / w/w , octinoxate 6 % / w/w;
∙ 2016-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS;
∙ DIN: 02445581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93087
∙ HAWAIIAN TROPIC OIL SPRAY MOISTURIZING SUNSCREEN SPF 4;
∙ avobenzone 2.8 % , octocrylene 2.2 % , oxybenzone 2 %;
∙ 2017-06-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02446898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93246
∙ RODAN + FIELDS REVERSE BRIGHTENING DEFENSE FLUID LOTION;
∙ avobenzone 2.8 % / w/w , homosalate 9.3 % / w/w , octisalate 4.67 % / w/w , octocrylene 6.1 % / w/w;
∙ 2021-03-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02498081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98788
∙ RODAN + FIELDS ESSENTIALS FACE + BODY SUNSCREEN;
∙ avobenzone 2.8 % / w/w , homosalate 9.6 % / w/w , octisalate 4.8 % / w/w , octocrylene 9.6 % / w/w;
∙ 2020-04-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02491001
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98103
∙ SUNSCREEN OIL;
∙ avobenzone 2.8 g / 100 g , octocrylene 2.2 g / 100 g , oxybenzone 2 g / 100 g;
∙ 2016-04-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Oil | Huile;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02448564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93426
∙ ANEW REVERSALIST COMPLETE RENEWAL DAY LOTION;
∙ avobenzone 2.85 % / w/w , homosalate 8.0 % / w/w , octinoxate 5.0 % / w/w , oxybenzone 4.0 % / w/w;
∙ 2014-03-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02414023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89870
∙ COOLA CLASSIC SPF 50 SUNSCREEN SPRAY FRAGRANCE-FREE;
∙ avobenzone 2.9 % / w/w , homosalate 4.3 % / w/w , octisalate 4.9 % / w/w , octocrylene 9.5 % / w/w;
∙ 2021-03-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02510081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99934
∙ TANNING OIL HUILE BRONZANTE 15;
∙ avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 10 %;
∙ 2018-03-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Oil | Huile;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02471795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96099
∙ SMART TONE BROAD-SPECTRUM SUNSCREEN SPF 50;
∙ avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 10 %;
∙ 2018-12-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ZO SKIN HEALTH INC;
∙ DIN: 02475294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96566
∙ PREMIUM SUNSCREEN SPRAY SUN BUM 30;
∙ avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 3.75 %;
∙ 2019-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02483335
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97377
∙ PREMIUM SUNSCREEN SPRAY SUN BUM 50;
∙ avobenzone 3 % , homosalate 15 % , octisalate 5 % , octocrylene 7 %;
∙ 2019-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02483726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97407
∙ EXTRA-FIRMING JOUR FPS/SPF 15;
∙ avobenzone 3 % , homosalate 9 % , octocrylene 6.5 %;
∙ 2018-12-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLARINS CANADA INC;
∙ DIN: 02481294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97178
∙ CETAPHIL DAILY FACIAL MOISTURIZER SPF 15;
∙ avobenzone 3 % , octocrylene 10 %;
∙ 2001-06-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GALDERMA CANADA INC;
∙ DIN: 02243329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67232
∙ SPORT SUNSCREEN LOTION SPF 50+;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , octocrylene 8 % / w/w;
∙ 2020-02-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02491036
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98105
∙ SPORT SUNSCREEN;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2016-02-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02447630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93321
∙ PREMIUM SUNSCREEN FACE LOTION SUN BUM FACE 50;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2020-04-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02478986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96970
∙ PREMIUM SUNSCREEN LOTION SUN BUM 50;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2019-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02479001
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96972
∙ SPORT SUNSCREEN LOTION SPF 30;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2019-11-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02488485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97857
∙ RODAN + FIELDS UNBLEMISH INVISIBLE MATTE DEFENSE;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2020-03-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02491761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98178
∙ SUNTHERA3 SPF 30 SUN PROTECTION LOTION;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2021-05-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02493403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98342
∙ LIFE BRAND SUNSCREEN LOTION SPF 30;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2021-03-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02497794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98759
∙ SENSITIVE SKIN SUNSCREEN CONTINUOUS SPRAY SPF 30;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2 % / w/w;
∙ 2020-09-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02488469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97855
∙ SPORT SUNSCREEN CONTINUOUS SPRAY SPF 30;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2 % / w/w;
∙ 2019-11-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02490862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98090
∙ SUNTHERA3 SPF 30 CONTINUOUS SPRAY;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2 % / w/w;
∙ 2021-02-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02493071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98306
∙ KIDS SUNSCREEN CONTINUOUS SPRAY SPF 50+;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02488663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97876
∙ SPORT SUNSCREEN CONTINUOUS SPRAY SPF 50+;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
∙ 2020-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02491052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98108
∙ SUNTHERA3 SPORT SPF 50+ CONTINUOUS SPRAY;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
∙ 2021-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02493438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98344
∙ SUNTHERA3 KIDS SPF 50+ CONTINUOUS SPRAY SUNSCREEN BROAD SPECTRUM UVA/UVB PROTECTION;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
∙ 2021-03-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02494183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98422
∙ SUNSCREEN CONTINUOUS SPRAY SPF 50 KIDS;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02494094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98412
∙ KIDS SUNSCREEN LOTION 50+;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02494833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98481
∙ SUNSCREEN CONTINUOUS SPRAY SPF 50;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02495201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98514
∙ SUNSCREEN CONTINUOUS SPRAY SPF 50 SPORT;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02495228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98515
∙ SUNSCREEN FACE STICK / ÉCRAN SOLAIRE BÂTON;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w;
∙ 2021-03-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02500612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99028
∙ SCALP MIST;
∙ avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 4 % / w/w , octisalate 5 % / w/w;
∙ 2020-12-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02506068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99541
∙ KIDS SUNSCREEN LOTION SPF 50+;
∙ avobenzone 3 % / w/w , homosalate 13 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2020-06-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02490382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98043
∙ SUNTHERA3 BABY SPF 50+ SUN PROTECTION LOTION;
∙ avobenzone 3 % / w/w , homosalate 13 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2021-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02494221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98426
∙ LIFE BRAND KIDS SUNSCREEN LOTION SPF 50+;
∙ avobenzone 3 % / w/w , homosalate 13 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2021-04-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02497727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98752
∙ SENSITIVE SKIN SUNSCREEN LOTION SPF 50+;
∙ avobenzone 3 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2020-01-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02491028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98104
∙ SUNTHERA3 SPF 50+ SUN PROTECTION LOTION;
∙ avobenzone 3 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2021-04-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02493101
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98308
∙ OLAY UV MOISTURIZING CREAM;
∙ avobenzone 3 % / w/w , homosalate 4 % / w/w , octisalate 4.5 % / w/w , octocrylene 2.6 % / w/w;
∙ 2016-01-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02442779
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92717
∙ OLAY AGE DEFYING ANTI WRINKLE DAY LOTION WITH SPF 15;
∙ avobenzone 3 % / w/w , homosalate 4 % / w/w , octisalate 4.5 % / w/w , octocrylene 2.6 % / w/w;
∙ 2016-01-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02444208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92910
∙ PREMIUM SUNSCREEN LOTION SUN BUM 30;
∙ avobenzone 3 % / w/w , homosalate 5 % / w/w , octisalate 3 % / w/w , octocrylene 10 % / w/w;
∙ 2019-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02478994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96971
∙ LIFTACTIV SPECIALIST FPS/SPF 30;
∙ avobenzone 3 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
∙ 2021-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02498642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98839
∙ SPORT 30 CONTINUOUS SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR;
∙ avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2019-11-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02492261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98230
∙ SUNSCREEN CONTINUOUS SPRAY SPF 30;
∙ avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02494108
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98413
∙ SUNSCREEN LOTION 30 SPF/FPS SPORT;
∙ avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02494825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98480
∙ SHEER OIL FREE SUNSCREEN LOTION 30 SPF/FPS;
∙ avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02494981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98495
∙ INSTANT BRONZER INSTANTANÉ 30 CONTINUOUS SPRAY SUNSCREEN;
∙ avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w;
∙ 2020-10-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02501058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99070
∙ INSTANT BRONZER INSTANTANÉ 30 SPRAY GEL SUNSCREEN;
∙ avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w;
∙ 2020-10-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02502054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99165
∙ OLAY LUMINOUS WHIP;
∙ avobenzone 3 % / w/w , homosalate 8 % / w/w , octisalate 4 % / w/w , octocrylene 5 % / w/w;
∙ 2018-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02463911
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95201
∙ COPPERTONE LOTION SUNSCREEN SPF 30 SPORT;
∙ avobenzone 3 % / w/w , homosalate 8 % / w/w , octisalate 4.5 % / w/w , octocrylene 6 % / w/w;
∙ 2016-10-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02452804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93921
∙ MOISTURE THERAPY LIP BALM SPF 25;
∙ avobenzone 3 % / w/w , octinoxate 7.5 % / w/w;
∙ 2013-07-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JACK BLACK LLC;
∙ DIN: 02381753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86761
∙ OLAY REGENERIST MICRO-SCULPTING CREAM WITH SUNSCREEN BROAD SPECTRUM SPF 30;
∙ avobenzone 3 % / w/w , octinoxate 7.5 % / w/w;
∙ 2016-07-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02436450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92079
∙ NIVEA MEN SENSITIVE;
∙ avobenzone 3 % / w/w , octisalate 4.7 % / w/w , octocrylene 8.4 % / w/w;
∙ 2021-03-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02507692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99705
∙ CLINIQUE SMART SPF 15 CUSTOM-REPAIR MOISTURIZER COMBINATION OILY TO OILY;
∙ avobenzone 3 % / w/w , octisalate 5 % / w/w;
∙ 2016-01-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02440083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92447
∙ ARTISTRY SKIN NUTRITION BALANCING MATTE DAY LOTION;
∙ avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
∙ 2021-04-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMWAY CORP.;
∙ DIN: 02502968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99248
∙ RODAN + FIELDS REDEFINE TRIPLE DEFENSE CREAM;
∙ avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
∙ 2020-09-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02492849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98284
∙ ARTISTRY SKIN NUTRITION HYDRATING DAY LOTION;
∙ avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
∙ 2021-04-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMWAY CORP.;
∙ DIN: 02502976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99249
∙ NO7 LIFT & LUMINATE TRIPLE ACTION DAY CREAM;
∙ avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 7.5 % / w/w;
∙ 2018-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE BOOTS COMPANY PLC;
∙ DIN: 02460300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94759
∙ SPF 50+ FPS FACE/ VISAGE;
∙ avobenzone 3 % / w/w , octocrylene 7.5 % / w/w , octisalate 5 % / w/w , octinoxate 4.5 % / w/w;
∙ 2020-08-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EMPACK SPRAYTECH INC;
∙ DIN: 02496321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98621
∙ POSITIVELY RADIANT DAILY MOISTURIZER SPF 15;
∙ avobenzone 3.0 % , octinoxate 7.5 % , octisalate 2.0 %;
∙ 2004-12-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02250942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73587
∙ HYDRAPHASE UV INTENSE;
∙ avobenzone 3.0 % / w/w , homosalate 4.7 % / w/w , octisalate 5.0 % / w/w , octocrylene 7.0 % / w/w;
∙ 2011-08-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02362058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84707
∙ EDARBYCLOR;
∙ azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg , chlorthalidone 12.5 mg;
∙ 2013-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02397749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88267
∙ EDARBYCLOR;
∙ azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg , chlorthalidone 25 mg;
∙ 2013-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02397765
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88269
∙ OZONOL ANTIBIOTICS PLUS;
∙ bacitracin 500 unit / g , lidocaine hydrochloride 40 mg / g , polymyxin b (polymyxin b sulfate) 10000 unit / g;
∙ 1998-05-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ EXZELL PHARMA INC;
∙ DIN: 02236917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60209
∙ JAMPOLYCIN;
∙ bacitracin 500 unit / g , polymyxin b sulfate 10000 unit / g;
∙ 2013-12-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02357569
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84267
∙ POLY ANTIBIOTIC OINTMENT;
∙ bacitracin 500 unit / g , polymyxin b sulfate 10000 unit / g;
∙ 2021-03-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02510383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99961
∙ POLYDERM OINTMENT USP;
∙ bacitracin zinc 500 unit / g , polymyxin b sulfate 10000 unit / g;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02181908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20134
∙ ANTIBIOTIC OINTMENT USP;
∙ bacitracin zinc 500 unit / g , polymyxin b sulfate 10000 unit / g;
∙ 2002-06-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02230251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48982
∙ STERISPORIN;
∙ bacitracin zinc 500 unit / g , polymyxin b sulfate 10000 unit / g;
∙ 2017-05-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Ointment | Pommade;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Otc | En Vente Libre;
∙ STERI-MED PHARMA INC.;
∙ DIN: 02359928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84489
∙ FOOTWORKS HEALTHY CRACKED HEEL CREAM;
∙ benzalkonium chloride 0.13 % / w/w , lidocaine 4 % / w/w;
∙ 2013-05-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 72:00.00 – LOCAL ANESTHETICS , 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02397587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88252
∙ CETACAINE LIQUID;
∙ benzocaine 14 % , butamben 2 % , tetracaine hydrochloride 2 %;
∙ 1996-09-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ CETYLITE INDUSTRIES INC.;
∙ DIN: 02028867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26564
∙ AURALGAN;
∙ benzocaine 14 mg / ml , antipyrine 54 mg / ml;
∙ 2011-02-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Otic | Otique;
∙ Solution | Solution;
∙ 52:16.00 – LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ PALADIN LABS INC.;
∙ DIN: 02332477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81814
∙ ZAP TOPICAL ANESTHETIC GEL;
∙ benzocaine 18 % , tetracaine hydrochloride 2 %;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ GERMIPHENE CORPORATION;
∙ DIN: 01930699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13347
∙ ONE TOUCH TOPICAL ANESTHETIC GEL;
∙ benzocaine 18 % , tetracaine hydrochloride 2 %;
∙ 1998-04-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Buccal | Buccale;
∙ Gel | Gel;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ABJ CUSTOM PACKAGING;
∙ DIN: 02230958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50238
∙ PROACTIV 3-STEP CONVENIENCE PAK;
∙ benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
∙ 2013-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel , Kit | Gel , Trousse;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ THE PROACTIV COMPANY, LLC;
∙ DIN: 02406179
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89090
∙ PROACTIV 3 PIECE SET;
∙ benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
∙ 2014-06-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel , Kit | Gel , Trousse;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ THE PROACTIV COMPANY, LLC;
∙ DIN: 02414422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89901
∙ ACTIVE ANTI-ACNE TREATMENT KIT;
∙ benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
∙ 2015-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Kit , Lotion | Trousse , Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02444054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92884
∙ CLINDOXYL ADV GEL;
∙ benzoyl peroxide 3 % / w/w , clindamycin (clindamycin phosphate) 1 % / w/w;
∙ 2013-08-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.04 – ANTIBIOTICS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02382822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86863
∙ STUBBORN ACNE SOLUTION;
∙ benzoyl peroxide 3.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
∙ 2017-01-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel , Kit , Paste | Gel , Trousse , Pâte;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02457938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94496
∙ RODAN+FIELDS SPOTLESS;
∙ benzoyl peroxide 5 % , benzoyl peroxide 2.5 %;
∙ 2019-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Kit , Lotion , Cream | Trousse , Lotion , Crème;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02469707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95852
∙ CLINDOXYL GEL;
∙ benzoyl peroxide 5 % / w/w , clindamycin (clindamycin phosphate) 1 % / w/w;
∙ 2001-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.04 – ANTIBIOTICS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02243158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67033
∙ TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL;
∙ benzoyl peroxide 5 % / w/w , clindamycin (clindamycin phosphate) 1 % / w/w;
∙ 2015-08-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.04 – ANTIBIOTICS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02440180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92456
∙ ACNE TREATMENT SYSTEM;
∙ benzoyl peroxide 5 % / w/w , salicylic acid 2 % / w/w;
∙ 2013-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Kit , Liquid , Lotion | Trousse , Liquide , Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ VIVIER CANADA INCORPORATED;
∙ DIN: 02402149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88701
∙ LOTRIDERM;
∙ betamethasone (betamethasone dipropionate) 0.05 % , clotrimazole 1 %;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.08 – AZOLES;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00611174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10748
∙ TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE;
∙ betamethasone (betamethasone dipropionate) 0.05 % / w/w , clotrimazole 1 % / w/w;
∙ 2020-04-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.08 – AZOLES;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02496410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98629
∙ ENSTILAR;
∙ betamethasone (betamethasone dipropionate) 0.5 mg / g , calcipotriol (calcipotriol monohydrate) 50 mcg / g;
∙ 2016-11-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Aerosol, Foam | Aérosol, Mousse;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 02457393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94445
∙ TEVA-BETAMETHASONE/ CALCIPOTRIOL;
∙ betamethasone (betamethasone dipropionate) 0.5 mg / g , calcipotriol 50 mcg / g;
∙ 2020-08-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02427419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91194
∙ RATIO-TOPISALIC;
∙ betamethasone (betamethasone dipropionate) 0.5 mg / g , salicylic acid 20 mg / g;
∙ 2002-05-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02245688
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69789
∙ DIPROSALIC;
∙ betamethasone (betamethasone dipropionate) 0.5 mg / g , salicylic acid 30 mg / g;
∙ 1983-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00578436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5287
∙ VALISONE-G;
∙ betamethasone (betamethasone valerate) 0.1 % / w/w , gentamicin (gentamicin sulfate) 0.1 % / w/w;
∙ 1972-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 00232351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1285
∙ CELESTONE SOLUSPAN;
∙ betamethasone acetate 3 mg / ml , betamethasone (betamethasone sodium phosphate) 3 mg / ml;
∙ 1965-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intra-Articular , Intrabursal , Intradermal , Intramuscular | Intra-Articulaire , Intrabursique , Intradermique , Intramusculaire;
∙ Suspension | Suspension;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00028096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=354
∙ BIKTARVY;
∙ bictegravir (bictegravir sodium) 50 mg , emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
∙ 2018-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02478579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96935
∙ STOMACH RELIEF CHEWABLE TABLETS;
∙ bismuth subsalicylate 262 mg , calcium carbonate 350 mg;
∙ 2013-11-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ GUARDIAN DRUG COMPANY INC;
∙ DIN: 02389215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87472
∙ PHOTODERM SPF/FPS 50+ CRÈME;
∙ bisoctrizole 6 % , octocrylene 10 % , bemotrizinol 2.5 % , avobenzone 5 %;
∙ 2012-02-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS CANADA INC.;
∙ DIN: 02354489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83965
∙ PHOTODERM SPF/FPS 50+ LAIT;
∙ bisoctrizole 6 % , octocrylene 10 % , bemotrizinol 2.5 % , avobenzone 5 %;
∙ 2012-02-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS CANADA INC.;
∙ DIN: 02354497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83966
∙ PHOTODERM SPF/FPS 40 SPRAY;
∙ bisoctrizole 6 % , octocrylene 8 % , avobenzone 4.5 %;
∙ 2012-02-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS CANADA INC.;
∙ DIN: 02354500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83967
∙ REXULTI;
∙ brexpiprazole 0.5 mg , brexpiprazole 1 mg;
∙ 2019-06-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02485923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97617
∙ ALUNBRIG;
∙ brigatinib 90 mg , brigatinib 180 mg;
∙ 2018-08-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02479230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96985
∙ COMBIGAN;
∙ brimonidine tartrate 0.2 % , timolol (timolol maleate) 0.5 %;
∙ 2003-12-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.04 – ALPHA-ADRENERGIC AGONISTS , 52:40.08 – BETA-ADRENERGIC AGENTS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02248347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72692
∙ SIMBRINZA;
∙ brinzolamide 1 % / w/v , brimonidine tartrate 0.2 % / w/v;
∙ 2015-02-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Suspension | Suspension;
∙ 52:40.04 – ALPHA-ADRENERGIC AGONISTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02435411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91973
∙ ROBITUSSIN CHILDREN’S COUGH & COLD BEDTIME;
∙ brompheniramine maleate 2 mg / 5 ml , phenylephrine hydrochloride 5 mg / 5 ml , dextromethorphan hydrobromide 10 mg / 5 ml;
∙ 2013-07-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02394707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87985
∙ SYMBICORT 100 TURBUHALER;
∙ budesonide 100 mcg / act , formoterol fumarate dihydrate 6 mcg / act;
∙ 2002-02-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02245385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69428
∙ ENTOCORT ENEMA;
∙ budesonide 2.3 mg , sodium chloride 115 ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal | Rectale;
∙ Enema , Kit , Tablet | Lavement , Trousse , Comprimé;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TILLOTTS PHARMA GMBH;
∙ DIN: 02052431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16264
∙ SYMBICORT 200 TURBUHALER;
∙ budesonide 200 mcg / act , formoterol fumarate dihydrate 6 mcg / act;
∙ 2002-02-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02245386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69429
∙ MARCAINE E;
∙ bupivacaine hydrochloride 100 mg / 20 ml , epinephrine bitartrate 0.182 mg / 20 ml;
∙ 2001-07-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration , Epidural | Bloc/Infiltration , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 02241916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65586
∙ SENSORCAINE WITH EPINEPHRINE;
∙ bupivacaine hydrochloride 5 mg / ml , epinephrine (epinephrine bitartrate) 5 mcg / ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration , Epidural | Bloc/Infiltration , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 01976206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16163
∙ VIVACAINE;
∙ bupivacaine hydrochloride 5 mg / ml , epinephrine bitartrate 0.0091 mg / ml;
∙ 2008-04-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT INC;
∙ DIN: 02305135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79063
∙ BUPIVACAINE HCL 0.5% AND EPINEPHRINE 1:200,000 INJECTION;
∙ bupivacaine hydrochloride 5 mg / ml , epinephrine bitartrate 0.0091 mg / ml;
∙ 2012-05-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ NOVOCOL PHARMACEUTICAL OF CANADA INC;
∙ DIN: 02381850
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86769
∙ MARCAINE;
∙ bupivacaine hydrochloride 5 mg / ml , epinephrine bitartrate 0.0091 mg / ml;
∙ 2019-04-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT INC;
∙ DIN: 02474247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96430
∙ MARCAINE E;
∙ bupivacaine hydrochloride 50 mg / 20 ml , epinephrine bitartrate 0.182 mg / 20 ml;
∙ 2001-07-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration , Epidural | Bloc/Infiltration , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 02241915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65585
∙ SUBOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 12 mg , naloxone (naloxone hydrochloride dihydrate) 3 mg;
∙ 2018-02-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02468085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95646
∙ SUBOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 12 mg , naloxone (naloxone hydrochloride) 3 mg;
∙ 2021-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Buccal , Sublingual | Buccale , Sublinguale;
∙ Film, Soluble | Pellicule, Soluble;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02502356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99192
∙ SUBOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 16 mg , naloxone (naloxone hydrochloride dihydrate) 4 mg;
∙ 2018-02-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02468093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95647
∙ SUBOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride dihydrate) 0.5 mg;
∙ 2007-11-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02295695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78104
∙ PMS-BUPRENORPHINE-NALOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride dihydrate) 0.5 mg;
∙ 2014-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PHARMASCIENCE INC;
∙ DIN: 02424851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90952
∙ TEVA-BUPRENORPHINE/NALOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride dihydrate) 0.5 mg;
∙ 2017-09-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02453908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94043
∙ SUBOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride) 0.5 mg;
∙ 2021-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Buccal , Sublingual | Buccale , Sublinguale;
∙ Film, Soluble | Pellicule, Soluble;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02502313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99189
∙ SUBOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 4 mg , naloxone (naloxone hydrochloride) 1 mg;
∙ 2021-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Buccal , Sublingual | Buccale , Sublinguale;
∙ Film, Soluble | Pellicule, Soluble;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02502321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99190
∙ SUBOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride dihydrate) 2 mg;
∙ 2007-11-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02295709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78105
∙ PMS-BUPRENORPHINE-NALOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride dihydrate) 2 mg;
∙ 2014-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PHARMASCIENCE INC;
∙ DIN: 02424878
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90953
∙ SUBOXONE;
∙ buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride) 2 mg;
∙ 2021-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Buccal , Sublingual | Buccale , Sublinguale;
∙ Film, Soluble | Pellicule, Soluble;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02502348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99191
∙ FIORINAL;
∙ butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
∙ 1971-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.04 – BARBITURATES , 28:08.04.24 – SALICYLATES;
∙ Schedule G (Cdsa Iv) | Annexe G (Lrcdas Iv);
∙ ARALEZ PHARMACEUTICALS CANADA INC;
∙ DIN: 00226327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1233
∙ TEVA-TECNAL;
∙ butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
∙ 1984-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES;
∙ Schedule G (Cdsa Iv) | Annexe G (Lrcdas Iv);
∙ TEVA CANADA LIMITED;
∙ DIN: 00608211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5779
∙ TEVA-TECNAL;
∙ butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
∙ 1985-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS , 28:08.04.24 – SALICYLATES;
∙ Schedule G (Cdsa Iv) | Annexe G (Lrcdas Iv);
∙ TEVA CANADA LIMITED;
∙ DIN: 00608238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6480
∙ TRIANAL TABLET;
∙ butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
∙ 1997-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES;
∙ Schedule G (Cdsa Iv) | Annexe G (Lrcdas Iv);
∙ LABORATOIRE RIVA INC.;
∙ DIN: 01971409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=23671
∙ TEVA-TECNAL C 1/2;
∙ butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg , codeine phosphate 30 mg;
∙ 1984-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.04.24 – SALICYLATES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00608181
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6419
∙ CABENUVA;
∙ cabotegravir 200 mg / ml , rilpivirine 300 mg / ml;
∙ 2020-09-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension (Extended-Release) , Kit | Suspension (À Libération Prolongée) , Trousse;
∙ 08:18.08.12 – HIV INTEGRASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02497220
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98706
∙ TEVA-LENOLTEC NO. 3;
∙ caffeine 15 mg , codeine phosphate 30 mg , acetaminophen 300 mg;
∙ 1985-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00653276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6346
∙ TEVA-TECNAL C 1/4;
∙ caffeine 40 mg , acetylsalicylic acid 330 mg , codeine phosphate 15 mg , butalbital 50 mg;
∙ 1984-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.04.24 – SALICYLATES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00608203
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6479
∙ AVEENO ANTI-ITCH LOTION;
∙ calamine 3.0 % , pramoxine hydrochloride 1.0 %;
∙ 2000-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02240105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63620
∙ CALAMINE LOTION WITH ANTIHISTAMINE;
∙ calamine 8 % , diphenhydramine hydrochloride 1 %;
∙ 1981-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Suspension | Suspension;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 00538493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41558
∙ LOTION CALAMINE AVEC ANTIHISTAMINIQUE;
∙ calamine 8 % , diphenhydramine hydrochloride 1 %;
∙ 2000-10-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Suspension | Suspension;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 02241462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65100
∙ DOVOBET GEL;
∙ calcipotriol (calcipotriol monohydrate) 50 mcg / g , betamethasone (betamethasone dipropionate) 0.5 mg / g;
∙ 2009-01-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 02319012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80450
∙ DOVOBET OINTMENT;
∙ calcipotriol 50 mcg / g , betamethasone (betamethasone dipropionate) 0.5 mg / g;
∙ 2001-11-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 02244126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68084
∙ DIOVOL PLUS ALUMINUM FREE SUSPENSION;
∙ calcium carbonate 200 mg / 5 ml , magnesium hydroxide 200 mg / 5 ml , simethicone 25 mg / 5 ml;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 02157616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19082
∙ PEPTO-BISMOL CHEWABLES;
∙ calcium carbonate 350 mg , bismuth subsalicylate 262 mg;
∙ 2000-02-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02237315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60637
∙ INVOKAMET;
∙ canagliflozin 150 mg , metformin hydrochloride 1000 mg;
∙ 2016-06-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02455455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94226
∙ INVOKAMET;
∙ canagliflozin 150 mg , metformin hydrochloride 500 mg;
∙ 2016-06-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02455439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94224
∙ INVOKAMET;
∙ canagliflozin 50 mg , metformin hydrochloride 1000 mg;
∙ 2016-06-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02455420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94223
∙ INVOKAMET;
∙ canagliflozin 50 mg , metformin hydrochloride 500 mg;
∙ 2016-06-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02455404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94221
∙ ATACAND PLUS;
∙ candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
∙ 2001-06-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02244021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67964
∙ SANDOZ CANDESARTAN PLUS;
∙ candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-09-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02327902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81340
∙ CANDESARTAN/HCTZ;
∙ candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-11-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02394804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87995
∙ CANDESARTAN HCT;
∙ candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-10-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02394812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87997
∙ TEVA-CANDESARTAN/HCTZ;
∙ candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
∙ 2013-09-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02395541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88063
∙ AURO-CANDESARTAN HCT;
∙ candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
∙ 2015-03-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02421038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90562
∙ JAMP CANDESARTAN-HCT;
∙ candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
∙ 2020-02-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02473240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96264
∙ PMS-CANDESARTAN HCTZ;
∙ candesartan cilexetil 16.0 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-09-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02391295
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87664
∙ CANDESARTAN-HCTZ;
∙ candesartan cilexetil 16.0 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-10-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02392275
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87755
∙ ATACAND PLUS;
∙ candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
∙ 2009-09-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02332922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81858
∙ TEVA-CANDESARTAN/HCTZ;
∙ candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
∙ 2013-06-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02395568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88064
∙ SANDOZ CANDESARTAN PLUS;
∙ candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
∙ 2014-02-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02420732
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90530
∙ AURO-CANDESARTAN HCT;
∙ candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
∙ 2015-03-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02421046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90563
∙ JAMP CANDESARTAN-HCT;
∙ candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
∙ 2020-02-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02473259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96265
∙ ATACAND PLUS;
∙ candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
∙ 2009-09-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02332957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81859
∙ SANDOZ CANDESARTAN PLUS;
∙ candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
∙ 2014-02-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02420740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90531
∙ AURO-CANDESARTAN HCT;
∙ candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
∙ 2015-03-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02421054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90564
∙ JAMP CANDESARTAN-HCT;
∙ candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
∙ 2020-02-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02473267
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96266
∙ DUODOPA;
∙ carbidopa (carbidopa monohydrate) 5 mg / ml , levodopa 20 mg / ml;
∙ 2008-11-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intraintestinal (Upper) | Intraintestinale (Supérieur);
∙ Gel | Gel;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ ABBVIE CORPORATION;
∙ DIN: 02292165
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77753
∙ APO-LEVOCARB – TAB 10MG/100MG;
∙ carbidopa 10 mg , levodopa 100 mg;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02195933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20189
∙ TEVA-LEVOCARBIDOPA;
∙ carbidopa 10 mg , levodopa 100 mg;
∙ 2002-07-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02244494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68470
∙ APO-LEVOCARB-TAB 25MG/100MG;
∙ carbidopa 25 mg , levodopa 100 mg;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02195941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20239
∙ TEVA-LEVOCARBIDOPA;
∙ carbidopa 25 mg , levodopa 100 mg;
∙ 2002-07-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02244495
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68471
∙ APO-LEVOCARB – TAB 25MG/250MG;
∙ carbidopa 25 mg , levodopa 250 mg;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02195968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20190
∙ TEVA-LEVOCARBIDOPA;
∙ carbidopa 25 mg , levodopa 250 mg;
∙ 2002-07-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02244496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68472
∙ CARBON DIOXIDE 7.1% W OXYGEN;
∙ carbon dioxide 12 % , oxygen 88 %;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 00882755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11058
∙ CARBON DIOXIDE, COMPRESSED AIR MEDICAL G.MIX.;
∙ carbon dioxide 15 % , air 85 %;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 02014343
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13896
∙ CARBOGEN;
∙ carbon dioxide 50 % , oxygen 50 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ MESSER CANADA INC.;
∙ DIN: 02154749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19293
∙ CARBON DIOXIDE USP, OXYGEN USP MEDICAL G.M.;
∙ carbon dioxide 7 % , oxygen 93 %;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 02014432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13910
∙ CO-HE-O2-N2 MIXTURE;
∙ carbon monoxide 0.3 % , helium 10.0 % , oxygen 21.0 % , nitrogen 68.7 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ MESSER CANADA INC.;
∙ DIN: 02154773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19101
∙ CARBON MONOX, HELIUM, OXYGEN, NITROGEN L.D.M.;
∙ carbon monoxide 0.3 % , helium 10.5 % , oxygen 21.5 % , nitrogen 67.7 %;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 02014424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13920
∙ LUNG DIFFUSION TEST MIX NO NE CO;
∙ carbon monoxide 0.3 % , neon 0.5 % , oxygen 21 % , nitrogen 78.2 %;
∙ 1968-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 00588075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8185
∙ CO-NE-O2-N2 MIXTURE;
∙ carbon monoxide 0.3 % / v/v , neon 0.5 % / v/v , oxygen 21 % / v/v , nitrogen 78.2 % / v/v;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ MESSER CANADA INC.;
∙ DIN: 02182238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19100
∙ REFRESH OPTIVE FUSION;
∙ carboxymethylcellulose sodium 0.5 % , glycerine 0.9 %;
∙ 2015-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02435578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91991
∙ REFRESH OPTIVE ADVANCED;
∙ carboxymethylcellulose sodium 0.5 % , glycerine 1.0 % , polysorbate 80 0.5 %;
∙ 2013-03-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02399148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88404
∙ REFRESH OPTIVE FUSION SENSITIVE;
∙ carboxymethylcellulose sodium 0.5 % / w/v , glycerine 1 % / w/v;
∙ 2016-04-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02450534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93669
∙ REFRESH OPTIVE ADVANCED SENSITIVE;
∙ carboxymethylcellulose sodium 0.5 % / w/v , glycerine 1.0 % / w/v , polysorbate 80 0.5 % / w/v;
∙ 2014-10-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Ophthalmic | Ophtalmique;
∙ Emulsion | Émulsion;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02425815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91045
∙ REFRESH OPTIVE GEL DROPS;
∙ carboxymethylcellulose sodium 1 % / w/v , glycerine 0.9 % / w/v;
∙ 2017-07-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02463652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95175
∙ ORABASE PASTE;
∙ carboxymethylcellulose sodium 13.3 % , gelatin 13.3 % , pectin 13.3 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral , Topical | Orale , Topique;
∙ Paste | Pâte;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Otc | En Vente Libre;
∙ CONVATEC CANADA LTD.;
∙ DIN: 02035286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42486
∙ CASIRIVIMAB AND IMDEVIMAB;
∙ casirivimab 1332 mg / 11.1 ml , imdevimab 1332 mg / 11.1 ml;
∙ 2021-07-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:18.24 – MONOCLONAL ANTIBODIES;
∙ Covid-19 – Io – Authorization , Prescription , Schedule D | Covid-19 – Au – Autorisation , Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02516705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100603
∙ ZERBAXA;
∙ ceftolozane (ceftolozane sulfate) 1 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
∙ 2016-01-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02446901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93248
∙ REACTINE COMPLETE;
∙ cetirizine hydrochloride 5 mg , pseudoephedrine hydrochloride 120 mg;
∙ 2003-03-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02246162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70312
∙ LIBRAX;
∙ chlordiazepoxide hydrochloride 5 mg , clidinium bromide 2.5 mg;
∙ 1961-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 00115630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=728
∙ CHLORAX;
∙ chlordiazepoxide hydrochloride 5 mg , clidinium bromide 2.5 mg;
∙ 1984-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00618454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6283
∙ STERIGEL PLUS;
∙ chlorhexidine gluconate 0.5 % , alcohol anhydrous 70 %;
∙ 1999-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02240800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64391
∙ SOLUPREP QD WIPE;
∙ chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02060019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16494
∙ SOLUPREP QD SWAB;
∙ chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
∙ 1996-09-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Swab | Coton-Tige;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02119803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=30398
∙ CHLORHEXIDINE AND ISOPROPYL ALCOHOL SWABSTICKS;
∙ chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
∙ 2001-06-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Swab | Coton-Tige;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ PROFESSIONAL DISPOSABLES INTERNATIONAL INC.;
∙ DIN: 02243002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66842
∙ CHLORHEXIDINE AND ISOPROPYL ALCOHOL PREP PADS;
∙ chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
∙ 2001-06-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Pad | Compresse;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ PROFESSIONAL DISPOSABLES INTERNATIONAL INC.;
∙ DIN: 02243003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66843
∙ DEXIDIN 0.5 SOLUTION;
∙ chlorhexidine gluconate 0.5 % , isopropyl alcohol 70.0 %;
∙ 2000-02-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 02240680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64263
∙ SOLUPREP QD SOLUTION;
∙ chlorhexidine gluconate 0.5 % / w/v , isopropyl alcohol 70 % / v/v;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Solution , Sponge | Solution , Éponge;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02116472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19626
∙ AVAGARD CHG;
∙ chlorhexidine gluconate 1 % , alcohol anhydrous 61 %;
∙ 2003-07-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Lotion | Lotion;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02246888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71113
∙ STANHEXIDINE 2% WITH ISOPROPYL ALCOHOL 4%;
∙ chlorhexidine gluconate 2 % , isopropyl alcohol 4 %;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 01938991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13289
∙ STANHEXIDINE AQUEOUS 2% WITH 4% ISOPROPYL ALCOHOL;
∙ chlorhexidine gluconate 2 % , isopropyl alcohol 4 %;
∙ 2002-12-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02246950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71177
∙ BAXEDIN 2% – 70%;
∙ chlorhexidine gluconate 2 % , isopropyl alcohol 70 %;
∙ 2004-07-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02251477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73640
∙ CHLORAPREP ONE-STEP;
∙ chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
∙ 1998-08-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ CAREFUSION CANADA ULC;
∙ DIN: 02160757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34222
∙ SOLUPREP SWAB;
∙ chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
∙ 2012-12-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Swab | Coton-Tige;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02382040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86791
∙ SOLUPREP WIPE;
∙ chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
∙ 2013-01-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02385708
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87132
∙ 3M SOLUPREP SPONGE;
∙ chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
∙ 2013-09-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Sponge | Éponge;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02404125
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88890
∙ CHLORAPREP;
∙ chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
∙ 2019-11-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ BECTON DICKINSON CANADA INC.;
∙ DIN: 02484374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97469
∙ LORIS – I.V.;
∙ chlorhexidine gluconate 2.0 % , isopropyl alcohol 70 %;
∙ 2009-02-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Swab | Coton-Tige;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LERNAPHARM (LORIS) INC.;
∙ DIN: 02297442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78280
∙ SOLUPREP;
∙ chlorhexidine gluconate 2.0 % / w/v , isopropyl alcohol 70 % / v/v;
∙ 2002-08-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02240356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63898
∙ SOLUPREP APPLICATOR;
∙ chlorhexidine gluconate 2.0 % / w/v , isopropyl alcohol 70.0 % / v/v;
∙ 2013-01-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02382113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86799
∙ STANHEXIDINE 4% WITH ISOPROPYL ALCOHOL 4%;
∙ chlorhexidine gluconate 4 % , isopropyl alcohol 4 %;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 01938983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13290
∙ CHILDREN’S TYLENOL COLD AND COUGH;
∙ chlorpheniramine maleate 1 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml , acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
∙ 1997-08-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02039990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26864
∙ BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER;
∙ chlorpheniramine maleate 1 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml , acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
∙ 2008-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02305496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79105
∙ CHILDREN’S TYLENOL COMPLETE COLD, COUGH & FEVER;
∙ chlorpheniramine maleate 1 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml , acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
∙ 2012-08-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02376474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86193
∙ EXTRA STRENGTH COLD MEDICATION NIGHTTIME RELIEF;
∙ chlorpheniramine maleate 2 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02039842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17887
∙ BUCKLEY’S COMPLETE EXTRA STRENGTH COUGH, COLD AND FLU NIGHT;
∙ chlorpheniramine maleate 2 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
∙ 2000-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02241592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65249
∙ VICKS CHILDREN’S NYQUIL COLD & COUGH MULTI-SYMPTOM RELIEF;
∙ chlorpheniramine maleate 2 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml;
∙ 2006-07-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02273330
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75882
∙ COLDASIDE COUGH & COLD;
∙ chlorpheniramine maleate 4 mg , dextromethorphan hydrobromide 30 mg;
∙ 2009-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02309440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79504
∙ NEOCITRAN ULTRA STRENGTH TOTAL FLU NIGHT;
∙ chlorpheniramine maleate 4 mg / sachet , dextromethorphan hydrobromide 30 mg / sachet , acetaminophen 1000 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet;
∙ 1998-08-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02217147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37105
∙ ACETAZONE FORTE C8;
∙ chlorzoxazone 250 mg , acetaminophen 300 mg , codeine phosphate 8 mg;
∙ 1991-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00834319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11339
∙ MICRO PLUS 4 REGULAR STRENGTH;
∙ chromium (chromic chloride) 4 mcg / ml , zinc (zinc sulfate) 1 mg / ml , copper (cupric sulfate) .4 mg / ml , manganese (manganese sulfate) .1 mg / ml;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02091135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19923
∙ INHIBACE PLUS;
∙ cilazapril (cilazapril monohydrate) 5 mg , hydrochlorothiazide 12.5 mg;
∙ 1999-04-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 02181479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44252
∙ APO-CILAZAPRIL/HCTZ;
∙ cilazapril (cilazapril monohydrate) 5 mg , hydrochlorothiazide 12.5 mg;
∙ 2006-08-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02284987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77051
∙ TEVA-CILAZAPRIL/HCTZ;
∙ cilazapril (cilazapril monohydrate) 5 mg , hydrochlorothiazide 12.5 mg;
∙ 2009-03-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02313731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79924
∙ CIPRODEX;
∙ ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , dexamethasone 0.1 % / w/v;
∙ 2004-05-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Otic | Otique;
∙ Suspension | Suspension;
∙ 52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02252716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73758
∙ TARO-CIPROFLOXACIN/DEXAMETHASONE;
∙ ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , dexamethasone 0.1 % / w/v;
∙ 2020-11-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Otic | Otique;
∙ Suspension | Suspension;
∙ 52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02481901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97239
∙ SANDOZ CIPROFLOXACIN / DEXAMETHASONE;
∙ ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , dexamethasone 0.1 % / w/v;
∙ 2021-01-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Otic | Otique;
∙ Suspension | Suspension;
∙ 52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02506882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99623
∙ OTIXAL;
∙ ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , fluocinolone acetonide 0.025 % / w/v;
∙ 2017-05-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Otic | Otique;
∙ Solution | Solution;
∙ 52:04.04 – ANTIBACTERIALS , 08:12.18 – QUINOLONES , 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ MEDEXUS PHARMACEUTICALS INC;
∙ DIN: 02459655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94696
∙ PICO-SALAX;
∙ citric acid 12 g / sachet , magnesium oxide 3.5 g / sachet , sodium picosulfate 10 mg / sachet;
∙ 2004-11-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Ethical | Spécialité Médicale;
∙ FERRING INC;
∙ DIN: 02254794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73995
∙ PURG-ODAN;
∙ citric acid 12 g / sachet , magnesium oxide 3.5 g / sachet , sodium picosulfate 10 mg / sachet;
∙ 2009-02-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Ethical | Spécialité Médicale;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02317966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80347
∙ ANTICOAGULANT SOLUTION CITRATE PHOSPHATE DEXTROSE (CPD);
∙ citric acid 3.27 g / l , sodium citrate dihydrate 26.3 g / l , sodium phosphate monobasic 2.51 g / l , dextrose 25.5 g / l;
∙ 2016-08-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ 0-Unassigned | 0-Non Attribuée;
∙ Solution | Solution;
∙ 20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
∙ Ethical | Spécialité Médicale;
∙ MACO PHARMA;
∙ DIN: 02444100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92893
∙ ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A;
∙ citric acid monohydrate 0.8 g / 100 ml , dextrose 2.45 g / 100 ml , sodium citrate dihydrate 2.2 g / 100 ml;
∙ 2018-06-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ 0-Unassigned | 0-Non Attribuée;
∙ Solution | Solution;
∙ 20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
∙ Ethical | Spécialité Médicale;
∙ TERUMO BCT, INC.;
∙ DIN: 02469731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95858
∙ AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION;
∙ clavulanic acid (clavulanate potassium) 100 mg / vial , amoxicillin (amoxicillin sodium) 500 mg / vial;
∙ 2020-07-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02495910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98581
∙ AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION;
∙ clavulanic acid (clavulanate potassium) 200 mg / vial , amoxicillin (amoxicillin sodium) 1000 mg / vial;
∙ 2020-07-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02495929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98582
∙ AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION;
∙ clavulanic acid (clavulanate potassium) 200 mg / vial , amoxicillin (amoxicillin sodium) 2000 mg / vial;
∙ 2020-07-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02495937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98583
∙ CLAVULIN 400;
∙ clavulanic acid (clavulanate potassium) 57 mg / 5 ml , amoxicillin (amoxicillin trihydrate) 400 mg / 5 ml;
∙ 1998-10-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02238830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62268
∙ BENZACLIN;
∙ clindamycin (clindamycin phosphate) 1 % / w/w , benzoyl peroxide 5 % / w/w;
∙ 2004-05-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.04 – ANTIBIOTICS , 84:28.00 – KERATOLYTIC AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02248472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72824
∙ TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT;
∙ clindamycin (clindamycin phosphate) 1 % / w/w , benzoyl peroxide 5 % / w/w;
∙ 2017-07-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.04 – ANTIBIOTICS , 84:28.00 – KERATOLYTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02464519
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95265
∙ BIACNA TOPICAL GEL;
∙ clindamycin phosphate 1.2 % / w/w , tretinoin 0.025 % / w/w;
∙ 2011-05-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02359685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84468
∙ LOCACORTEN VIOFORM;
∙ clioquinol 3 % , flumethasone pivalate 0.02 %;
∙ 1968-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.92 – MISCELLANEOUS ANTIFUNGALS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 00074462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=631
∙ VIOFORM HYDROCORTISONE;
∙ clioquinol 3 % / w/w , hydrocortisone 1 % / w/w;
∙ 1957-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.92 – MISCELLANEOUS ANTIFUNGALS;
∙ Otc | En Vente Libre;
∙ PALADIN LABS INC.;
∙ DIN: 00074500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=810
∙ CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS;
∙ clotrimazole 1 % / w/w , clotrimazole 10 % / w/w;
∙ 1997-06-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical , Vaginal | Topique , Vaginale;
∙ Kit , Cream | Trousse , Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02230509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49563
∙ CANESTEN COMBI 3 DAY COMFORTAB + EXTERNAL CREAM;
∙ clotrimazole 200 mg / vtab , clotrimazole 1 % / w/w;
∙ 2006-06-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical , Vaginal | Topique , Vaginale;
∙ Vaginal Tablet , Kit , Cream | Comprimé Vaginal , Trousse , Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02264099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74951
∙ CANESTEN COMBI 1 DAY COMFORTAB + EXTERNAL CREAM;
∙ clotrimazole 500 mg / vtab , clotrimazole 1 % / w/w;
∙ 2006-05-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical , Vaginal | Topique , Vaginale;
∙ Vaginal Tablet , Kit , Cream | Comprimé Vaginal , Trousse , Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02264102
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74952
∙ TARGEL SA;
∙ coal tar 10 % , salicylic acid 3 %;
∙ 1980-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS , 84:32.00 – KERATOPLASTIC AGENTS;
∙ Otc | En Vente Libre;
∙ ODAN LABORATORIES LTD;
∙ DIN: 00510335
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4037
∙ DENOREX EXTRA STRENGTH MEDICATED SHAMPOO;
∙ coal tar 2.4 % / w/w , menthol 1.5 % / w/w , chloroxylenol 0.5 % / w/w;
∙ 2007-04-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Shampoo | Shampoing;
∙ 84:32.00 – KERATOPLASTIC AGENTS;
∙ Otc | En Vente Libre;
∙ NEOTERIC COSMETICS INC.;
∙ DIN: 02285703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77120
∙ DENOREX EXTRA STRENGTH MEDICATED SHAMPOO WITH CONDITIONERS;
∙ coal tar 2.4 % / w/w , menthol 1.5 % / w/w , chloroxylenol 0.5 % / w/w;
∙ 2007-04-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Shampoo | Shampoing;
∙ 84:32.00 – KERATOPLASTIC AGENTS;
∙ Otc | En Vente Libre;
∙ NEOTERIC COSMETICS INC.;
∙ DIN: 02285711
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77121
∙ DAMYLIN WITH CODEINE SYRUP;
∙ codeine phosphate 3.3 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
∙ 2002-09-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02245592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69689
∙ COUGH AND ALLERGY SYRUP WITH CODEINE;
∙ codeine phosphate 3.3 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
∙ 2019-10-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02486903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97706
∙ COUGH SYRUP WITH CODEINE;
∙ codeine phosphate 3.3 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02099748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19625
∙ CALMYLIN PSE WITH CODEINE;
∙ codeine phosphate 3.3 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml;
∙ 1996-08-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02172917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34650
∙ CALMYLIN;
∙ codeine phosphate 3.33 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
∙ 1981-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00535230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4469
∙ COUGH SYRUP;
∙ codeine phosphate 3.33 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
∙ 1986-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00690074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6844
∙ MERSYNDOL WITH CODEINE;
∙ codeine phosphate 8 mg , doxylamine succinate 5 mg , acetaminophen 325 mg;
∙ 1982-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02047667
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15805
∙ PMS-ACETAMINOPHEN WITH CODEINE ELIXIR;
∙ codeine phosphate 8 mg / 5 ml , acetaminophen 160 mg / 5 ml;
∙ 1991-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Elixir | Élixir;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PHARMASCIENCE INC;
∙ DIN: 00816027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11384
∙ CYESTRA-35;
∙ cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
∙ 2007-04-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02290308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77558
∙ TEVA-CYPROTERONE / ETHINYL ESTRADIOL;
∙ cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
∙ 2008-09-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02309556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79517
∙ TARO-CYPROTERONE/ETHINYL ESTRADIOL;
∙ cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
∙ 2015-03-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02425017
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90968
∙ CLÉO -35;
∙ cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
∙ 2015-10-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ ALTIUS HEALTHCARE INC;
∙ DIN: 02436736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92104
∙ DIANE-35;
∙ cyproterone acetate 2 mg , ethinyl estradiol 35 mcg;
∙ 1998-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02233542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=53444
∙ XIGDUO;
∙ dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg , metformin hydrochloride 1000 mg;
∙ 2016-02-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02449943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93581
∙ XIGDUO;
∙ dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg , metformin hydrochloride 850 mg;
∙ 2016-02-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02449935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93580
∙ PREZCOBIX;
∙ darunavir (darunavir ethanolate) 800 mg , cobicistat 150 mg;
∙ 2014-08-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS , 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02426501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91108
∙ SYMTUZA;
∙ darunavir (darunavir ethanolate) 800 mg , cobicistat 150 mg , emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg;
∙ 2018-04-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08 – ANTIRETROVIRALS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02473720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96312
∙ VYXEOS;
∙ daunorubicin 44 mg , cytarabine 100 mg;
∙ 2021-07-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder | Poudre;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JAZZ PHARMACEUTICALS IRELAND LIMITED;
∙ DIN: 02515490
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100489
∙ INQOVI;
∙ decitabine 35 mg , cedazuridine 100 mg;
∙ 2020-11-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02501600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99121
∙ SATIVEX;
∙ delta-9-tetrahydrocannabinol (cannabis sativa extract) 2.7 mg / act , cannabidiol (cannabis sativa extract) 2.5 mg / act;
∙ 2005-06-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Buccal | Buccale;
∙ Spray | Pulvérisation;
∙ 92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ GW PHARMA LIMITED;
∙ DIN: 02266121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75157
∙ ALLERGENIC EXTRACT, STANDARDIZED MITE MIXED;
∙ dermatophagoides farinae 5000 unit / ml , dermatophagoides pteronyssinus 5000 unit / ml;
∙ 2006-02-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intradermal , Subcutaneous , Percutaneous | Intradermique , Sous-Cutanée , Percutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ ALK-ABELLO INC;
∙ DIN: 02270919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75630
∙ ALLERGENIC EXTRACT – STANDARDIZED MITE MIX;
∙ dermatophagoides pteronyssinus 5000 unit / ml , dermatophagoides farinae 5000 unit / ml;
∙ 2002-08-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intracutaneous , Subcutaneous | Intracutanée , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ GREER LABORATORIES INC;
∙ DIN: 02231325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50632
∙ ACARIZAX;
∙ dermatophagoides pteronyssinus 6 unit , dermatophagoides farinae 6 unit;
∙ 2017-11-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ALK-ABELLO A/S;
∙ DIN: 02463644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95174
∙ AERIUS DOUBLE ACTION 12 HOUR;
∙ desloratadine 2.5 mg , pseudoephedrine sulfate 120 mg;
∙ 2010-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02309300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79491
∙ MARVELON 21;
∙ desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02042487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14354
∙ APRI 21;
∙ desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
∙ 2008-09-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02317192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80270
∙ APRI 28;
∙ desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
∙ 2008-09-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02317206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80272
∙ FREYA 21;
∙ desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
∙ 2012-11-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02396491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88154
∙ MIRVALA 21;
∙ desogestrel 0.1500 mg / tab , ethinyl estradiol 0.0300 mg / tab;
∙ 2014-01-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02410249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89490
∙ MIRVALA 28;
∙ desogestrel 0.1500 mg / tab , ethinyl estradiol 0.0300 mg / tab;
∙ 2014-01-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02410257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89491
∙ MAXITROL;
∙ dexamethasone 0.1 % / w/v , neomycin (neomycin sulfate) 3.5 mg / ml , polymyxin b sulfate 6000 unit / ml;
∙ 1963-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Ophthalmic | Ophtalmique;
∙ Suspension | Suspension;
∙ 52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00042676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=259
∙ LMD 10% IN DEXTROSE 5%;
∙ dextran 10 % , dextrose 5 %;
∙ 1968-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 00224235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1744
∙ LMD 10% IN 0.9% SODIUM CHLORIDE;
∙ dextran 10 % , sodium chloride 0.9 %;
∙ 1968-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 00224227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1743
∙ TEARS NATURALE FORTE;
∙ dextran 70 0.1 % , glycerine 0.2 % , hypromellose 0.3 %;
∙ 2003-01-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALCON CANADA INC;
∙ DIN: 02246397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70567
∙ TEARS NATURALE II;
∙ dextran 70 0.1 % / w/v , hypromellose 0.3 % / w/v;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALCON CANADA INC;
∙ DIN: 00743445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10032
∙ VISINE FOR RED EYE TRIPLE ACTION;
∙ dextran 70 0.1 % / w/v , polyethylene glycol 400 1 % / w/v , povidone 1 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
∙ 2005-03-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:32.00 – VASOCONSTRICTORS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02248657
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73019
∙ ADVANCED RELIEF EYE DROPS;
∙ dextran 70 0.1 % / w/v , polyethylene glycol 400 1 % / w/v , povidone 1 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
∙ 2010-08-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02344319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82979
∙ VISINE FOR RED EYE WORKPLACE;
∙ dextran 70 0.1 % / w/v , polyethylene glycol 400 1 % / w/v , povidone 1 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
∙ 2016-06-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:32.00 – VASOCONSTRICTORS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02436086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92041
∙ COLD & SINUS LIQUID FASTGELS;
∙ dextromethorphan hydrobromide 10 mg , acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg;
∙ 2009-01-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02305356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79088
∙ NYQUIL COMPLETE + VICKS VAPOCOOL;
∙ dextromethorphan hydrobromide 10 mg , doxylamine succinate 6.25 mg , phenylephrine hydrochloride 5 mg , acetaminophen 325 mg;
∙ 2020-07-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02481928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97241
∙ TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF;
∙ dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg , acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2009-08-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02295326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78062
∙ BENYLIN ALL-IN-ONE COLD, FLU & COUGH LIQUID GELS;
∙ dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg , acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2010-08-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02345110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83056
∙ ROBITUSSIN SUGAR FREE COUGH CONTROL;
∙ dextromethorphan hydrobromide 10 mg / 5 ml , guaifenesin 100 mg / 5 ml;
∙ 2006-08-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02248568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72923
∙ NYQUIL COUGH DM + CONGESTION;
∙ dextromethorphan hydrobromide 10 ml / 15 ml , doxylamine succinate 6.25 mg / 15 ml , phenylephrine hydrochloride 5 mg / 15 ml;
∙ 2021-07-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02503611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99307
∙ DAYTIME COLD & FLU LIQUID CAPSULES;
∙ dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2005-01-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02258919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74414
∙ VICKS NYQUIL LIQUICAPS COLD & FLU MULTI-SYMPTOM RELIEF;
∙ dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg , acetaminophen 325 mg;
∙ 2006-06-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02272792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75829
∙ BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH;
∙ dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
∙ 1997-08-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02218186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37150
∙ BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF;
∙ dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
∙ 2010-08-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02347652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83303
∙ EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU;
∙ dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
∙ 2010-08-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02347660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83304
∙ EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU DAYTIME;
∙ dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
∙ 2011-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02365731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85062
∙ VICKS NYQUIL COUGH;
∙ dextromethorphan hydrobromide 15 mg / 15 ml , doxylamine succinate 6.25 mg / 15 ml;
∙ 2010-08-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02244662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68650
∙ BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU;
∙ dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml;
∙ 2003-07-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02245710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69814
∙ BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF;
∙ dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml;
∙ 2011-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02366207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85106
∙ BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 01944762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12449
∙ COUGH & CHEST CONGESTION;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
∙ 2013-07-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ TRILLIUM HEALTH CARE PRODUCTS INC;
∙ DIN: 02405938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89068
∙ MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
∙ 2013-09-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ TRILLIUM HEALTH CARE PRODUCTS INC;
∙ DIN: 02405857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89062
∙ COUGH & CHEST CONGESTION EXTRA STRENGTH;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
∙ 2013-08-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ TRILLIUM HEALTH CARE PRODUCTS INC;
∙ DIN: 02405911
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89067
∙ BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
∙ 2005-03-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02265419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75088
∙ BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
∙ 2009-07-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02320959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80637
∙ ROBITUSSIN EXTRA STRENGTH COUGH & COLD;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02172380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19060
∙ BENYLIN EXTRA STRENGTH FOR PEOPLE WITH DIABETES;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , menthol 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
∙ 2015-07-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02436485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92082
∙ BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02003317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13440
∙ BENYLIN EXTRA STRENGTH COUGH COMPLETE;
∙ dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
∙ 2005-09-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02265400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75087
∙ ROBITUSSIN EXTRA STRENGTH HONEY COUGH & CONGESTION;
∙ dextromethorphan hydrobromide 20 mg / 20 ml , guaifenesin 400 mg / 20 ml;
∙ 2019-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02485524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97576
∙ NIGHTTIME COMPLETE;
∙ dextromethorphan hydrobromide 20 mg / 30 ml , acetaminophen 650 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
∙ 2018-12-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 48:08.00 – ANTITUSSIVES , 52:24.00 – MYDRIATICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02458462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94559
∙ DAYQUIL COUGH DM + CONGESTION;
∙ dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
∙ 2021-07-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02503247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99274
∙ DIMETAPP EXTRA STRENGTH DM COUGH & COLD;
∙ dextromethorphan hydrobromide 20 mg / 5 ml , brompheniramine maleate 4 mg / 5 ml , phenylephrine hydrochloride 10 mg / 5 ml;
∙ 2002-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ FOUNDATION CONSUMER BRANDS, LLC;
∙ DIN: 02245076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69080
∙ ROBITUSSIN HONEY COUGH & COLD NIGHTTIME;
∙ dextromethorphan hydrobromide 30 mg / 20 ml , doxylamine succinate 12.5 mg / 20 ml;
∙ 2019-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02485443
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97569
∙ NIGHTTIME COLD AND FLU RELIEF;
∙ dextromethorphan hydrobromide 30 mg / 30 ml , acetaminophen 650 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
∙ 2013-02-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02378655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86446
∙ NIGHTTIME COLD & FLU RELIEF;
∙ dextromethorphan hydrobromide 30 mg / 30 ml , acetaminophen 650 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
∙ 2021-05-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02492857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98285
∙ COLD FLU RELIEF;
∙ dextromethorphan hydrobromide 30 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , pseudoephedrine hydrochloride 60 mg / 30 ml , acetaminophen 1 g / 30 ml;
∙ 1997-01-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02218836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37183
∙ TOTAL COLD AND FLU EXTRA STRENGTH;
∙ dextromethorphan hydrobromide 30 mg / 30 ml , pseudoephedrine hydrochloride 60 mg / 30 ml , guaifenesin 200 mg / 30 ml , acetaminophen 1000 mg / 30 ml;
∙ 2007-07-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ TRILLIUM HEALTH CARE PRODUCTS INC;
∙ DIN: 02289385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77475
∙ JACK & JILL COUGH & COLD;
∙ dextromethorphan hydrobromide 5.0 mg / 5 ml , phenylephrine hydrochloride 2.5 mg / 5 ml;
∙ 2014-08-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02412357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89697
∙ BENYLIN FOR CHILDREN COUGH & COLD;
∙ dextromethorphan hydrobromide 7.5 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 01944746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12504
∙ ROBITUSSIN CHILDREN’S COUGH AND COLD;
∙ dextromethorphan hydrobromide 7.5 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02044013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14551
∙ CHILDREN’S COUGH & COLD RELIEF;
∙ dextromethorphan hydrobromide 7.5 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
∙ 2013-08-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ TRILLIUM HEALTH CARE PRODUCTS INC;
∙ DIN: 02405903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89066
∙ DEXTROSE 10% AND 0.9% SOD CHLORIDE INJ;
∙ dextrose 10 g / 100 ml , sodium chloride 900 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00060755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10441
∙ ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A;
∙ dextrose 2.45 g / 100 ml , sodium citrate 2.2 g / 100 ml , citric acid 730 mg / 100 ml;
∙ 1991-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ 0-Unassigned | 0-Non Attribuée;
∙ Solution | Solution;
∙ 20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI AG;
∙ DIN: 00788139
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11376
∙ DEXTROSE 0.2% AND 0.9% SOD CHLOR SOLUTION;
∙ dextrose 200 mg / 100 ml , sodium chloride 900 mg / 100 ml;
∙ 1991-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Irrigation | Irrigation;
∙ Solution | Solution;
∙ 40:36.00 – IRRIGATING SOLUTIONS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00783641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12171
∙ SCLERODEX;
∙ dextrose 250 mg / ml , sodium chloride 100 mg / ml;
∙ 1977-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 24:16.00 – SCLEROSING AGENTS;
∙ Ethical | Spécialité Médicale;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02020939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14183
∙ POTASSIUM CHLORIDE 20 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE;
∙ dextrose 3.3 g / 100 ml , sodium chloride 0.3 g / 100 ml , potassium chloride 0.149 g / 100 ml;
∙ 1979-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00472085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3538
∙ DEXTROSE 3.3% AND 0.3% SOD CHLORIDE INJ;
∙ dextrose 3.3 g / 100 ml , sodium chloride 300 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00060712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10515
∙ (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP;
∙ dextrose 3.3 g / 100 ml , sodium chloride 300 mg / 100 ml , potassium chloride 150 mg / 100 ml;
∙ 1978-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00438014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3132
∙ (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP;
∙ dextrose 3.3 g / 100 ml , sodium chloride 300 mg / 100 ml , potassium chloride 300 mg / 100 ml;
∙ 1978-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00438022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3133
∙ 3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE;
∙ dextrose 33.3 mg / ml , sodium chloride 3 mg / ml;
∙ 1976-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00038881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2575
∙ HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ;
∙ dextrose 5 g / 100 ml , heparin sodium 4000 unit / 100 ml;
∙ 1996-09-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 02209713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36794
∙ POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE;
∙ dextrose 5 g / 100 ml , potassium chloride 0.149 g / 100 ml;
∙ 1979-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00466697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3536
∙ POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE;
∙ dextrose 5 g / 100 ml , potassium chloride 0.3 g / 100 ml;
∙ 1983-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00606820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6400
∙ POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE;
∙ dextrose 5 g / 100 ml , potassium chloride 0.3 g / 100 ml , sodium chloride 0.45 g / 100 ml;
∙ 1983-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00603244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6228
∙ POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE;
∙ dextrose 5 g / 100 ml , potassium chloride 0.3 g / 100 ml , sodium chloride 0.9 g / 100 ml;
∙ 2008-04-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 02299135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78453
∙ (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP;
∙ dextrose 5 g / 100 ml , potassium chloride 150 mg / 100 ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00438049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10041
∙ (40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP;
∙ dextrose 5 g / 100 ml , potassium chloride 300 mg / 100 ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00438030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10042
∙ POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE;
∙ dextrose 5 g / 100 ml , sodium chloride 0.45 g / 100 ml , potassium chloride 0.149 g / 100 ml;
∙ 1979-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00466670
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3534
∙ DEXTROSE 5% AND 0.2% SOD CHLORIDE INJ;
∙ dextrose 5 g / 100 ml , sodium chloride 200 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00060704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10438
∙ 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP;
∙ dextrose 5 g / 100 ml , sodium chloride 200 mg / 100 ml , potassium chloride 150 mg / 100 ml;
∙ 1998-09-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 01931598
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=21753
∙ DEXTROSE 5% AND 0.45% SOD CHLORIDE INJ;
∙ dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00060739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10439
∙ 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP;
∙ dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 01927531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13033
∙ (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP;
∙ dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml , potassium chloride 150 mg / 100 ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00437999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10044
∙ (40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP;
∙ dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml , potassium chloride 300 mg / 100 ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00438006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10045
∙ DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ;
∙ dextrose 5 g / 100 ml , sodium chloride 900 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00060747
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10440
∙ (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP;
∙ dextrose 5 g / 100 ml , sodium chloride 900 mg / 100 ml , potassium chloride 150 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00786292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10866
∙ POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR;
∙ dextrose 5 g / 100 ml , sodium chloride 900 mg / 100 ml , potassium chloride 300 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00786306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10867
∙ HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML;
∙ dextrose 5 g / 100 ml , sodium phosphate dibasic 410 mg / 100 ml , citric acid 93 mg / 100 ml , heparin sodium 5000 unit / 100 ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 01935941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16794
∙ 5% DEXTROSE AND 0.225% SODIUM CHLORIDE;
∙ dextrose 50 mg / ml , sodium chloride 2.25 mg / ml;
∙ 1955-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00038873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1751
∙ 5% DEXTROSE AND 0.45% SODIUM CHLORIDE;
∙ dextrose 50 mg / ml , sodium chloride 4.5 mg / ml;
∙ 1951-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00038903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1750
∙ 5% DEXTROSE AND 0.9% SODIUM CHLORIDE;
∙ dextrose 50 mg / ml , sodium chloride 9 mg / ml;
∙ 1951-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00038946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1747
∙ 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP;
∙ dextrose 50 mg / ml , sodium chloride 9 mg / ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 01924435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13288
∙ GASTROGRAFIN – LIQ ORL;
∙ diatrizoate meglumine 66 % , diatrizoate sodium 10 %;
∙ 1978-12-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 36:68.00 – ROENTGENOGRAPHY;
∙ Ethical | Spécialité Médicale;
∙ BRACCO IMAGING CANADA;
∙ DIN: 02228564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37570
∙ ANTIBACTERIAL THROAT LOZENGES;
∙ dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg;
∙ 2013-03-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Lozenge | Pastille;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ QUIMICA CANADA LIMITED;
∙ DIN: 02375567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86098
∙ CEPACOL SENSATIONS SORE THROAT & BLOCKED NOSE;
∙ dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg , levomenthol 8 mg;
∙ 2012-07-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Lozenge | Pastille;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ RB HEALTH (CANADA) INC.;
∙ DIN: 02382881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86869
∙ CEPACOL SENSATIONS SORE THROAT & COUGH;
∙ dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg , menthol 8 mg;
∙ 2012-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Lozenge | Pastille;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ RB HEALTH (CANADA) INC.;
∙ DIN: 02388642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87415
∙ ARTHROTEC 50;
∙ diclofenac sodium 50 mg , misoprostol 200 mcg;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 01917056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13636
∙ GD-DICLOFENAC/MISOPROSTOL 50;
∙ diclofenac sodium 50 mg , misoprostol 200 mcg;
∙ 2014-07-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
∙ Prescription | Prescription;
∙ GENMED A DIVISION OF PFIZER CANADA ULC;
∙ DIN: 02341689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82718
∙ PMS-DICLOFENAC-MISOPROSTOL;
∙ diclofenac sodium 50 mg , misoprostol 200 mcg;
∙ 2018-12-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02413469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89812
∙ ARTHROTEC 75;
∙ diclofenac sodium 75 mg , misoprostol 200 mcg;
∙ 1996-11-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02229837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48191
∙ GD-DICLOFENAC/MISOPROSTOL 75;
∙ diclofenac sodium 75 mg , misoprostol 200 mcg;
∙ 2014-07-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
∙ Prescription | Prescription;
∙ GENMED A DIVISION OF PFIZER CANADA ULC;
∙ DIN: 02341697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82719
∙ PMS-DICLOFENAC-MISOPROSTOL;
∙ diclofenac sodium 75 mg , misoprostol 200 mcg;
∙ 2018-12-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02413477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89813
∙ HUMATROPE;
∙ diluent 3.15 ml , somatropin 12 mg;
∙ 2001-08-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Liquid , Powder For Solution | Liquide , Poudre Pour Solution;
∙ 68:28.00 – PITUITARY;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02243078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66944
∙ HUMATROPE;
∙ diluent 3.15 ml , somatropin 24 mg;
∙ 2003-12-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Liquid , Powder For Solution | Liquide , Poudre Pour Solution;
∙ 68:28.00 – PITUITARY;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02243079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66945
∙ HUMATROPE;
∙ diluent 3.15 ml , somatropin 6 mg;
∙ 2001-09-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Liquid , Powder For Solution | Liquide , Poudre Pour Solution;
∙ 68:28.00 – PITUITARY;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02243077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66943
∙ BAZA PROTECT II;
∙ dimethicone 1 % / w/w , zinc oxide 12 % / w/w;
∙ 2009-05-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ COLOPLAST A/S;
∙ DIN: 02315793
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80131
∙ ABC ARBONNE BABY CARE DIAPER RASH CREAM;
∙ dimethicone 1 % / w/w , zinc oxide 12 % / w/w;
∙ 2014-09-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ ARBONNE INTERNATIONAL LLC;
∙ DIN: 02417693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90232
∙ ADVIL COLD & FLU;
∙ diphenhydramine citrate 38 mg , ibuprofen 200 mg;
∙ 2011-10-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02362643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84765
∙ BENADRYL ITCH STOPPING CREAM;
∙ diphenhydramine hydrochloride 2 % , zinc acetate 0.1 %;
∙ 2020-01-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02484838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97511
∙ BENADRYL BUG BITE RELIEF;
∙ diphenhydramine hydrochloride 2 % / w/v , zinc acetate 0.1 % / w/v;
∙ 2007-03-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02280868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76653
∙ BENADRYL SPRAY;
∙ diphenhydramine hydrochloride 2.0 % , zinc acetate 0.1 %;
∙ 2007-03-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02280876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76655
∙ ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME;
∙ diphenhydramine hydrochloride 25 mg , acetaminophen 500 mg;
∙ 2018-02-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 02238183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61574
∙ EXTRA STRENGTH FLU RELIEF NIGHTIME;
∙ diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
∙ 2004-01-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02248700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73064
∙ BENADRYL ALLERGY, SINUS & PAIN TOTAL;
∙ diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
∙ 2004-10-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02250993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73592
∙ EXTRA STRENGTH ALLERGY TOTAL;
∙ diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
∙ 2008-03-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02303833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78913
∙ NIGHTTIME TOTAL COLD AND FLU;
∙ diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
∙ 2009-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02305305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79084
∙ NIGHTTIME FLU, COUGH & COLD COMPLETE RELIEF EXTRA STRENGTH;
∙ diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
∙ 2014-07-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02404974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88980
∙ NEOCITRAN EXTRA STRENGTH TOTAL COLD NIGHT;
∙ diphenhydramine hydrochloride 25 mg / sachet , acetaminophen 650 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
∙ 2015-08-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02409178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89389
∙ JACK & JILL BEDTIME COUGH & COLD;
∙ diphenhydramine hydrochloride 6.25 mg / 5 ml , phenylephrine hydrochloride 2.5 mg / 5 ml;
∙ 2014-08-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02412349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89696
∙ LOMOTIL;
∙ diphenoxylate hydrochloride 2.5 mg , atropine sulfate .025 mg;
∙ 1960-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:08.00 – ANTIDIARRHEA AGENTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PFIZER CANADA ULC;
∙ DIN: 00036323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=937
∙ TD ADSORBED;
∙ diphtheria toxoid adsorbed 2 lf / 0.5 ml , tetanus toxoid adsorbed 5 lf / 0.5 ml;
∙ 1980-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:08.00 – TOXOIDS;
∙ Schedule D | Annexe D;
∙ SANOFI PASTEUR LIMITED;
∙ DIN: 00514462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4109
∙ TARO-DIPYRIDAMOLE/ ASA;
∙ dipyridamole 200 mg , acetylsalicylic acid 25 mg;
∙ 2018-11-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule (Immediate And Extended Release) | Capsule (À Libération Immédiate Et Prolongée);
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS , 28:08.04.24 – SALICYLATES;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02471051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96015
∙ TRIUMEQ;
∙ dolutegravir (dolutegravir sodium) 50 mg , abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
∙ 2014-10-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02430932
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91536
∙ DOVATO;
∙ dolutegravir (dolutegravir sodium) 50 mg , lamivudine 300 mg;
∙ 2019-09-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02491753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98173
∙ JULUCA;
∙ dolutegravir (dolutegravir sodium) 50 mg , rilpivirine (rilpivirine hydrochloride) 25 mg;
∙ 2018-06-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02475774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96645
∙ DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP;
∙ dopamine hydrochloride .8 mg / ml , dextrose 50 mg / ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 00761850
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12256
∙ DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP;
∙ dopamine hydrochloride 1.6 mg / ml , dextrose 50 mg / ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 00761826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11625
∙ DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP;
∙ dopamine hydrochloride 3.2 mg / ml , dextrose 50 mg / ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 00761834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11624
∙ DELSTRIGO;
∙ doravirine 100 mg , lamivudine 300 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2018-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02482592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97302
∙ COSOPT;
∙ dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2005-11-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ ELVIUM LIFE SCIENCES;
∙ DIN: 02258692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74388
∙ APO-DORZO-TIMOP;
∙ dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2010-12-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02299615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78499
∙ SANDOZ DORZOLAMIDE/TIMOLOL;
∙ dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2010-10-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02344351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82984
∙ ACT DORZOTIMOLOL;
∙ dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2013-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02404389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88915
∙ MED-DORZOLAMIDE-TIMOLOL;
∙ dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2016-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ GENERIC MEDICAL PARTNERS INC;
∙ DIN: 02437686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92207
∙ RIVA-DORZOLAMIDE/TIMOLOL;
∙ dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2015-07-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02441659
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92604
∙ JAMP DORZOLAMIDE-TIMOLOL;
∙ dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2019-12-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02457539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94459
∙ DORZOLAMIDE AND TIMOLOL EYE DROPS BP;
∙ dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2020-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ TELIGENT CANADA INC;
∙ DIN: 02489635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97971
∙ DICLECTIN;
∙ doxylamine succinate 10 mg , pyridoxine hydrochloride 10 mg;
∙ 1983-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:22.08 – ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ DUCHESNAY INC;
∙ DIN: 00609129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5509
∙ PMS-DOXYLAMINE-PYRIDOXINE;
∙ doxylamine succinate 10 mg , pyridoxine hydrochloride 10 mg;
∙ 2017-07-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:22.92 – MISCELLANEOUS ANTIEMETICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02406187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89091
∙ APO-DOXYLAMINE/B6;
∙ doxylamine succinate 10 mg , pyridoxine hydrochloride 10 mg;
∙ 2017-08-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:22.92 – MISCELLANEOUS ANTIEMETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02413248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89791
∙ SINUS MEDICATION;
∙ doxylamine succinate 6.25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
∙ 2003-03-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02245016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69017
∙ ANGELIQ;
∙ drospirenone 1.0 mg , estradiol 1.0 mg;
∙ 2008-10-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:32.00 – PROGESTINS , 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02268825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75422
∙ YAZ;
∙ drospirenone 3 mg , ethinyl estradiol 0.02 mg;
∙ 2009-01-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02321157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80656
∙ YASMIN 21;
∙ drospirenone 3 mg , ethinyl estradiol 0.03 mg;
∙ 2004-12-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02261723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74710
∙ YASMIN 28;
∙ drospirenone 3 mg , ethinyl estradiol 0.03 mg;
∙ 2004-12-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02261731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74711
∙ ZAMINE 21;
∙ drospirenone 3 mg , ethinyl estradiol 0.03 mg;
∙ 2014-01-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02410788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89544
∙ ZAMINE 28;
∙ drospirenone 3 mg , ethinyl estradiol 0.03 mg;
∙ 2014-01-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02410796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89545
∙ MYA;
∙ drospirenone 3.00 mg , ethinyl estradiol 0.02 mg;
∙ 2014-05-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02415380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89999
∙ YAZ PLUS;
∙ drospirenone 3.00 mg , ethinyl estradiol 0.02 mg , levomefolate calcium 0.451 mg , levomefolate calcium 0.451 mg;
∙ 2013-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02387433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87302
∙ JALYN;
∙ dutasteride 0.5 mg , tamsulosin hydrochloride 0.4 mg;
∙ 2011-11-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule (Immediate And Extended Release) | Capsule (À Libération Immédiate Et Prolongée);
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS , 12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02372010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85714
∙ ATRIPLA;
∙ efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2007-10-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES, LLC;
∙ DIN: 02300699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78602
∙ TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR;
∙ efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2017-07-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02393549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87876
∙ MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE;
∙ efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2017-07-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02461412
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94902
∙ APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR;
∙ efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2018-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02468247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95665
∙ AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR;
∙ efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2020-03-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02478404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96916
∙ SANDOZ EFAVIRENZ/EMTRICITABINE/TENOFOVIR;
∙ efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2019-09-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02484676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97496
∙ PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR;
∙ efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2019-10-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02487284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97744
∙ ZEPATIER;
∙ elbasvir 50 mg , grazoprevir 100 mg;
∙ 2016-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.40.24 – HCV Replication Complex Inhibitors;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02451131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93740
∙ SYNJARDY;
∙ empagliflozin 12.5 mg , metformin hydrochloride 1000 mg;
∙ 2016-08-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02456621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94362
∙ SYNJARDY;
∙ empagliflozin 12.5 mg , metformin hydrochloride 500 mg;
∙ 2016-08-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02456605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94360
∙ SYNJARDY;
∙ empagliflozin 12.5 mg , metformin hydrochloride 850 mg;
∙ 2016-08-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02456613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94361
∙ GLYXAMBI;
∙ empagliflozin 25 mg , linagliptin 5 mg;
∙ 2016-12-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02459760
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94709
∙ SYNJARDY;
∙ empagliflozin 5 mg , metformin hydrochloride 1000 mg;
∙ 2016-08-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02456591
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94359
∙ SYNJARDY;
∙ empagliflozin 5 mg , metformin hydrochloride 500 mg;
∙ 2016-08-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02456575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94357
∙ SYNJARDY;
∙ empagliflozin 5 mg , metformin hydrochloride 850 mg;
∙ 2016-08-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02456583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94358
∙ GENVOYA;
∙ emtricitabine 200 mg , elvitegravir 150 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg , cobicistat 150 mg;
∙ 2016-02-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02449498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93532
∙ STRIBILD;
∙ emtricitabine 200 mg , elvitegravir 150 mg , tenofovir disoproxil fumarate 300 mg , cobicistat 150 mg;
∙ 2012-12-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS , 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02397137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88208
∙ ODEFSEY;
∙ emtricitabine 200 mg , rilpivirine (rilpivirine hydrochloride) 25 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
∙ 2017-03-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02461463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94909
∙ COMPLERA;
∙ emtricitabine 200 mg , rilpivirine (rilpivirine hydrochloride) 25 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2011-10-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02374129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85932
∙ DESCOVY;
∙ emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg;
∙ 2016-06-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02454416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94099
∙ DESCOVY;
∙ emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
∙ 2016-06-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02454424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94100
∙ TEVA-EMTRICITABINE/TENOFOVIR;
∙ emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
∙ 2017-07-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02399059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88396
∙ ENALAPRIL MALEATE/HCTZ;
∙ enalapril maleate 10 mg , hydrochlorothiazide 25 mg;
∙ 2011-02-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02352931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83817
∙ ENALAPRIL MALEATE/HCTZ;
∙ enalapril maleate 5 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-02-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02352923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83816
∙ VASERETIC;
∙ enalapril sodium (enalapril maleate) 8 mg , hydrochlorothiazide 25 mg;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00657298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10913
∙ ARTISTRY EXACT FIT BEAUTY BALM PERFECTING PRIMER;
∙ ensulizole 2 % / w/w , octinoxate 5 % / w/w , zinc oxide 5.49 % / w/w;
∙ 2015-09-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMWAY CORP.;
∙ DIN: 02434865
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91916
∙ SOOTHING DAY CREAM;
∙ ensulizole 2.25 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
∙ 2018-04-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02466600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95494
∙ ZORCAINE;
∙ epinephrine (epinephrine bitartrate) 0.01 mg / ml , articaine hydrochloride 40 mg / ml;
∙ 2019-07-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT;
∙ DIN: 02474239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96424
∙ SEPTANEST SP;
∙ epinephrine (epinephrine bitartrate) 0.01 mg / ml , articaine hydrochloride 40.0 mg / ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT;
∙ DIN: 02123398
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16850
∙ LIDOCAINE 2% AND EPINEPHRINE 1:100,000;
∙ epinephrine (epinephrine bitartrate) 0.01 mg / ml , lidocaine hydrochloride 20 mg / ml;
∙ 2019-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT;
∙ DIN: 02473518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96290
∙ LIDOCAINE 2% AND EPINEPHRINE 1:50,000;
∙ epinephrine (epinephrine bitartrate) 0.02 mg / ml , lidocaine hydrochloride 20 mg / ml;
∙ 2019-05-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT;
∙ DIN: 02473526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96291
∙ SENSORCAINE WITH EPINEPHRINE;
∙ epinephrine (epinephrine bitartrate) 5 mcg / ml , bupivacaine hydrochloride 2.5 mg / ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration , Epidural | Bloc/Infiltration , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 01976184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16162
∙ ULTRACAINE D-S FORTE INJECTION;
∙ epinephrine 0.01 mg / ml , articaine hydrochloride 40 mg / ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ HANSAMED LIMITED;
∙ DIN: 01988557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16511
∙ ULTRACAINE D-S INJECTION;
∙ epinephrine 5 mcg / ml , articaine hydrochloride 40 mg / ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ HANSAMED LIMITED;
∙ DIN: 01988530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16508
∙ TEVETEN PLUS;
∙ eprosartan (eprosartan mesylate) 600 mg , hydrochlorothiazide 12.5 mg;
∙ 2004-07-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02253631
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73859
∙ BENZAMYCIN;
∙ erythromycin 3 % / w/w , benzoyl peroxide 5 % / w/w;
∙ 1996-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.04 – ANTIBIOTICS , 84:28.00 – KERATOLYTIC AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02225271
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43428
∙ NEXTSTELLIS;
∙ estetrol monohydrate 15 mg , drospirenone 3 mg;
∙ 2021-06-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02513218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100241
∙ ACTIVELLE LD;
∙ estradiol 0.5 mg , norethindrone acetate 0.1 mg;
∙ 2008-05-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:32.00 – PROGESTINS , 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02309009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79461
∙ ACTIVELLE;
∙ estradiol 1.0 mg , norethindrone acetate 0.5 mg;
∙ 2008-05-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:32.00 – PROGESTINS , 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02249405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73420
∙ ESTALIS 140/50 MCG;
∙ estradiol 50 mcg / 24 hour , norethindrone acetate 140 mcg / 24 hour;
∙ 2000-05-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02241835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65502
∙ ESTALIS 250/50 MCG;
∙ estradiol 50 mcg / 24 hour , norethindrone acetate 250 mcg / 24 hour;
∙ 2000-05-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02241837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65503
∙ ENBREL;
∙ etanercept 25 mg / kit , water 1 ml / kit;
∙ 2001-03-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Kit , Liquid , Powder For Solution | Trousse , Liquide , Poudre Pour Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ IMMUNEX CORPORATION;
∙ DIN: 02242903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66735
∙ BREVICON 0.5/35 TABLETS (28-DAY PACK);
∙ ethinyl estradiol .035 mg , norethindrone .5 mg;
∙ 1996-08-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02187094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42888
∙ SEASONIQUE;
∙ ethinyl estradiol 0.01 mg , levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
∙ 2011-04-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02346176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83160
∙ MARVELON 28;
∙ ethinyl estradiol 0.03 mg , desogestrel 0.15 mg;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02042479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14355
∙ FREYA 28;
∙ ethinyl estradiol 0.03 mg , desogestrel 0.15 mg;
∙ 2012-11-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02396610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88165
∙ BREVICON 0.5/35 TABLETS (21-DAY PACK);
∙ ethinyl estradiol 0.035 mg , norethindrone 0.5 mg;
∙ 1976-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02187086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20162
∙ SYNPHASIC 28 TABLETS;
∙ ethinyl estradiol 0.035 mg , norethindrone 0.5 mg , ethinyl estradiol 0.035 mg , norethindrone 1.0 mg;
∙ 1996-08-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02187116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42890
∙ NUVARING;
∙ etonogestrel 11.4 mg , ethinyl estradiol 2.6 mg;
∙ 2004-12-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Vaginal | Vaginale;
∙ Ring (Slow-Release) | Anneau (À Libération Lente);
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02253186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73815
∙ DEMO-CINEOL ENFANTS/CHILDREN;
∙ eucalyptol 185 mg , guaiacol 90 mg , camphor 20 mg , guaiacol carbonate 100 mg;
∙ 1977-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES CONFAB INC;
∙ DIN: 00319724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2787
∙ DEMO-CINEOL ADULTES/ADULTS;
∙ eucalyptol 370 mg , guaiacol 180 mg , camphor 40 mg , guaiacol carbonate 200 mg;
∙ 1986-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES CONFAB INC;
∙ DIN: 00319716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6645
∙ PEPCID COMPLETE;
∙ famotidine 10 mg , calcium carbonate 800 mg , magnesium hydroxide 165 mg;
∙ 2001-05-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 56:04.00 – ANTACIDS AND ADSORBENTS , 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02243053
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66915
∙ ALLEGRA-D;
∙ fexofenadine hydrochloride 60 mg , pseudoephedrine hydrochloride 120 mg;
∙ 1999-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Immediate And Extended Release) | Comprimé(À Libération Immédiate Et Prolongée);
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC;
∙ DIN: 02239853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63341
∙ EVICEL;
∙ fibrinogen (human) 90 mg / ml , thrombin (human) 1200 unit / ml;
∙ 2011-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution , Kit | Solution , Trousse;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ OMRIX BIOPHARMACEUTICALS LTD;
∙ DIN: 02348497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83385
∙ CANESORAL COMBI 1 DAY;
∙ fluconazole 150 mg , clotrimazole 2 % / w/w;
∙ 2020-02-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral , Topical | Orale , Topique;
∙ Capsule , Cream | Capsule , Crème;
∙ #N/A;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02490935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98097
∙ MONICURE COMBO;
∙ fluconazole 150 mg , miconazole nitrate 2 %;
∙ 2012-10-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral , Topical | Orale , Topique;
∙ Kit , Capsule , Cream | Trousse , Capsule , Crème;
∙ 84:04.08.08 – AZOLES , 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ INSIGHT PHARMACEUTICALS, LLC;
∙ DIN: 02382628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86844
∙ CANESORAL COMBI;
∙ fluconazole 150 mg / cap , clotrimazole 1 %;
∙ 2010-03-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral , Topical , Vaginal | Orale , Topique , Vaginale;
∙ Capsule , Cream | Capsule , Crème;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02311739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79728
∙ CLOTRIMADERM-FLUCONAZOLE COMBI-PACK;
∙ fluconazole 150 mg / cap , clotrimazole 1 % / w/w;
∙ 2017-02-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral , Topical | Orale , Topique;
∙ Kit , Capsule , Cream | Trousse , Capsule , Crème;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02445131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93036
∙ CLOTRIMAZOLE-FLUCONAZOLE COMBI;
∙ fluconazole 150 mg / cap , clotrimazole 1 % / w/w;
∙ 2017-02-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral , Topical | Orale , Topique;
∙ Kit , Capsule , Cream | Trousse , Capsule , Crème;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02451727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93803
∙ LOCACORTEN VIOFORM EARDROPS;
∙ flumethasone pivalate 0.02 % , clioquinol 1 %;
∙ 1969-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Otic | Otique;
∙ Drops | Gouttes;
∙ 52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 00074454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=868
∙ ACTIKERALL;
∙ fluorouracil 0.5 % / w/w , salicylic acid 10 % / w/w;
∙ 2016-02-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
∙ Prescription | Prescription;
∙ CIPHER PHARMACEUTICALS INC;
∙ DIN: 02428946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91338
∙ TRELEGY ELLIPTA;
∙ fluticasone furoate 100 mcg / act , umeclidinium (umeclidinium bromide) 62.5 mcg / act , vilanterol (vilanterol trifenatate) 25 mcg / act;
∙ 2018-05-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02474522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96469
∙ BREO ELLIPTA;
∙ fluticasone furoate 200 mcg / act , vilanterol (vilanterol trifenatate) 25 mcg / act;
∙ 2015-10-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02444186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92906
∙ PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI;
∙ fluticasone propionate 100 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
∙ 2020-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02494507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98451
∙ WIXELA INHUB;
∙ fluticasone propionate 100 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
∙ 2020-02-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02495597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98549
∙ PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI;
∙ fluticasone propionate 250 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
∙ 2020-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02494515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98452
∙ WIXELA INHUB;
∙ fluticasone propionate 250 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
∙ 2020-02-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02495600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98550
∙ DYMISTA;
∙ fluticasone propionate 50 mcg / act , azelastine hydrochloride 137 mcg / act;
∙ 2015-03-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:02.00 – ANTIALLERGIC AGENTS , 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02432889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91729
∙ PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI;
∙ fluticasone propionate 500 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
∙ 2020-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02494523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98453
∙ WIXELA INHUB;
∙ fluticasone propionate 500 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
∙ 2020-02-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02495619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98551
∙ SOFRAMYCIN NASAL SPRAY;
∙ framycetin sulfate 12.5 mg / ml , gramicidin 0.05 mg / ml , phenylephrine hydrochloride 2.5 mg / ml;
∙ 2001-05-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Nasal | Nasale;
∙ Spray | Pulvérisation;
∙ 52:32.00 – VASOCONSTRICTORS;
∙ Prescription | Prescription;
∙ ERFA CANADA 2012 INC;
∙ DIN: 02224860
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37384
∙ SOFRACORT;
∙ framycetin sulfate 5 mg / ml , dexamethasone (dexamethasone sodium metasulphobenzoate) 0.5 mg / ml , gramicidin 0.05 mg / ml;
∙ 2002-07-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Ophthalmic , Otic | Ophtalmique , Otique;
∙ Drops | Gouttes;
∙ 52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02224623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37363
∙ FUCIDIN H;
∙ fusidic acid 2 % , hydrocortisone acetate 1 %;
∙ 1998-11-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 02238578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62005
∙ FUCIBET;
∙ fusidic acid 2 % / w/w , betamethasone (betamethasone valerate) 0.1 % / w/w;
∙ 2018-10-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 02474883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96510
∙ VALISONE-G;
∙ gentamicin (gentamicin sulfate) 0.1 % / w/w , betamethasone (betamethasone valerate) 0.1 % / w/w;
∙ 1970-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 00177016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=816
∙ ARTIFICIAL TEARS;
∙ glycerine 0.2 % / w/v , hypromellose 0.2 % / w/v;
∙ 2011-04-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02354535
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83970
∙ DRY EYE TEARS;
∙ glycerine 0.2 % / w/v , hypromellose 0.2 % / w/v;
∙ 2014-02-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02389886
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87535
∙ LUBRICANT EYE DROPS/ ARTIFICIAL TEARS;
∙ glycerine 0.3 % / w/v , propylene glycol 1 % / w/v;
∙ 2009-08-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ BAUSCH & LOMB INC;
∙ DIN: 02321696
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80709
∙ SOOTHE DRY EYES;
∙ glycerine 0.3 % / w/v , propylene glycol 1.0 % / w/v;
∙ 2004-12-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ BAUSCH & LOMB INC;
∙ DIN: 02242370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66081
∙ PH 12 STERILE DILUENT FOR FLOLAN;
∙ glycine 94 mg / vial , sodium chloride 73.3 mg / vial , water 50 ml / vial;
∙ 2016-08-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:50.00* – DILUENTS;
∙ Ethical | Spécialité Médicale;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02443651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92834
∙ OPTIMYXIN;
∙ gramicidin 0.025 mg / ml , polymyxin b (polymyxin b sulfate) 10000 unit / ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic , Otic | Ophtalmique , Otique;
∙ Drops | Gouttes;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Otc | En Vente Libre;
∙ EURO-PHARM INTERNATIONAL CANADA INC;
∙ DIN: 00701785
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10025
∙ VIADERM KC ONT;
∙ gramicidin 0.25 mg / g , nystatin 100000 unit / g , triamcinolone acetonide 1 mg / g , neomycin (neomycin sulfate) 2.5 mg / g;
∙ 1983-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00717029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9449
∙ CREO-RECTAL ENFANTS/CHILDREN;
∙ guaiacol carbonate 200 mg , diphenylpyraline hydrochloride 0.5 mg , camphor 2 mg;
∙ 1951-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES CONFAB INC;
∙ DIN: 00299596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2150
∙ CREO-RECTAL ADULTES/ADULTS;
∙ guaiacol carbonate 600 mg , diphenylpyraline hydrochloride 1.5 mg , camphor 5 mg;
∙ 1951-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES CONFAB INC;
∙ DIN: 00299561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2148
∙ ROBITUSSIN COUGH CONTROL;
∙ guaifenesin 100 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 01931024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13296
∙ ROBITUSSIN COUGH AND COLD;
∙ guaifenesin 100 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02068419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16698
∙ BUCKLEY’S CHEST CONGESTION;
∙ guaifenesin 100 mg / 5 ml , menthol 10 mg / 5 ml;
∙ 2007-08-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02289164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77454
∙ BUCKLEY’S MUCUS & PHLEGM;
∙ guaifenesin 100 mg / 5 ml , menthol 10 mg / 5 ml;
∙ 2010-08-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02346451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83190
∙ CALMYLIN ACE;
∙ guaifenesin 100 mg / 5 ml , pheniramine maleate 7.5 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02198630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19690
∙ ROBITUSSIN EXTRA STRENGTH COUGH CONTROL;
∙ guaifenesin 200 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02142775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19026
∙ BENYLIN EXTRA STRENGTH CHEST CONGESTION & COLD;
∙ guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
∙ 2005-09-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02265427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75089
∙ BENYLIN EXTRA STRENGTH SORE THROAT & COUGH;
∙ guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
∙ 2019-07-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02479869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97024
∙ FLUZONE QUADRIVALENT;
∙ haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
∙ 2014-10-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SANOFI PASTEUR LIMITED;
∙ DIN: 02420643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90522
∙ FLULAVAL TETRA;
∙ haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
∙ 2015-10-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ ID BIOMEDICAL CORPORATION OF QUEBEC;
∙ DIN: 02420783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90535
∙ AFLURIA TETRA;
∙ haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
∙ 2019-10-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SEQIRUS PTY LTD;
∙ DIN: 02473283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96268
∙ AFLURIA TETRA;
∙ haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
∙ 2020-09-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SEQIRUS PTY LTD;
∙ DIN: 02473313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96272
∙ INFLUVAC TETRA;
∙ haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
∙ 2019-10-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ BGP PHARMA ULC;
∙ DIN: 02484854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97512
∙ FLUCELVAX QUAD;
∙ haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
∙ 2020-09-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SEQIRUS UK LIMITED;
∙ DIN: 02494248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98427
∙ FLUAD;
∙ haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b 15 mcg / 0.5 ml;
∙ 2011-09-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SEQIRUS UK LIMITED;
∙ DIN: 02362384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84739
∙ FLUVIRAL;
∙ haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b 15 mcg / 0.5 ml;
∙ 2015-09-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ ID BIOMEDICAL CORPORATION OF QUEBEC;
∙ DIN: 02420686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90524
∙ FLUAD PEDIATRIC;
∙ haemagglutinin-strain a (h1n1) 7.5 mcg / 0.25 ml , haemagglutinin-strain a (h3n2) 7.5 mcg / 0.25 ml , haemagglutinin-strain b 7.5 mcg / 0.25 ml;
∙ 2015-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SEQIRUS UK LIMITED;
∙ DIN: 02434881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91919
∙ FLUZONE QUADRIVALENT;
∙ haemagglutinin-strain b (yamagata) 30 mcg / ml , haemagglutinin-strain a (h1n1) 30 mcg / ml , haemagglutinin-strain a (h3n2) 30 mcg / ml , haemagglutinin-strain b (victoria) 30 mcg / ml;
∙ 2015-09-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SANOFI PASTEUR LIMITED;
∙ DIN: 02432730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91717
∙ ACT-HIB;
∙ haemophilus influenzae type b-prp 10 mcg / 0.5 ml , tetanus protein 30 mcg / 0.5 ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular | Intramusculaire;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SANOFI PASTEUR LIMITED;
∙ DIN: 01959034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13140
∙ DUOBRII;
∙ halobetasol propionate 0.01 % / w/w , tazarotene 0.045 % / w/w;
∙ 2020-08-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS , 84:06.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02499967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98967
∙ HELIOX 70/30;
∙ helium 70 % , oxygen 30 %;
∙ 2014-12-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ VITALAIRE CANADA INC;
∙ DIN: 02416468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90106
∙ HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ;
∙ heparin sodium 10000 unit / 100 ml , dextrose 5 g / 100 ml;
∙ 1996-09-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 02209721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36795
∙ TWINRIX;
∙ hepatitis a vaccine – inactivated 720 unit / 1.0 ml , hepatitis b surface antigen (recombinant) 20 mcg / 1.0 ml;
∙ 1997-09-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02230578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49687
∙ TWINRIX JUNIOR;
∙ hepatitis b surface antigen (recombinant) 10 mcg / 0.5 ml , hepatitis a vaccine – inactivated 360 unit / 0.5 ml;
∙ 1998-11-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02237548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60885
∙ STREPSILS EXTRA BLACK CHERRY;
∙ hexylresorcinol 2.4 mg , levomenthol 4 mg;
∙ 2007-03-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Lozenge | Pastille;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ RB HEALTH (CANADA) INC.;
∙ DIN: 02263998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74940
∙ ULTRA-LIGHT MOISTURIZING LOTION SPF 30;
∙ homosalate 10 % , octisalate 5 % , avobenzone 3 % , octocrylene 2.7 %;
∙ 2019-08-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CERAVE CANADA;
∙ DIN: 02481944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97242
∙ OIL AND PORE CONTROL MATTIFIER BROAD SPECTRUM SPF 45;
∙ homosalate 10 % , octisalate 5 % , octocrylene 5 % , avobenzone 3 %;
∙ 2019-07-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MURAD LLC;
∙ DIN: 02483866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97422
∙ BROAD SPECTRUM SPF/FPS 30;
∙ homosalate 10 % , octocrylene 10 % , octisalate 5 % , avobenzone 3 %;
∙ 2017-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02444232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92916
∙ ULTRA SHEER BODY MIST SUNSCREEN SPF 45;
∙ homosalate 10 % , octocrylene 10 % , octisalate 5 % , avobenzone 3 %;
∙ 2020-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02487942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97806
∙ CLEAR SUNSCREEN STICK 50+;
∙ homosalate 10 % / w/w , avobenzone 2.5 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w;
∙ 2021-04-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02501384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99101
∙ SENSITIVE SKIN SUNSCREEN LOTION SPF 30;
∙ homosalate 10 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
∙ 2020-01-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02490390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98044
∙ LOTION SOLAIRE CORPS FPS 30;
∙ homosalate 10 % / w/w , bisoctrizole 5 % / w/w , octocrylene 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-12-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC;
∙ DIN: 02504871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99426
∙ SUNSCREEN LIP BALM;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 8 % / w/w;
∙ 2020-10-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02501406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99103
∙ ULTRA SHEER FACE MIST SUNSCREEN;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w , avobenzone 3 % / w/w;
∙ 2020-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02486458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97665
∙ PRISMA PROTECT SPF 30;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w , avobenzone 3 % / w/w;
∙ 2019-07-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DERMALOGICA, LLC;
∙ DIN: 02486687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97685
∙ ÉMULSION HYDRATANTE VISAGE FPS 30;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2.7 % / w/w , avobenzone 3 % / w/w;
∙ 2020-12-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC;
∙ DIN: 02494205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98424
∙ DREAM URBAN COVER;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
∙ 2019-07-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MAYBELLINE CANADA;
∙ DIN: 02486784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97695
∙ ULTRA SUN PROTECTOR LOTION LAIT SOLAIRE ULTRA PROTECTION 50+;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 2.3 % / w/w;
∙ 2020-12-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02497050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98691
∙ BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN SPRAY SPF 50+;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
∙ 2014-12-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02422360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90705
∙ SPF/FPS 30;
∙ homosalate 10 % / w/w , octocrylene 10 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
∙ 2014-07-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02404338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88910
∙ SPF 30 FPS SUNSCREEN LOTION LOTION ÉCRAN SOLAIRE;
∙ homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2014-05-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EMPACK SPRAYTECH INC;
∙ DIN: 02415321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89994
∙ NEUTROGENA CLEAR FACE SUNSCREEN LOTION;
∙ homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02496240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98611
∙ SPF 50 FACE CREAM;
∙ homosalate 10 % / w/w , octocrylene 10 % / w/w , zinc oxide 7 % / w/w , octisalate 5 % / w/w;
∙ 2020-12-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SUN BUM LLC;
∙ DIN: 02494965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98493
∙ SPF/FPS 15;
∙ homosalate 10 % / w/w , octocrylene 5 % / w/w , avobenzone 2 % / w/w , octisalate 5 % / w/w;
∙ 2014-07-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02404362
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88913
∙ COPPERTONE SPRAY SUNSCREEN SPF 50 DEFEND & CARE;
∙ homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
∙ 2020-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02488892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97894
∙ COPPERTONE SPRAY SUNSCREEN SPF 50 KIDS;
∙ homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2019-12-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02487705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97785
∙ COPPERTONE SPRAY SUNSCREEN SPF 50 SPORT;
∙ homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02487934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97805
∙ SPORT 50 CONTINUOUS SPRAY SUNSCREEN ECRAN SOLAIRE EN VAPORISATEUR;
∙ homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2019-11-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02491567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98155
∙ SUNSCREEN LOTION 50 SPF FPS;
∙ homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02495171
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98512
∙ COOLA ENVIRONMENTAL 360° DAILY PROTECTION SPF 18 REFRESHING WATER MIST SUNSCREEN;
∙ homosalate 10 % / w/w , octocrylene 5.5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
∙ 2021-03-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02510537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99974
∙ BANANA BOAT KIDS SUNSCREEN LOTION SPF/FPS 60;
∙ homosalate 10 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
∙ 2015-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02430215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91470
∙ SUN SILK DROPS;
∙ homosalate 10 % / w/w , octocrylene 6 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
∙ 2020-07-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02490854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98089
∙ BANANA BOAT KIDS TEAR-FREE SUNSCREEN SPRAY SPF 50+;
∙ homosalate 10 % / w/w , octocrylene 6 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2017-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02464977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95318
∙ CRÈME SOLAIRE VISAGE TOUCHER SEC FPS 30;
∙ homosalate 10 % / w/w , octocrylene 8 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
∙ 2020-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLARINS CANADA INC;
∙ DIN: 02494450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98446
∙ CRÈME SOLAIRE CORPS FPS 30;
∙ homosalate 10 % / w/w , octocrylene 8 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
∙ 2020-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLARINS CANADA INC;
∙ DIN: 02494655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98465
∙ COPPERTONE LOTION SUNSCREEN SPF 50 KIDS;
∙ homosalate 10 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02478269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96902
∙ COPPERTONE LOTION SUNSCREEN SPF 50 SUN GUARD;
∙ homosalate 10 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02478277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96903
∙ COPPERTONE LOTION SUNSCREEN SPF 50 DEFEND & CARE;
∙ homosalate 10 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02489791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97987
∙ OLAY REGENERIST WHIP SUN PROTECTION FACTOR 40;
∙ homosalate 10 % / w/w , octocrylene 9 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02493098
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98307
∙ SKIN TONE CORRECTING & BEAUTIFYING BB CREAM;
∙ homosalate 10.0 % / w/w , octisalate 5.0 % / w/w , octocrylene 5.0 % / w/w , titanium dioxide 4.5 % / w/w;
∙ 2013-06-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02406195
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89092
∙ PROTECT + HYDRATE MOISTURIZING SUNSCREEN SPF 50;
∙ homosalate 13.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 10 % / w/w;
∙ 2021-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02496801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98665
∙ PROTECT + HYDRATE FACE;
∙ homosalate 13.5 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02497336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98716
∙ HYDRO BOOST WATER GEL LOTION SUNSCREEN;
∙ homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02496585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98644
∙ LIFE BRAND SUNSCREEN LOTION SPF 50+;
∙ homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-03-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02497123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98696
∙ ULTRA SHEER BODY MIST SUNSCREEN;
∙ homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02502526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99209
∙ ULTRA SHEER DRY-TOUCH SUNSCREEN;
∙ homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02502534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99210
∙ ULTRA SHEER FACE SUNSCREEN;
∙ homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02502542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99211
∙ COOLA CLASSIC BODY SPF 30 SUNSCREEN LOTION TROPICAL COCONUT SCENT;
∙ homosalate 2.25 % / w/w , avobenzone 1.75 % / w/w , octisalate 1.5 % / w/w , octocrylene 3.75 % / w/w;
∙ 2021-03-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02510456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99967
∙ OLAY COMPLETE UV365* DAILY MOISTURIZING CREAM WITH SUNSCREEN BROAD SPECTRUM SPF 15 NORMAL;
∙ homosalate 4 % , avobenzone 3 % , octisalate 4.5 % , octocrylene 2.6 %;
∙ 2017-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02461196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94870
∙ OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 15 NORMAL;
∙ homosalate 4 % , avobenzone 3 % , octisalate 4.5 % , octocrylene 2.6 %;
∙ 2017-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02461234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94874
∙ CRÈME HYDRA FINISH CREAM CRÈME HYDRATATION RÉVÉLATRICE DE TEINT FPS 15 LARGE SPECTRE VISAGE MOISTURIZING COMPLEXION ENHACING CREAM SPF 15 BROAD SPECTRUM FACE;
∙ homosalate 4 % , octinoxate 6 %;
∙ 2019-04-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GUINOT;
∙ DIN: 02480441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97097
∙ INVISIBLUR PERFECTING SHIELD BROAD SPECTRUM SPF 30 PA+++;
∙ homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
∙ 2015-05-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MURAD LLC;
∙ DIN: 02433710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91807
∙ AGE BALANCING MOISTURE BROAD SPECTRUM SPF 30 | PA+++;
∙ homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
∙ 2017-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MURAD LLC;
∙ DIN: 02445743
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93102
∙ HYDRO BOOST GEL CREAM SPF 25;
∙ homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
∙ 2020-01-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02484285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97460
∙ RAPID WRINKLE REPAIR MOISTURIZER;
∙ homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
∙ 2012-01-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02368382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85335
∙ RAPID TONE REPAIR MOISTURIZER;
∙ homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
∙ 2013-01-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02384159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86990
∙ TRIPLE AGE REPAIR MOISTURIZER;
∙ homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
∙ 2015-01-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02387557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87316
∙ DEEP MOISTURE;
∙ homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
∙ 2015-06-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02405342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89014
∙ ABSOLUTELY AGELESS DAILY MOISTURIZER;
∙ homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
∙ 2016-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02440873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92523
∙ ESTEE LAUDER DAYWEAR 72H-HYDRATION SORBET CREME CRÈME SORBET HYDRATATION 72H SPF/FPS 15;
∙ homosalate 4 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
∙ 2019-03-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ESTEE LAUDER DIST.;
∙ DIN: 02481448
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97188
∙ OLAY REGENERIST ENHANCING UV LOTION WITH SPF 15;
∙ homosalate 4.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 2.6 % / w/w , octisalate 4.5 % / w/w;
∙ 2014-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02376466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86192
∙ ORIGINS PLANTSCRIPTION SPF 25 POWER ANTI-AGING CREAM;
∙ homosalate 5 % , octisalate 4.5 % , avobenzone 3 % , octocrylene 2.8 %;
∙ 2016-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ORIGINS NATURAL RESOURCES DIST;
∙ DIN: 02444216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92912
∙ COOLA CLASSIC FACE SPF 50 SUNSCREEN LOTION WHITE TEA SCENT;
∙ homosalate 5 % / w/w , avobenzone 1.75 % / w/w , octocrylene 5 % / w/w , octisalate 2 % / w/w;
∙ 2021-03-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02510812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100001
∙ STOKODERM SUNSCREEN PURE;
∙ homosalate 5 % / w/w , avobenzone 3 % / w/w , octisalate 3 % / w/w , octocrylene 10 % / w/w;
∙ 2021-05-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SC JOHNSON PROFESSIONAL CA INC;
∙ DIN: 02497093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98695
∙ LAB SERIES DAY RESCUE DEFENSE LOTION SPF 35;
∙ homosalate 5 % / w/w , octisalate 4.5 % / w/w , octocrylene 3.3 % / w/w , avobenzone 3 % / w/w;
∙ 2018-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LAB SERIES DIST.;
∙ DIN: 02462648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95043
∙ SUPERDEFENSE FATIGUE + 1ST SIGNS OF AGE MULTI-CORRECTING CREAM CRÈME MULTI-CORRECTION FATIGUE + 1ERS SIGNES DE L’ÂGE VERY DRY TO DRY COMBINATION / TRÈS SÈCHE À MIXTE SPF 25 FPS;
∙ homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02492083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98208
∙ COPPERTONE LOTION SUNSCREEN SPF 15 SUN GUARD;
∙ homosalate 5 % / w/w , octocrylene 3 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w;
∙ 2020-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02478730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96948
∙ HAWAIIAN TROPIC PROTECTIVE ARGAN DRY OIL SUNSCREEN SPRAY SPF 15;
∙ homosalate 5 % / w/w , octocrylene 3.5 % / w/w , avobenzone 1.5 % / w/w;
∙ 2019-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02477874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96872
∙ HAWAIIAN TROPIC SILK HYDRATION WEGHTLESS FACE;
∙ homosalate 5.5 % , octisalate 4.5 % , octocrylene 4 % , avobenzone 2 %;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02458160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94521
∙ SILK HYDRATION WEIGHTLESS CLEAR SUNSCREEN SPRAY SPF 30;
∙ homosalate 5.5 % , octocrylene 4 % , avobenzone 2 % , octisalate 4.5 %;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02455315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94213
∙ SHEER TOUCH/TOUCHER SOYEUX OIL-FREE SUNSCREEN/ÉCRAN SOLAIRE SANS HUILE SPF/FPS 30;
∙ homosalate 5.5 % / w/w , octisalate 4.5 % / w/w , octocrylene 4 % / w/w , avobenzone 2 % / w/w;
∙ 2014-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02409488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89418
∙ BB CREAM SUNSCREEN SPF 30;
∙ homosalate 5.9 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.4 % / w/w , avobenzone 2.2 % / w/w;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02456281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94317
∙ BANANA BOAT ULTRA SPORT SUNSCREEN LOTION SPF 30;
∙ homosalate 6 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.5 % / w/w , avobenzone 2.7 % / w/w;
∙ 2019-10-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02477521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96858
∙ DUO DEFENCE SUNSCREEN LOTION SPF 30;
∙ homosalate 6 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2017-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02464934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95314
∙ BANANA BOAT DAILY PROTECT SUNSCREEN LOTION SPF 30;
∙ homosalate 6 % / w/w , octocrylene 4.5 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
∙ 2021-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02505304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99467
∙ BANANA BOAT DAILY PROTECT SUNSCREEN SPRAY SPF 30;
∙ homosalate 6 % / w/w , octocrylene 6 % / w/w , avobenzone 2 % / w/w;
∙ 2021-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02505959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99531
∙ HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS DAILY USE SUNSCREEN MIST SPRAY SPF 30;
∙ homosalate 6 % / w/w , octocrylene 6 % / w/w , avobenzone 2.7 % / w/w;
∙ 2019-12-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02490919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98095
∙ COPPERTONE LOTION SUNSCREEN SPF 15 GLOW;
∙ homosalate 6 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02487969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97808
∙ HAWAIIAN TROPIC MATTE EFFECT MINERAL ENRICHED SUNSCREEN LOTION SPF 30;
∙ homosalate 6 % / w/w , zinc oxide 5.6 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.5 % / w/w;
∙ 2019-12-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02488310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97841
∙ ULTRA FACIAL MOISTURIZER SPF 30;
∙ homosalate 7 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
∙ 2013-07-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02401908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88678
∙ HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN LOTION SPF 30;
∙ homosalate 7 % / w/w , octocrylene 4.2 % / w/w , avobenzone 2.2 % / w/w;
∙ 2020-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02494787
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98476
∙ BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN SPRAY SPF 30;
∙ homosalate 7 % / w/w , octocrylene 5 % / w/w , avobenzone 2 % / w/w;
∙ 2014-12-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02422352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90704
∙ BANANA BOAT SUNCOMFORT SUNSCREEN SPRAY SPF 30;
∙ homosalate 7 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w , octocrylene 1.5 % / w/w;
∙ 2015-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02426722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91129
∙ ANEW REVERSALIST COMPLETE RENEWAL DAY CREAM;
∙ homosalate 7.0 % / w/w , octinoxate 7.0 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.85 % / w/w;
∙ 2014-03-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02414031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89871
∙ SPORT 30 LOTION SUNSCREEN LOTION ÉCRAN SOLAIRE;
∙ homosalate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w;
∙ 2020-10-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02502070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99167
∙ SUNSCREEN LOTION 30 SPF FPS;
∙ homosalate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02495163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98511
∙ ANEW ULTIMATE DAY MULTI-PERFORMANCE CREAM;
∙ homosalate 8 % / w/w , avobenzone 2.9 % / w/w , octinoxate 5 % / w/w , oxybenzone 4 % / w/w;
∙ 2015-05-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02431432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91585
∙ DAILYSCREEN;
∙ homosalate 8 % / w/w , octisalate 5 % / w/w , avobenzone 2.5 % / w/w;
∙ 2020-05-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ TAYLOR JAMES LLC;
∙ DIN: 02494957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98488
∙ ANTI-AGING MOISTURIZER BROAD SPECTRUM SPF 30 | PA+++;
∙ homosalate 8 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 7.5 % / w/w;
∙ 2016-04-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MURAD LLC;
∙ DIN: 02445751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93103
∙ UNSEEN SUNSCREEN;
∙ homosalate 8 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w , avobenzone 3 % / w/w;
∙ 2020-05-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ TAYLOR JAMES LLC;
∙ DIN: 02495481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98540
∙ MATTE DEFENSE SPF 30;
∙ homosalate 8 % / w/w , octisalate 5 % / w/w , octocrylene 8 % / w/w , avobenzone 3 % / w/w;
∙ 2020-11-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DERMALOGICA, LLC;
∙ DIN: 02490455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98050
∙ COPPERTONE LOTION SUNSCREEN SPF 30 SUN GUARD;
∙ homosalate 8 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02478749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96949
∙ COPPERTONE SPRAY SUNSCREEN SPF 30 SPORT;
∙ homosalate 8 % / w/w , octocrylene 7 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w;
∙ 2019-12-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02478250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96901
∙ ULTRA SHEER BODY MIST SUNSCREEN SPF 30;
∙ homosalate 8 % / w/w , octocrylene 8 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02486474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97667
∙ HAWAIIAN TROPIC MATTE EFFECT MINERAL ENRICHED SUNSCREEN LOTION SPF 50;
∙ homosalate 8 % / w/w , zinc oxide 7.3 % / w/w , octocrylene 5.7 % / w/w , octisalate 4.5 % / w/w;
∙ 2019-12-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02488329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97842
∙ ANEW VITALE DAY LOTION;
∙ homosalate 8.0 % / w/w , octinoxate 5.0 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.85 % / w/w;
∙ 2015-06-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02424363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90907
∙ COMPLETE DRY MIST SPRAY HYPOALLERGENIC UVA + UVB SPF 30;
∙ homosalate 8.78 % / w/w , octocrylene 5.92 % / w/w , octisalate 4.88 % / w/w , avobenzone 2.96 % / w/w;
∙ 2014-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02415313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89993
∙ HAUTE EXIGENCE JOUR SPF 20 MULTI-INTENSIVE;
∙ homosalate 9 % , avobenzone 3 % , octocrylene 2.7 %;
∙ 2015-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLARINS CANADA INC;
∙ DIN: 02425289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90992
∙ DENTEC LOTION;
∙ homosalate 9 % , octinoxate 7.5 % , octisalate 5 % , oxybenzone 4 %;
∙ 2019-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DENTEC SAFETY SPECIALISTS INC;
∙ DIN: 02440792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92515
∙ HYDRA-ESSENTIEL FLUIDE FONDANT DÉSALTÉRANT PEAUX NORMALES À MIXTES FPS/SPF 15;
∙ homosalate 9 % , octocrylene 5 % , avobenzone 3 %;
∙ 2018-04-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLARINS CANADA INC;
∙ DIN: 02471043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96014
∙ DUO DEFENCE SUNSCREEN LOTION SPF 50+;
∙ homosalate 9 % / w/w , octisalate 4 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
∙ 2017-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02464926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95312
∙ INTO REPAIR DRY SKIN / PEAUX SÈCHES;
∙ homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
∙ 2020-06-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS;
∙ DIN: 02489104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97916
∙ SUN ULTIMATE FACE CREAM / CRÈME VISAGE;
∙ homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
∙ 2020-05-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS;
∙ DIN: 02489112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97917
∙ HYDRA VIZOR;
∙ homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-12-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KENDO HOLDINGS, INC;
∙ DIN: 02496577
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98643
∙ SUNSCREEN OIL SPRAY;
∙ homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.4 % / w/w;
∙ 2013-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02388154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87370
∙ BANANA BOAT SIMPLY PROTECT SPORT SUNSCREEN SPRAY SPF 50+;
∙ homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 7 % / w/w , avobenzone 3 % / w/w;
∙ 2017-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02465051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95329
∙ BANANA BOAT SPORT FOR KIDS SUNSCREEN STICK SPF 50+;
∙ homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 9 % / w/w , avobenzone 2.7 % / w/w;
∙ 2017-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02464861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95306
∙ BANANA BOAT ULTRA SPORT SUNSCREEN STICK SPF 50+;
∙ homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 9 % / w/w , avobenzone 2.7 % / w/w;
∙ 2017-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02464969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95317
∙ HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN LOTION SPF 50;
∙ homosalate 9 % / w/w , octocrylene 5 % / w/w , avobenzone 2.7 % / w/w , octisalate 4 % / w/w;
∙ 2020-08-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02494795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98477
∙ BANANA BOAT DAILY PROTECT SUNSCREEN SPRAY SPF 50+;
∙ homosalate 9 % / w/w , octocrylene 6 % / w/w , avobenzone 2.7 % / w/w , octisalate 4.5 % / w/w;
∙ 2021-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02505967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99532
∙ BANANA BOAT SIMPLY PROTECT KIDS SUNSCREEN LOTION SPRAY SPF 50+;
∙ homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2017-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02466627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95496
∙ OLAY REGENERIST MICRO-SCULPTING CREAM WITH SUNSCREEN;
∙ homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2019-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02482177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97264
∙ BANANA BOAT SIMPLY PROTECT SENSITIVE FACES VISAGES SUNCREEN LOTION SPF 50 PLUS;
∙ homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , zinc oxide 7.3 % / w/w;
∙ 2019-01-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02478056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96878
∙ BANANA BOAT ULTRA SPORT SUNSCREEN LOTION SPF 50+;
∙ homosalate 9 % / w/w , octocrylene 6.5 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
∙ 2019-10-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02475405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96579
∙ BANANA BOAT DAILY PROTECT SUNSCREEN LOTION SPF 50+;
∙ homosalate 9 % / w/w , octocrylene 6.5 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
∙ 2021-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02505290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99466
∙ HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRAY SPF 50;
∙ homosalate 9 % / w/w , octocrylene 7 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
∙ 2021-01-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02495031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98499
∙ BANANA BOAT SIMPLY PROTECT SPORT SUNSCREEN LOTION SPF 50+;
∙ homosalate 9 % / w/w , octocrylene 7.5 % / w/w , avobenzone 3 % / w/w;
∙ 2017-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02467445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95582
∙ COPPERTONE LOTION SUNSCREEN SPF 30 GLOW;
∙ homosalate 9 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02488124
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97823
∙ COPPERTONE LOTION SUNSCREEN SPF 50 WATERBABIES;
∙ homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02487799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97795
∙ COPPERTONE LOTION SUNSCREEN SPF 50 GLOW;
∙ homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02487950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97807
∙ COPPERTONE CLEAR SUNSCREEN SPF 50 SPORT;
∙ homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02489538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97961
∙ COPPERTONE CLEAR ORANGE SUNSCREEN;
∙ homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-02-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02490293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98035
∙ COPPERTONE CLEAR BLUE SUNSCREEN;
∙ homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-02-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02490358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98040
∙ BANANA BOAT SIMPLY PROTECT SENSITIVE SUNSCREEN LOTION SPF 50 PLUS;
∙ homosalate 9 % / w/w , zinc oxide 7.3 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w;
∙ 2019-01-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02478064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96879
∙ RODAN+FIELDS REVERSE KIT;
∙ homosalate 9.3 % / w/w , octocrylene 6.1 % / w/w , octisalate 4.67 % / w/w , avobenzone 2.8 % / w/w;
∙ 2021-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Kit , Lotion | Trousse , Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02513641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100283
∙ FIVE STAR LIP PROTECTION;
∙ homosalate 9.6 % / w/w , octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , oxybenzone 5.0 % / w/w;
∙ 2010-09-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BLISTEX CORPORATION;
∙ DIN: 02353822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83903
∙ TEVA-IRBESARTAN HCTZ;
∙ hydrochlorothiazide 12.5 mg , irbesartan 300 mg;
∙ 2011-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02330520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81625
∙ ZESTORETIC;
∙ hydrochlorothiazide 12.5 mg , lisinopril 10 mg;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02103729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16636
∙ ACH-OLMESARTAN HCTZ;
∙ hydrochlorothiazide 12.5 mg , olmesartan medoxomil 20 mg;
∙ 2019-06-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02468948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95759
∙ OLMESARTAN/HCTZ;
∙ hydrochlorothiazide 12.5 mg , olmesartan medoxomil 20 mg;
∙ 2021-06-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02509601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99889
∙ ACH-OLMESARTAN HCTZ;
∙ hydrochlorothiazide 12.5 mg , olmesartan medoxomil 40 mg;
∙ 2019-06-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02468956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95760
∙ OLMESARTAN/HCTZ;
∙ hydrochlorothiazide 12.5 mg , olmesartan medoxomil 40 mg;
∙ 2021-06-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02509636
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99891
∙ TEVA-IRBESARTAN HCTZ;
∙ hydrochlorothiazide 25 mg , irbesartan 300 mg;
∙ 2011-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02330539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81626
∙ ACH-OLMESARTAN HCTZ;
∙ hydrochlorothiazide 25 mg , olmesartan medoxomil 40 mg;
∙ 2019-06-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02468964
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95761
∙ OLMESARTAN/HCTZ;
∙ hydrochlorothiazide 25 mg , olmesartan medoxomil 40 mg;
∙ 2021-06-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02509628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99890
∙ AA-AMILZIDE;
∙ hydrochlorothiazide 50 mg , amiloride hydrochloride 5 mg;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.16 – POTASSIUM-SPARING DIURETICS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00784400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10494
∙ TEVA-PROCTOSONE;
∙ hydrocortisone (hydrocortisone acetate) 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
∙ 1997-02-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Rectal | Rectale;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02226383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37454
∙ PRAMOX HC CREAM;
∙ hydrocortisone (hydrocortisone acetate) 1 % , pramoxine hydrochloride 1 %;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ DERMTEK PHARMA INC;
∙ DIN: 00770957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10052
∙ PRAMOX HC LOTION;
∙ hydrocortisone (hydrocortisone acetate) 1 % , pramoxine hydrochloride 1 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ DERMTEK PHARMA INC;
∙ DIN: 01954210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15948
∙ PROCTOSEDYL;
∙ hydrocortisone 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
∙ 2003-04-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Rectal | Rectale;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ APTALIS PHARMA CANADA ULC;
∙ DIN: 02223252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37334
∙ PROCTOL OINTMENT;
∙ hydrocortisone 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
∙ 2003-08-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Rectal | Rectale;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02247322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71565
∙ PROCTOL SUPPOSITORIES;
∙ hydrocortisone 5 mg , dibucaine hydrochloride 5 mg , framycetin sulfate 10 mg , esculin 10 mg;
∙ 2004-03-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02247882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72190
∙ ANUSOL-HC OINTMENT;
∙ hydrocortisone acetate 0.5 % , zinc sulfate 0.5 %;
∙ 1981-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal | Rectale;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 00505773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4389
∙ ANODAN-HC OINTMENT;
∙ hydrocortisone acetate 0.5 % , zinc sulfate 0.5 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal , Topical | Rectale , Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02128446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18240
∙ JAMPZINC-HC;
∙ hydrocortisone acetate 0.5 % / w/w , zinc sulfate monohydrate 0.5 % / w/w;
∙ 2012-07-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal , Topical | Rectale , Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02387239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87281
∙ PROCTOFOAM HC;
∙ hydrocortisone acetate 1 % , pramoxine hydrochloride 1 %;
∙ 1979-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal | Rectale;
∙ Aerosol | Aérosol;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ DUCHESNAY INC;
∙ DIN: 00363014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3492
∙ ANUSOL-HC SUPPOSITORIES;
∙ hydrocortisone acetate 10 mg , zinc sulfate 10 mg;
∙ 1975-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 00476285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4630
∙ ANODAN-HC 10MG SUPPOSITORIES;
∙ hydrocortisone acetate 10 mg , zinc sulfate 10 mg;
∙ 1998-08-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02236399
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59873
∙ VISINE FOR DRY EYE EYE REVIVAL;
∙ hypromellose 0.2 % / w/v , glycerine 0.2 % / v/v;
∙ 2016-05-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02436132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92046
∙ VISINE FOR DRY EYE TIRED EYE RELIEF;
∙ hypromellose 0.2 % / w/v , glycerine 0.2 % / w/v;
∙ 2016-06-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02438585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92296
∙ TEARS NATURALE FREE;
∙ hypromellose 0.3 % / w/v , dextran 70 0.1 % / w/v;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALCON CANADA INC;
∙ DIN: 01943308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13167
∙ NIGHTTIME PAIN RELIEF;
∙ ibuprofen (ibuprofen – ibuprofen potassium) 200 mg , diphenhydramine hydrochloride 25 mg;
∙ 2017-10-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02424630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90931
∙ CHILDREN’S ADVIL COLD;
∙ ibuprofen 100 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
∙ 2004-08-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02248435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72786
∙ CHILDREN’S ADVIL COLD & FLU MULTI-SYMPTOM;
∙ ibuprofen 100 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml , chlorpheniramine maleate 1 mg / 5 ml;
∙ 2010-01-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02268701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75412
∙ ADVIL NIGHTTIME;
∙ ibuprofen 200 mg , diphenhydramine hydrochloride 25 mg;
∙ 2011-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02355841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84104
∙ ADVIL COLD, COUGH & FLU NIGHTTIME;
∙ ibuprofen 200 mg , diphenhydramine hydrochloride 25 mg;
∙ 2013-08-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02401193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88592
∙ ADVIL DAY/NIGHT CONVENIENCE PACK;
∙ ibuprofen 200 mg , ibuprofen 200 mg , diphenhydramine hydrochloride 25 mg;
∙ 2014-06-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Kit , Capsule | Trousse , Capsule;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02410583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89525
∙ ROBAX PLATINUM;
∙ ibuprofen 200 mg , methocarbamol 500 mg;
∙ 2003-07-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02247147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71388
∙ MOTRIN PLATINUM MUSCLE & BODY;
∙ ibuprofen 200 mg , methocarbamol 500 mg;
∙ 2014-06-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02418967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90351
∙ ADVIL COLD AND SINUS;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02036312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14492
∙ SUDAFED SINUS ADVANCE;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2000-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02242217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65897
∙ ADVIL COLD & SINUS LIQUI-GELS;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2005-07-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02250705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73565
∙ ADVIL COLD AND SINUS DAYTIME;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2006-08-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02267616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75302
∙ COLD + SINUS;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2010-10-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02352281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83757
∙ COLD & SINUS RELIEF CAPSULES;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
∙ 2014-03-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02407779
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89248
∙ ADVIL COLD & SINUS PLUS;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
∙ 2004-08-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02248645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73002
∙ ADVIL COLD AND SINUS NIGHTTIME;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
∙ 2006-08-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02267632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75304
∙ ADVIL COLD, SINUS & FLU EXTRA STRENGTH;
∙ ibuprofen 400 mg , pseudoephedrine hydrochloride 60 mg , chlorpheniramine maleate 4 mg;
∙ 2018-08-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02471604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96076
∙ TARO-IMIPENEM-CILASTATIN;
∙ imipenem 250 mg / vial , cilastatin (cilastatin sodium) 250 mg / vial;
∙ 2010-08-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.08 – CARBAPENEMS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02351692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83695
∙ IMIPENEM AND CILASTATIN FOR INJECTION USP;
∙ imipenem 250 mg / vial , cilastatin (cilastatin sodium) 250 mg / vial;
∙ 2010-12-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.08 – CARBAPENEMS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02358336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84339
∙ PRIMAXIN 500;
∙ imipenem 500 mg / vial , cilastatin (cilastatin sodium) 500 mg / vial;
∙ 1987-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.08 – CARBAPENEMS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 00717282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8054
∙ TARO-IMIPENEM-CILASTATIN;
∙ imipenem 500 mg / vial , cilastatin (cilastatin sodium) 500 mg / vial;
∙ 2010-08-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.08 – CARBAPENEMS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02351706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83696
∙ IMIPENEM AND CILASTATIN FOR INJECTION USP;
∙ imipenem 500 mg / vial , cilastatin (cilastatin sodium) 500 mg / vial;
∙ 2010-12-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.08 – CARBAPENEMS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02358344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84340
∙ IMOVAX POLIO;
∙ inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney 40 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1 8 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett 32 unit / 0.5 ml;
∙ 2007-03-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SANOFI PASTEUR LIMITED;
∙ DIN: 01959042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44019
∙ ENERZAIR BREEZHALER;
∙ indacaterol (indacaterol acetate) 150 mcg , glycopyrronium (glycopyrronium bromide) 50 mcg , mometasone furoate 160 mcg;
∙ 2020-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Inhalation | Inhalation;
∙ Capsule | Capsule;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02501244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99087
∙ ATECTURA BREEZHALER;
∙ indacaterol (indacaterol acetate) 150 mcg , mometasone furoate 160 mcg;
∙ 2020-08-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Capsule | Capsule;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02498707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98849
∙ ATECTURA BREEZHALER;
∙ indacaterol (indacaterol acetate) 150 mcg , mometasone furoate 320 mcg;
∙ 2020-08-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Capsule | Capsule;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02498693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98848
∙ ATECTURA BREEZHALER;
∙ indacaterol (indacaterol acetate) 150 mcg , mometasone furoate 80 mcg;
∙ 2020-08-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Capsule | Capsule;
∙ 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02498685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98847
∙ ULTIBRO BREEZHALER;
∙ indacaterol (indacaterol maleate) 110 mcg , glycopyrronium (glycopyrronium bromide) 50 mcg;
∙ 2014-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Capsule | Capsule;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02418282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90285
∙ APO-PERINDOPRIL-INDAPAMIDE;
∙ indapamide 2.5 mg , perindopril erbumine 8 mg;
∙ 2021-02-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02453061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93947
∙ FLUMIST QUADRIVALENT;
∙ influenza virus type a (h1n1) 32000000 ffu / 0.2 ml , influenza virus type a (h3n2) 32000000 ffu / 0.2 ml , influenza virus type b (victoria) 32000000 ffu / 0.2 ml , influenza virus type b (yamagata) 32000000 ffu / 0.2 ml;
∙ 2014-10-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Nasal | Nasale;
∙ Spray | Pulvérisation;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02426544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91111
∙ HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ);
∙ insulin 30 unit / ml , insulin isophane (nph) 70 unit / ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 00795879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9788
∙ NOVOMIX 30;
∙ insulin aspart 30 unit / ml , insulin aspart protamine 70 unit / ml;
∙ 2005-09-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02265435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75090
∙ XULTOPHY;
∙ insulin degludec 100 unit / ml , liraglutide 3.6 mg / ml;
∙ 2018-06-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:20.08 – INSULINS , 68:20.06 – INCRETIN MIMETICS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02474875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96506
∙ SOLIQUA;
∙ insulin glargine 100 unit / ml , lixisenatide 33 mcg / ml;
∙ 2018-09-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:20.08 – INSULINS , 68:20.06 – INCRETIN MIMETICS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02478293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96906
∙ HUMULIN 30/70 CARTRIDGE;
∙ insulin injection human biosynthetic 30 unit / ml , insulin isophane human biosynthetic 70 unit / ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 01959212
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12568
∙ NOVOLIN GE 30/70;
∙ insulin injection human biosynthetic 30 unit / ml , insulin isophane human biosynthetic 70 unit / ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02024217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14269
∙ NOVOLIN GE 40/60 PENFILL;
∙ insulin injection human biosynthetic 40 unit / ml , insulin isophane human biosynthetic 60 unit / ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02024314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14262
∙ NOVOLIN GE 50/50 PENFILL;
∙ insulin injection human biosynthetic 50 unit / ml , insulin isophane human biosynthetic 50 unit / ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02024322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14270
∙ NOVOLIN GE 30/70 PENFILL;
∙ insulin isophane human biosynthetic 70 unit / ml , insulin injection human biosynthetic 30 unit / ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02025248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14265
∙ HUMALOG MIX 25 (CARTRIDGE);
∙ insulin lispro 25 unit / ml , insulin lispro protamine suspension 75 unit / ml;
∙ 1999-07-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02240294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63832
∙ HUMALOG MIX 25 (KWIKPEN);
∙ insulin lispro 25 unit / ml , insulin lispro protamine suspension 75 unit / ml;
∙ 2013-09-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02403420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88823
∙ HUMALOG MIX 50 (CARTRIDGE);
∙ insulin lispro 50 unit / ml , insulin lispro protamine suspension 50 unit / ml;
∙ 2007-01-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02240297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63835
∙ HUMALOG MIX 50 (KWIKPEN);
∙ insulin lispro 50 unit / ml , insulin lispro protamine suspension 50 unit / ml;
∙ 2014-01-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Suspension | Suspension;
∙ 68:20.08 – INSULINS;
∙ Schedule D | Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02403439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88824
∙ INTRON A;
∙ interferon alfa-2b 10000000 unit / vial , water 1 ml / vial;
∙ 1997-03-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intralesional , Intramuscular , Intravenous , Subcutaneous | Intralésionnelle , Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Liquid , Powder For Solution | Liquide , Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS , 08:18.20 – INTERFERONS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 02223406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43361
∙ IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION;
∙ ipratropium bromide (ipratropium bromide monohydrate) 0.5 mg / 2.5 ml , salbutamol (salbutamol sulfate) 2.5 mg / 2.5 ml;
∙ 2019-08-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:12.04.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02483394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97384
∙ COMBIVENT RESPIMAT;
∙ ipratropium bromide (ipratropium bromide monohydrate) 20 mcg / act , salbutamol (salbutamol sulfate) 100 mcg / act;
∙ 2014-09-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:12.04.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02419106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90364
∙ AVALIDE;
∙ irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
∙ 2000-03-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02241818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65483
∙ PMS-IRBESARTAN-HCTZ;
∙ irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02328518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81403
∙ TEVA-IRBESARTAN HCTZ;
∙ irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02330512
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81624
∙ SANDOZ IRBESARTAN HCT;
∙ irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02337428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82301
∙ IRBESARTAN-HCTZ;
∙ irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-05-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02365162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85001
∙ IRBESARTAN/HCTZ;
∙ irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-10-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02372886
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85799
∙ IRBESARTAN HCT;
∙ irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-06-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02385317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87095
∙ JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE;
∙ irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
∙ 2014-01-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02418223
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90280
∙ AVALIDE;
∙ irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
∙ 2000-03-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02241819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65484
∙ PMS-IRBESARTAN-HCTZ;
∙ irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02328526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81404
∙ SANDOZ IRBESARTAN HCT;
∙ irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02337436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82302
∙ IRBESARTAN-HCTZ;
∙ irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-05-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02365170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85002
∙ IRBESARTAN/HCTZ;
∙ irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-10-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02372894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85800
∙ IRBESARTAN HCT;
∙ irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-06-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02385325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87096
∙ JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE;
∙ irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
∙ 2014-01-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02418231
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90281
∙ PMS-IRBESARTAN-HCTZ;
∙ irbesartan 300 mg , hydrochlorothiazide 25 mg;
∙ 2011-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02328534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81405
∙ SANDOZ IRBESARTAN HCT;
∙ irbesartan 300 mg , hydrochlorothiazide 25 mg;
∙ 2011-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02337444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82303
∙ IRBESARTAN-HCTZ;
∙ irbesartan 300 mg , hydrochlorothiazide 25 mg;
∙ 2011-05-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02365189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85003
∙ IRBESARTAN/HCTZ;
∙ irbesartan 300 mg , hydrochlorothiazide 25 mg;
∙ 2011-10-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02372908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85801
∙ IRBESARTAN HCT;
∙ irbesartan 300 mg , hydrochlorothiazide 25 mg;
∙ 2012-06-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02385333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87097
∙ JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE;
∙ irbesartan 300 mg , hydrochlorothiazide 25 mg;
∙ 2014-01-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02418258
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90282
∙ GERMI-STAT PREP GEL;
∙ isopropyl alcohol 70 % , chlorhexidine gluconate 0.5 %;
∙ 2002-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GERMIPHENE CORPORATION;
∙ DIN: 02241528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65180
∙ ORKAMBI;
∙ ivacaftor 125 mg , lumacaftor 100 mg;
∙ 2017-05-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
∙ Prescription | Prescription;
∙ VERTEX PHARMACEUTICALS (CANADA) INCORPORATED;
∙ DIN: 02463040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95094
∙ ORKAMBI;
∙ ivacaftor 125 mg , lumacaftor 200 mg;
∙ 2016-01-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
∙ Prescription | Prescription;
∙ VERTEX PHARMACEUTICALS (CANADA) INCORPORATED;
∙ DIN: 02451379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93762
∙ COMBIVIR;
∙ lamivudine 150 mg , zidovudine 300 mg;
∙ 1998-12-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02239213
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62673
∙ APO-LAMIVUDINE-ZIDOVUDINE;
∙ lamivudine 150 mg , zidovudine 300 mg;
∙ 2012-06-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02375540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86096
∙ AURO-LAMIVUDINE/ZIDOVUDINE;
∙ lamivudine 150 mg , zidovudine 300 mg;
∙ 2014-03-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02414414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89907
∙ APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN;
∙ lansoprazole 30 mg / cap , amoxicillin 500 mg / cap , clarithromycin 500 mg / tab;
∙ 2018-08-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) , Kit , Capsule , Tablet | Capsule (À Libération Retardée) , Trousse , Capsule , Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES , 08:12.16.08 – AMINOPENICILLINS , 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02470780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95983
∙ ACT LATANOPROST/TIMOLOL;
∙ latanoprost 50 mcg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2015-09-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02436256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92058
∙ MED-LATANOPROST-TIMOLOL;
∙ latanoprost 50 mcg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2019-08-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
∙ Prescription | Prescription;
∙ GENERIC MEDICAL PARTNERS INC;
∙ DIN: 02454505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94108
∙ LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION;
∙ latanoprost 50 mcg / ml , timolol (timolol maleate) 5 mg / ml;
∙ 2020-07-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
∙ Prescription | Prescription;
∙ TELIGENT CANADA INC;
∙ DIN: 02489368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97945
∙ PROLOPA CAP 100-25;
∙ levodopa 100 mg , benserazide (benserazide hydrochloride) 25 mg;
∙ 1977-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 00386464
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2723
∙ AA-LEVOCARB CR;
∙ levodopa 100 mg , carbidopa 25 mg;
∙ 2009-02-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02272873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75839
∙ STALEVO;
∙ levodopa 100 mg , carbidopa 25 mg , entacapone 200 mg;
∙ 2008-04-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02305941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79151
∙ STALEVO;
∙ levodopa 125 mg , carbidopa 31.25 mg , entacapone 200 mg;
∙ 2010-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02337835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82348
∙ STALEVO;
∙ levodopa 150 mg , carbidopa 37.5 mg , entacapone 200 mg;
∙ 2008-04-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02305968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79152
∙ PROLOPA CAP 200-50;
∙ levodopa 200 mg , benserazide (benserazide hydrochloride) 50 mg;
∙ 1977-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 00386472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2724
∙ AA-LEVOCARB CR;
∙ levodopa 200 mg , carbidopa 50 mg;
∙ 2003-11-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02245211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69226
∙ PROLOPA CAP 50-12.5;
∙ levodopa 50 mg , benserazide (benserazide hydrochloride) 12.5 mg;
∙ 1981-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 00522597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4459
∙ STALEVO;
∙ levodopa 50 mg , carbidopa 12.5 mg , entacapone 200 mg;
∙ 2008-04-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02305933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79150
∙ STALEVO;
∙ levodopa 75 mg , carbidopa 18.75 mg , entacapone 200 mg;
∙ 2010-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02337827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82347
∙ PORTIA 21;
∙ levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
∙ 2007-08-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02295946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78129
∙ PORTIA 28;
∙ levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
∙ 2007-08-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02295954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78130
∙ SEASONALE;
∙ levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
∙ 2008-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02296659
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78201
∙ INDAYO;
∙ levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
∙ 2016-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02398869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88378
∙ ALESSE 21;
∙ levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
∙ 1998-01-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02236974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60269
∙ ALESSE 28;
∙ levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
∙ 1998-01-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02236975
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60270
∙ AVIANE 21;
∙ levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
∙ 2007-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02298538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78383
∙ AVIANE 28;
∙ levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
∙ 2007-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02298546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78384
∙ ALYSENA 21;
∙ levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
∙ 2012-11-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02387875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87345
∙ ALYSENA 28;
∙ levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
∙ 2012-11-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02387883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87346
∙ MIN-OVRAL 21;
∙ levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02042320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18754
∙ MIN-OVRAL 28;
∙ levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02042339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18755
∙ OVIMA 21;
∙ levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
∙ 2013-08-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02387085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87265
∙ OVIMA 28;
∙ levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
∙ 2013-08-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02387093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87266
∙ XYLONOR;
∙ lidocaine 15 g / 100 g , cetrimide 150 mg / 100 g;
∙ 1997-03-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Buccal | Buccale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT;
∙ DIN: 02218607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37164
∙ EMLA PATCH;
∙ lidocaine 2.5 % , prilocaine 2.5 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Patch | Timbre;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02057794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16733
∙ XYLONOR GEL;
∙ lidocaine 5 g / 100 g , cetrimonium bromide 150 mg / 100 g;
∙ 1981-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 52:16.00 – LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ SEPTODONT;
∙ DIN: 00479896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4410
∙ PLIAGLIS;
∙ lidocaine 7 % , tetracaine 7 %;
∙ 2015-09-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Prescription | Prescription;
∙ INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC;
∙ DIN: 02398028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88297
∙ INSTILLAGEL;
∙ lidocaine hydrochloride (lidocaine hydrochloride monohydrate) 2 % / w/w , chlorhexidine gluconate 0.05 % / w/w;
∙ 2007-12-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Urethral | Urétrale;
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02294990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78032
∙ XYLOCAINE 1% W EPINEPHRINE 1:100000;
∙ lidocaine hydrochloride 10 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
∙ 1954-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 00001791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=589
∙ XYLOCAINE 1% W EPINEPHRINE 1:200000;
∙ lidocaine hydrochloride 10 mg / ml , epinephrine (epinephrine bitartrate) 5 mcg / ml;
∙ 1954-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 00001805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=590
∙ BACTINE FIRST AID SPRAY;
∙ lidocaine hydrochloride 2.5 % / w/w , benzalkonium chloride 0.13 % / w/w;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ WELLSPRING PHARMACEUTICAL CANADA CORP;
∙ DIN: 02150379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19488
∙ XYLOCAINE 2% WITH EPINEPHRINE 1:200000;
∙ lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
∙ 2012-04-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02373130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85829
∙ OCTOCAINE HCL 2% EPINEPHRINE 1:100000;
∙ lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
∙ 1964-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Liquid | Liquide;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ NOVOCOL PHARMACEUTICAL OF CANADA INC;
∙ DIN: 00151866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=636
∙ LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP;
∙ lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
∙ 2016-01-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02436221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92056
∙ OCTOCAINE HCL 2% EPINEPHRINE 1:50000;
∙ lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.02 mg / ml;
∙ 1964-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Liquid | Liquide;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ NOVOCOL PHARMACEUTICAL OF CANADA INC;
∙ DIN: 00151874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=635
∙ XYLOCAINE DENTAL LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:50,000;
∙ lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.02 mg / ml;
∙ 2010-07-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ DENTSPLY CANADA LIMITED;
∙ DIN: 02345072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83052
∙ XYLOCAINE 2% W EPINEPHRINE 1:200000;
∙ lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 5 mcg / ml;
∙ 1965-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Epidural | Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 00284106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1830
∙ LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP;
∙ lidocaine hydrochloride 20 mg / ml , epinephrine 0.01 mg / ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 01901915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12648
∙ XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000;
∙ lidocaine hydrochloride 20.00 mg / ml , epinephrine 0.01 mg / ml;
∙ 2009-10-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ DENTSPLY CANADA LIMITED;
∙ DIN: 02331640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81732
∙ LIGNOSPAN FORTE;
∙ lidocaine hydrochloride 36 mg / 1.8 ml , epinephrine (epinephrine bitartrate) 36 mcg / 1.8 ml;
∙ 1976-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Liquid | Liquide;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT;
∙ DIN: 00375799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2506
∙ LIGNOSPAN STANDARD;
∙ lidocaine hydrochloride 36 mg / 1.8 ml , epinephrine 18 mcg / 1.8 ml;
∙ 1976-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Liquid | Liquide;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ SEPTODONT;
∙ DIN: 00375780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2541
∙ 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION;
∙ lidocaine hydrochloride 4 mg / ml , dextrose 50 mg / ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:04.04.08 – CLASS IB ANTIARRYTHMICS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00828602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10519
∙ TPR20;
∙ lidocaine hydrochloride 5 % / w/w , menthol 1 % / w/w;
∙ 2009-05-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ HUMN PHARMACEUTICALS INC;
∙ DIN: 02309076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79467
∙ JENTADUETO;
∙ linagliptin 2.5 mg , metformin hydrochloride 1000 mg;
∙ 2013-04-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02403277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88809
∙ JENTADUETO;
∙ linagliptin 2.5 mg , metformin hydrochloride 500 mg;
∙ 2013-04-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02403250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88807
∙ JENTADUETO;
∙ linagliptin 2.5 mg , metformin hydrochloride 850 mg;
∙ 2013-04-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02403269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88808
∙ CREON MINIMICROSPHERES 10;
∙ lipase 10000 unit , amylase 11200 unit , protease 730 unit;
∙ 1996-10-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02200104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36179
∙ COTAZYM;
∙ lipase 10000 unit , amylase 40000 unit , protease 35000 unit;
∙ 1973-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Immediate Release) | Capsule (À Libération Immédiate);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00263818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1649
∙ COTAZYM ECS 8;
∙ lipase 10800 unit , amylase 42000 unit , protease 45000 unit;
∙ 1980-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00502790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3891
∙ PANCREASE MT 16;
∙ lipase 16800 unit , amylase 70000 unit , protease 40000 unit;
∙ 1988-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ VIVUS INC.;
∙ DIN: 00789429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9512
∙ PANCREASE MT 20;
∙ lipase 21000 unit , amylase 61000 unit , protease 37000 unit;
∙ 2020-12-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ VIVUS INC.;
∙ DIN: 02503441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99292
∙ COTAZYM ECS 20;
∙ lipase 25000 unit , amylase 100000 unit , protease 100000 unit;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00821373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9892
∙ CREON MINIMICROSPHERES 25;
∙ lipase 25000 unit , amylase 25500 unit , protease 1600 unit;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 01985205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13302
∙ PANCREASE MT 2;
∙ lipase 2600 unit , amylase 10850 unit , protease 6200 unit;
∙ 2020-12-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ VIVUS INC.;
∙ DIN: 02503433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99291
∙ CREON MINIMICROSPHERES 35;
∙ lipase 35000 unit , amylase 35700 unit , protease 2240 unit;
∙ 2021-01-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02494639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98463
∙ PANCREASE MT 4;
∙ lipase 4200 unit , amylase 17500 unit , protease 10000 unit;
∙ 1988-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ VIVUS INC.;
∙ DIN: 00789445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9514
∙ CREON MINIMICROSPHERES MICRO;
∙ lipase 5000 unit / 100 mg , amylase 5100 unit / 100 mg , protease 320 unit / 100 mg;
∙ 2015-11-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Granules For Suspension, Delayed Release | Granules Pour Suspension, À Libération Retardée;
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02445158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93037
∙ TEVA-LISINOPRIL/HCTZ (TYPE Z);
∙ lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
∙ 2007-11-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02301768
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78710
∙ TEVA-LISINOPRIL/HCTZ (TYPE P);
∙ lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
∙ 2007-11-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02302136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78744
∙ SANDOZ LISINOPRIL HCT;
∙ lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
∙ 2007-11-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02302365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78769
∙ LISINOPRIL/HCTZ (TYPE Z);
∙ lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-06-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02362945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84793
∙ TEVA-LISINOPRIL/HCTZ (TYPE Z);
∙ lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2007-11-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02301776
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78711
∙ TEVA-LISINOPRIL/HCTZ (TYPE P);
∙ lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2007-11-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02302144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78745
∙ SANDOZ LISINOPRIL HCT;
∙ lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2007-11-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02302373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78770
∙ LISINOPRIL/HCTZ (TYPE Z);
∙ lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2011-06-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02362953
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84794
∙ TEVA-LISINOPRIL/HCTZ (TYPE Z);
∙ lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
∙ 2007-11-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02301784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78712
∙ TEVA-LISINOPRIL/HCTZ (TYPE P);
∙ lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
∙ 2007-11-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02302152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78746
∙ SANDOZ LISINOPRIL HCT;
∙ lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
∙ 2007-11-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02302381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78771
∙ LISINOPRIL/HCTZ (TYPE Z);
∙ lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
∙ 2011-06-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02362961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84795
∙ ZESTORETIC;
∙ lisinopril 20 mg , hydrochlorothiazide 12.5 mg;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02045737
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16903
∙ ZESTORETIC;
∙ lisinopril 20 mg , hydrochlorothiazide 25 mg;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02045729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17903
∙ IMODIUM COMPLETE;
∙ loperamide hydrochloride 2 mg , simethicone 125 mg;
∙ 2002-06-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:08.00 – ANTIDIARRHEA AGENTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02245185
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69200
∙ KALETRA;
∙ lopinavir 100 mg , ritonavir 25 mg;
∙ 2008-08-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ ABBVIE CORPORATION;
∙ DIN: 02312301
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79781
∙ KALETRA;
∙ lopinavir 200 mg , ritonavir 50 mg;
∙ 2006-09-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ ABBVIE CORPORATION;
∙ DIN: 02285533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77104
∙ KALETRA;
∙ lopinavir 400 mg / 5 ml , ritonavir 100 mg / 5 ml;
∙ 2001-03-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ ABBVIE CORPORATION;
∙ DIN: 02243644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67570
∙ CLARITIN ALLERGY + SINUS;
∙ loratadine 5 mg , pseudoephedrine sulfate 120 mg;
∙ 1991-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Immediate And Extended Release) | Comprimé(À Libération Immédiate Et Prolongée);
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 01945157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11974
∙ HYZAAR;
∙ losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
∙ 2007-09-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02297841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78318
∙ SANDOZ LOSARTAN HCT;
∙ losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02362449
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84745
∙ TEVA-LOSARTAN/HCTZ;
∙ losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02377144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86273
∙ LOSARTAN HCT;
∙ losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-07-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02388979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87450
∙ MINT-LOSARTAN/HCTZ;
∙ losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-07-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02389665
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87516
∙ PMS-LOSARTAN-HCTZ;
∙ losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02392232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87751
∙ AURO-LOSARTAN HCT;
∙ losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
∙ 2014-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02423650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90836
∙ LOSARTAN/HCTZ;
∙ losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
∙ 2014-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02427656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91216
∙ HYZAAR DS;
∙ losartan potassium 100 mg , hydrochlorothiazide 25 mg;
∙ 2000-01-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02241007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64599
∙ SANDOZ LOSARTAN HCT DS;
∙ losartan potassium 100 mg , hydrochlorothiazide 25 mg;
∙ 2012-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02313383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79891
∙ TEVA-LOSARTAN/HCTZ;
∙ losartan potassium 100 mg , hydrochlorothiazide 25 mg;
∙ 2012-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02377152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86274
∙ LOSARTAN HCT;
∙ losartan potassium 100 mg , hydrochlorothiazide 25 mg;
∙ 2012-07-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02388987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87451
∙ PMS-LOSARTAN-HCTZ;
∙ losartan potassium 100 mg , hydrochlorothiazide 25 mg;
∙ 2012-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02392240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87752
∙ JAMP-LOSARTAN HCTZ;
∙ losartan potassium 100 mg , hydrochlorothiazide 25 mg;
∙ 2014-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02408252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89298
∙ AURO-LOSARTAN HCT;
∙ losartan potassium 100 mg , hydrochlorothiazide 25 mg;
∙ 2014-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02423669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90837
∙ LOSARTAN/HCTZ;
∙ losartan potassium 100 mg , hydrochlorothiazide 25 mg;
∙ 2014-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02427664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91217
∙ MINT-LOSARTAN/HCTZ DS;
∙ losartan potassium 100.0 mg , hydrochlorothiazide 25.0 mg;
∙ 2012-07-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02389673
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87517
∙ HYZAAR;
∙ losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
∙ 1996-11-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02230047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48580
∙ SANDOZ LOSARTAN HCT;
∙ losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02313375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79890
∙ LOSARTAN HCT;
∙ losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-07-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02388960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87449
∙ MINT-LOSARTAN/HCTZ;
∙ losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-07-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02389657
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87515
∙ PMS-LOSARTAN-HCTZ;
∙ losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02392224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87750
∙ JAMP-LOSARTAN HCTZ;
∙ losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
∙ 2014-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02408244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89297
∙ AURO-LOSARTAN HCT;
∙ losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
∙ 2014-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02423642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90835
∙ LOSARTAN/HCTZ;
∙ losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
∙ 2014-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02427648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91215
∙ TEVA-LOSARTAN/HCTZ;
∙ losartan potassium 50.0 mg , hydrochlorothiazide 12.5 mg;
∙ 2012-04-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02358263
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84332
∙ ORKAMBI;
∙ lumacaftor 100 mg / sachet , ivacaftor 125 mg / sachet;
∙ 2018-12-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Granules | Granules;
∙ 48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
∙ Prescription | Prescription;
∙ VERTEX PHARMACEUTICALS (CANADA) INCORPORATED;
∙ DIN: 02483831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97420
∙ ORKAMBI;
∙ lumacaftor 150 mg / sachet , ivacaftor 188 mg / sachet;
∙ 2018-12-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Granules | Granules;
∙ 48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
∙ Prescription | Prescription;
∙ VERTEX PHARMACEUTICALS (CANADA) INCORPORATED;
∙ DIN: 02483858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97421
∙ LUBRICATING NASAL GEL;
∙ macrogol 15 % , propylene glycol 20 %;
∙ 1997-01-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Nasal | Nasale;
∙ Gel | Gel;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02220806
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37257
∙ RHINARIS NASAL GEL;
∙ macrogol 15 % , propylene glycol 20 %;
∙ 2011-11-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Nasal | Nasale;
∙ Gel | Gel;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02352699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83795
∙ EYE STREAM;
∙ magnesium chloride 0.03 % / w/v , sodium chloride 0.64 % / w/v , potassium chloride 0.075 % / w/v , calcium chloride 0.048 % / w/v;
∙ 1987-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Otc | En Vente Libre;
∙ ALCON CANADA INC;
∙ DIN: 00707937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7474
∙ PRISM0CAL;
∙ magnesium chloride 0.108 g / 1000 ml , sodium chloride 6.449 g / 1000 ml , lactic acid 0.284 g / 1000 ml , sodium bicarbonate 58.8 g / 1000 ml;
∙ 2005-12-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intravenous , Dialysis | Intraveineuse , Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02274876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76040
∙ PRISM0CAL B22K0/0;
∙ magnesium chloride 3.05 g / l , sodium chloride 7.14 g / l , sodium bicarbonate 2.12 g / l;
∙ 2016-06-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Intravenous , Dialysis | Intraveineuse , Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02441691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92609
∙ GELUSIL ANTACID AND ANTI-GAS;
∙ magnesium hydroxide 200 mg , aluminum hydroxide-sucrose dried gel 200 mg , simethicone 25 mg;
∙ 2014-01-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ BOYD PHARMACEUTICALS INC.;
∙ DIN: 02409836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89449
∙ DIOVOL PLUS ALUMINUM FREE;
∙ magnesium hydroxide 200 mg , simethicone 25 mg , calcium carbonate 200 mg;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 02157624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19075
∙ STOMAAX PLUS;
∙ magnesium hydroxide 200 mg / 5 ml , aluminum hydroxide 200 mg / 5 ml , dimethicone 25 mg / 5 ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 00623709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10217
∙ ARIDOL;
∙ mannitol 5 mg / cap , mannitol 10 mg / cap , mannitol 20 mg / cap , mannitol 40 mg / cap;
∙ 2020-06-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Inhalation | Inhalation;
∙ Kit , Powder | Trousse , Poudre;
∙ 36:00.00 – DIAGNOSTIC AGENTS;
∙ Prescription Recommended | Prescription (Recommandé);
∙ PHARMAXIS LTD;
∙ DIN: 02489562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97957
∙ CYSTOSOL W 3% HEXITOLS;
∙ mannitol 500 mg / 100 ml , sorbitol 2.5 g / 100 ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Irrigation | Irrigation;
∙ Liquid | Liquide;
∙ 40:36.00 – IRRIGATING SOLUTIONS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00799963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9829
∙ PROQUAD;
∙ measles virus vaccine live attenuated (edmonston b strain) 3.00 log10 tcid50 / 0.5 ml , mumps virus vaccine live attenuated (jeryl lynn strain) 4.30 log10 tcid50 / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 3.00 log10 tcid50 / 0.5 ml , varicella-zoster virus vaccine live attenuated (oka/merck strain) 3.99 log10 pfu / 0.5 ml;
∙ 2014-05-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 02399229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88411
∙ M-M-R II;
∙ measles virus vaccine live attenuated 1000 unit / 0.5 ml , mumps virus vaccine live attenuated (jeryl lynn strain) 5000 unit / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000 unit / 0.5 ml;
∙ 1979-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 00466085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3569
∙ TELEBRIX 38 ORAL;
∙ meglumine ioxitalamate 513 mg / ml , sodium ioxitalamate 255 mg / ml;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 36:68.00 – ROENTGENOGRAPHY;
∙ Ethical | Spécialité Médicale;
∙ LIEBEL-FLARSHEIM CANADA INC;
∙ DIN: 02131684
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17800
∙ ALKERAN;
∙ melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intra-Arterial , Intravenous | Intra-Artérielle , Intraveineuse;
∙ Solution , Kit , Powder For Solution | Solution , Trousse , Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02087286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18786
∙ MELPHALAN FOR INJECTION;
∙ melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
∙ 2018-11-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution , Kit , Powder For Solution | Solution , Trousse , Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02468921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95758
∙ MELPHALAN FOR INJECTION;
∙ melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
∙ 2018-06-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intra-Arterial , Intravenous | Intra-Artérielle , Intraveineuse;
∙ Solution , Kit , Powder For Solution | Solution , Trousse , Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02473348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96274
∙ TARO-MELPHALAN;
∙ melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
∙ 2021-01-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intra-Arterial , Intravenous | Intra-Artérielle , Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02480026
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97057
∙ MENJUGATE LIQUID;
∙ meningococcal group c oligosaccharide 10 mcg / 0.5 ml , corynebacterium diphtheriae crm-197 protein 25 mcg / 0.5 ml;
∙ 2015-10-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:08.00 – TOXOIDS , 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02440709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92507
∙ NEISVAC-C;
∙ meningococcal polysaccharide vaccine grp c 10 mcg / 0.5 ml , tetanus toxoid 20 mcg / 0.5 ml;
∙ 2002-01-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02245057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69061
∙ MENACTRA;
∙ meningococcal polysaccharide-diphtheria toxoid conjugate – group a 4.0 mcg / 0.5 ml , meningococcal polysaccharide-diphtheria toxoid conjugate – group c 4.0 mcg / 0.5 ml , meningococcal polysaccharide-diphtheria toxoid conjugate – group y 4.0 mcg / 0.5 ml , meningococcal polysaccharide-diphtheria toxoid conjugate – group w 135 4.0 mcg / 0.5 ml;
∙ 2006-10-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SANOFI PASTEUR LIMITED;
∙ DIN: 02279924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76550
∙ GOLD BOND ANTI-ITCH LOTION;
∙ menthol 0.5 % / w/w , pramoxine hydrochloride 1 % / w/w , dimethicone 5 % / w/w;
∙ 2009-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC;
∙ DIN: 02318482
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80397
∙ GOLD BOND MEDICATED ANTI-ITCH CREAM;
∙ menthol 1 % / w/w , pramoxine hydrochloride 1 % / w/w;
∙ 1999-01-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC;
∙ DIN: 02236991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60289
∙ ABSORBINE JR LINIMENT;
∙ menthol 1.25 % , chloroxylenol 0.5 %;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:24.04 – BASIC LOTIONS AND LINIMENTS;
∙ Otc | En Vente Libre;
∙ CLARION BRANDS LLC;
∙ DIN: 01942301
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42113
∙ BENYLIN EXTRA STRENGTH MUCUS & PHLEGM;
∙ menthol 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
∙ 2009-07-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02320940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80636
∙ BUCKLEY’S NIGHTTIME COUGH & CONGESTION;
∙ menthol 22 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml;
∙ 1997-06-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02230939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50217
∙ ABSORBINE JR EXTRA STRENGTH LINIMENT;
∙ menthol 4.0 % , chloroxylenol 0.5 %;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:24.04 – BASIC LOTIONS AND LINIMENTS;
∙ Otc | En Vente Libre;
∙ BRIDGES CONSUMER HEALTHCARE LLC;
∙ DIN: 01942271
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41939
∙ ISOCAINE HCL INJ 2%;
∙ mepivacaine hydrochloride 20 mg / ml , corbadrine 0.05 mg / ml;
∙ 1977-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ NOVOCOL PHARMACEUTICAL OF CANADA INC;
∙ DIN: 00393711
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2744
∙ CARBOCAINE 2% WITH NEO-COBEFRIN;
∙ mepivacaine hydrochloride 20 mg / ml , corbadrine 0.05 mg / ml;
∙ 2019-07-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ NOVOCOL PHARMACEUTICAL OF CANADA INC;
∙ DIN: 02474182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96421
∙ MARCELLE/ OIL FREE MULTI-DÉFENSE LOTION SPF 15 FPS/ FLUIDE MULTI-DÉFENSE SANS HUILE;
∙ meradimate 4.0 % , ensulizole 2.0 % , octinoxate 7.5 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GROUPE MARCELLE INC;
∙ DIN: 02093006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42376
∙ MUSCLE & BACK PAIN RELIEF CAPLETS;
∙ methocarbamol 400 mg , acetaminophen 325 mg;
∙ 1997-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02230790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50062
∙ ROBAXACET-8;
∙ methocarbamol 400 mg , acetaminophen 325 mg , codeine phosphate 8 mg;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 01934767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12942
∙ ROBAXACET EXTRA STRENGTH;
∙ methocarbamol 400 mg , acetaminophen 500 mg;
∙ 1997-07-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02231176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50484
∙ EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF;
∙ methocarbamol 400 mg , acetaminophen 500 mg;
∙ 1999-06-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02239141
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62597
∙ EXTRA STRENGTH TYLENOL BODY PAIN NIGHT;
∙ methocarbamol 400 mg , acetaminophen 500 mg;
∙ 2011-03-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02357356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84247
∙ MUSCLE AND BACK PAIN RELIEF;
∙ methocarbamol 400 mg , acetaminophen 500 mg;
∙ 2018-04-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02451298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93755
∙ ROBAXISAL C 1/2;
∙ methocarbamol 400 mg , acetylsalicylic acid 325 mg , codeine phosphate 32.4 mg;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 01934791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12946
∙ ROBAXISAL EXTRA STRENGTH;
∙ methocarbamol 400 mg , acetylsalicylic acid 500 mg;
∙ 1997-07-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02230949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50227
∙ EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG;
∙ methocarbamol 400 mg , acetylsalicylic acid 500 mg;
∙ 2005-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02252228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73710
∙ EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA;
∙ methocarbamol 400 mg , acetylsalicylic acid 500 mg;
∙ 2014-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02426625
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91119
∙ ROBAXISAL C 1/4;
∙ methocarbamol 400 mg , codeine phosphate 16.2 mg , acetylsalicylic acid 325 mg;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 01934783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12944
∙ MUSCLE AND BACK PAIN PLATINUM RELIEF;
∙ methocarbamol 500 mg , ibuprofen 200 mg;
∙ 2014-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02422042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90673
∙ ANALGESIC AND MUSCLE RELAXANT;
∙ methocarbamol 500 mg , ibuprofen 400 mg;
∙ 2012-03-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02377462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86317
∙ DEPO-MEDROL WITH LIDOCAINE;
∙ methylprednisolone acetate 40 mg / ml , lidocaine hydrochloride 10 mg / ml;
∙ 1973-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intra-Articular , Intrabursal | Intra-Articulaire , Intrabursique;
∙ Suspension | Suspension;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00260428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1619
∙ FLAGYSTATIN;
∙ metronidazole 500 mg , nystatin 100000 unit;
∙ 1979-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Vaginal | Vaginale;
∙ Suppository | Suppositoire;
∙ 84:04.04 – ANTIBIOTICS , 84:04.08.28 – POLYENES;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 01926829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12654
∙ MONISTAT 7 DUAL-PAK;
∙ miconazole nitrate 100 mg / sup , miconazole nitrate 2 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical , Vaginal | Topique , Vaginale;
∙ Suppository , Cream | Suppositoire , Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ INSIGHT PHARMACEUTICALS, LLC;
∙ DIN: 02126257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16611
∙ MONISTAT 1 COMBINATION PACK;
∙ miconazole nitrate 1200 mg / sup , miconazole nitrate 2 %;
∙ 1999-02-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical , Vaginal | Topique , Vaginale;
∙ Suppository , Cream | Suppositoire , Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ INSIGHT PHARMACEUTICALS, LLC;
∙ DIN: 02239600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63070
∙ MONISTAT 3 DUAL-PAK;
∙ miconazole nitrate 400 mg / sup , miconazole nitrate 2 %;
∙ 1986-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical , Vaginal | Topique , Vaginale;
∙ Ovule , Cream | Ovule , Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ INSIGHT PHARMACEUTICALS, LLC;
∙ DIN: 02126249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16610
∙ MIFEGYMISO;
∙ mifepristone 200 mg , misoprostol 200 mcg;
∙ 2017-01-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Buccal , Oral | Buccale , Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 76:00.00 – OXYTOCICS , 56:28.28 – PROSTAGLANDINS;
∙ Prescription | Prescription;
∙ LINEPHARMA INTERNATIONAL LIMITED;
∙ DIN: 02444038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92881
∙ MAGNOLAX;
∙ mineral oil 0.25 ml / ml , magnesium hydroxide 60 mg / ml;
∙ 1972-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Emulsion | Émulsion;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 00202045
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1281
∙ SYSTANE OINTMENT;
∙ mineral oil 3 % , lanolin 3 % , white petrolatum 94 %;
∙ 2016-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Ophthalmic | Ophtalmique;
∙ Ointment | Pommade;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALCON CANADA INC;
∙ DIN: 02444062
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92885
∙ SOOTHE RESTORE;
∙ mineral oil 4.5 % , mineral oil light 1 %;
∙ 2018-05-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ BAUSCH & LOMB INC;
∙ DIN: 02465302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95350
∙ REFRESH LACRI-LUBE;
∙ mineral oil 42.5 % , white petrolatum 57.3 %;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Ointment | Pommade;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 00210889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9820
∙ HUILE DE BAIN THERAPEUTIQUE;
∙ mineral oil 91.7 % , lanolin 3 %;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 01939068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12947
∙ POLLINEX R;
∙ modified ragweed tyrosine adsorbate 210 unit / ml , modified ragweed tyrosine adsorbate 500 unit / ml , modified ragweed tyrosine adsorbate 1400 unit / ml , modified ragweed tyrosine adsorbate 4300 unit / ml;
∙ 1979-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ ALLERGY THERAPEUTICS (UK) LTD;
∙ DIN: 00464988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3409
∙ ZENHALE;
∙ mometasone furoate 100 mcg / act , formoterol fumarate dihydrate 5 mcg / act;
∙ 2011-03-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Aerosol, Metered Dose | Aérosol, Dose Mesurée;
∙ 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:10.08.08 – ORALLY INHALED PREPARATIONS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02361752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84680
∙ ZENHALE;
∙ mometasone furoate 200 mcg / act , formoterol fumarate dihydrate 5 mcg / act;
∙ 2011-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Aerosol, Metered Dose | Aérosol, Dose Mesurée;
∙ 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:10.08.08 – ORALLY INHALED PREPARATIONS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02361760
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84681
∙ PRIORIX;
∙ mumps virus vaccine live attenuated (jeryl lynn strain) 10000 ccid50 / 0.5 ml , measles virus vaccine live attenuated 1000 ccid50 / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000 ccid50 / 0.5 ml , water 0.5 ml;
∙ 1998-12-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02239208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62666
∙ PRIORIX-TETRA;
∙ mumps virus vaccine live attenuated (jeryl lynn strain) 25118.9 ccid50 / 0.5 ml , measles virus vaccine live attenuated 1000 ccid50 / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000 ccid50 / 0.5 ml , varicella-zoster virus vaccine live attenuated (oka/merck strain) 1995.2623 ccid50 / 0.5 ml;
∙ 2008-06-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02297884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78322
∙ TEVA-BUPRENORPHINE/NALOXONE;
∙ naloxone (naloxone hydrochloride dihydrate) 2 mg , buprenorphine (buprenorphine hydrochloride) 8 mg;
∙ 2017-09-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02453916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94044
∙ CONTRAVE;
∙ naltrexone hydrochloride 8 mg , bupropion hydrochloride 90 mg;
∙ 2018-03-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:20.08.92 – Anorexigenic Agents, Miscellaneous;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02472945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96230
∙ CLEAR EYES ALLERGY;
∙ naphazoline hydrochloride 0.012 % , glycerine 0.26 % , zinc sulfate 0.25 %;
∙ 2004-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Ophthalmic | Ophtalmique;
∙ Liquid | Liquide;
∙ 52:32.00 – VASOCONSTRICTORS;
∙ Otc | En Vente Libre;
∙ PRESTIGE BRANDS INC;
∙ DIN: 02248059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72379
∙ NAPHCON A;
∙ naphazoline hydrochloride 0.025 % , pheniramine maleate 0.3 %;
∙ 1980-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ ALCON CANADA INC;
∙ DIN: 00481408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3743
∙ OPTI-TEARS ALLERGY;
∙ naphazoline hydrochloride 0.025 % , pheniramine maleate 0.3 %;
∙ 2017-04-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ ALCON CANADA INC;
∙ DIN: 02445573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93086
∙ SOOTHE ALLERGY;
∙ naphazoline hydrochloride 0.02675 % / w/v , pheniramine maleate 0.315 % / w/v;
∙ 1987-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ BAUSCH & LOMB INC;
∙ DIN: 00750794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8155
∙ CLEAR EYES EXTRA STRENGTH REDNESS RELIEF;
∙ naphazoline hydrochloride 0.03 % / w/v , glycerine 0.50 % / w/v;
∙ 2011-04-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS;
∙ Otc | En Vente Libre;
∙ PRESTIGE BRANDS INC;
∙ DIN: 02360837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84583
∙ VIMOVO;
∙ naproxen 375 mg , esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
∙ 2011-02-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Immediate And Delayed-Release) | Comprimé (À Libération Immédiate Et Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02361701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84676
∙ MYLAN-NAPROXEN/ESOMEPRAZOLE MR;
∙ naproxen 375 mg , esomeprazole (esomeprazole magnesium) 20 mg;
∙ 2017-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Immediate And Delayed-Release) | Comprimé (À Libération Immédiate Et Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02458608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94575
∙ VIMOVO;
∙ naproxen 500 mg , esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
∙ 2011-02-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Immediate And Delayed-Release) | Comprimé (À Libération Immédiate Et Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02361728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84677
∙ MYLAN-NAPROXEN/ESOMEPRAZOLE MR;
∙ naproxen 500 mg , esomeprazole (esomeprazole magnesium) 20 mg;
∙ 2017-02-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Immediate And Delayed-Release) | Comprimé (À Libération Immédiate Et Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02443449
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92813
∙ ALEVE NIGHTTIME;
∙ naproxen sodium 220 mg , diphenhydramine hydrochloride 25 mg;
∙ 2016-02-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02444593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92965
∙ TRUMENBA;
∙ neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a 60 mcg / 0.5 ml , neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b 60 mcg / 0.5 ml;
∙ 2018-01-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02468751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95723
∙ MAXITROL;
∙ neomycin (neomycin sulfate) 3.5 mg / g , polymyxin b sulfate 6000 unit / g , dexamethasone 0.1 % / w/w;
∙ 1970-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Ophthalmic | Ophtalmique;
∙ Ointment | Pommade;
∙ 52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00358177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2423
∙ OXYGEN USP, NITROGEN NF, MEDICAL GAS MIXTURE;
∙ nitrogen 50 % , oxygen 50 %;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 02014378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13894
∙ NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML;
∙ nitroglycerin 20 mg / 100 ml , dextrose 5 g / 100 ml;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:12.08 – NITRATES AND NITRITES;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02145308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18086
∙ NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML;
∙ nitroglycerin 40 mg / 100 ml , dextrose 5 g / 100 ml;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:12.08 – NITRATES AND NITRITES;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02145316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18085
∙ LIQUI-MED ANALGESIC GAS;
∙ nitrous oxide 50 % , oxygen 50 %;
∙ 1983-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 28:04.16 – INHALATION ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 00693596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6850
∙ ALNOX GAS;
∙ nitrous oxide 50 % , oxygen 50 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 28:04.16 – INHALATION ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ AIR LIQUIDE CANADA INC.;
∙ DIN: 02071010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18513
∙ EVRA;
∙ norelgestromin 200 mcg / 24 hour , ethinyl estradiol 35 mcg / 24 hour;
∙ 2003-12-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Transdermal | Transdermique;
∙ Patch (Extended Release) | Timbre (À Libération Prolongée);
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02248297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72637
∙ SYNPHASIC 21 TABLETS;
∙ norethindrone 0.5 mg , ethinyl estradiol 0.035 mg , norethindrone 1.0 mg , ethinyl estradiol 0.035 mg;
∙ 1996-08-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02187108
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42889
∙ BREVICON 1/35 TABLETS (21-DAY PACK);
∙ norethindrone 1 mg , ethinyl estradiol 0.035 mg;
∙ 1996-08-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02189054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42921
∙ BREVICON 1/35 TABLETS (28-DAY PACK);
∙ norethindrone 1 mg , ethinyl estradiol 0.035 mg;
∙ 1996-09-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02189062
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42922
∙ SELECT 1/35 (21-DAY);
∙ norethindrone 1.0 mg , ethinyl estradiol 0.035 mg;
∙ 1997-05-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02197502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42952
∙ SELECT 1/35 (28-DAY);
∙ norethindrone 1.0 mg , ethinyl estradiol 0.035 mg;
∙ 1997-05-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02199297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42960
∙ LOLO;
∙ norethindrone acetate 1 mg , ethinyl estradiol 10 mcg , ethinyl estradiol 10 mcg;
∙ 2014-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02417456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90215
∙ MINESTRIN 1/20;
∙ norethindrone acetate 1 mg , ethinyl estradiol 20 mcg;
∙ 1975-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 00343838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2254
∙ MINESTRIN 1/20;
∙ norethindrone acetate 1 mg , ethinyl estradiol 20 mcg;
∙ 1975-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 00315966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2255
∙ LOESTRIN 1.5/30;
∙ norethindrone acetate 1.5 mg , ethinyl estradiol 30 mcg;
∙ 1974-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 00297143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1922
∙ LOESTRIN 1.5/30;
∙ norethindrone acetate 1.5 mg , ethinyl estradiol 30 mcg;
∙ 1976-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 00353027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2386
∙ COPHYLAC;
∙ normethadone hydrochloride 10 mg / ml , p-hydroxyephedrine hydrochloride 20 mg / ml;
∙ 1997-01-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Drops | Gouttes;
∙ 48:08.00 – ANTITUSSIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02224577
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37358
∙ THERADERM CREAM;
∙ nystatin 100000 unit / g , neomycin (neomycin sulfate) 2.5 mg / g , gramicidin 0.25 mg / g , triamcinolone acetonide 1 mg / g;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BIMEDA-MTC ANIMAL HEALTH INC;
∙ DIN: 02022818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15598
∙ ALMOST POWDER MAKEUP TEINT POUDRE NATUREL SPF 18 / FPS 18;
∙ octinoxate 2 % / w/w , titanium dioxide 1.2 % / w/w;
∙ 2019-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Powder | Poudre;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02482991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97339
∙ CC CREAM BROAD SPECTRUM SPF 30;
∙ octinoxate 2.5 % / w/w , homosalate 7.0 % / w/w , oxybenzone 2.0 % / w/w , titanium dioxide 4.1 % / w/w;
∙ 2014-09-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MERLE NORMAN COSMETICS INC;
∙ DIN: 02426145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91075
∙ M.A.C STUDIO FIX FLUID SPF 15;
∙ octinoxate 2.5 % / w/w , titanium dioxide 1.0 % / w/w;
∙ 2010-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MAKE-UP ART COSMETICS, DIST.;
∙ DIN: 02328259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81378
∙ LE FOND DE TEINT;
∙ octinoxate 3.9 % / w/w , titanium dioxide 3.3 % / w/w;
∙ 2017-09-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02458284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94538
∙ ELIZABETH ARDEN NOURISHING LIP BALM SPF 20;
∙ octinoxate 4 % / w/w , avobenzone 3 % / w/w;
∙ 2013-02-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELIZABETH ARDEN (CANADA) LIMITED;
∙ DIN: 02392895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87816
∙ ARTISTRY HYDRA-V SHEER WEIGHTLESS FOUNDATION;
∙ octinoxate 4 % / w/w , zinc oxide 2.74 % / w/w;
∙ 2018-05-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMWAY CORP.;
∙ DIN: 02463490
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95157
∙ CERAMIDE LIFT AND FIRM EYE CREAM SPF 15;
∙ octinoxate 4.09 % / w/w , oxybenzone 1.40 % / w/w;
∙ 2011-03-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELIZABETH ARDEN (CANADA) LIMITED;
∙ DIN: 02354470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83964
∙ PREVAGE ANTI-AGING EYE CREAM SPF 15;
∙ octinoxate 4.09 % / w/w , oxybenzone 1.40 % / w/w;
∙ 2010-10-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELIZABETH ARDEN (CANADA) LIMITED;
∙ DIN: 02355302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84055
∙ CLÉ DE PEAU BEAUTÉ RADIANT CREAM FOUNDATION;
∙ octinoxate 4.4 % / w/w , titanium dioxide 1.2 % / w/w;
∙ 2016-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02446952
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93252
∙ PHELITYL DAY LOTION SPF 15;
∙ octinoxate 5 % , avobenzone 2 %;
∙ 2012-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ERNO LASZLO;
∙ DIN: 02383314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86907
∙ MAC STUDIO FINISH CONCEALER SPF 35;
∙ octinoxate 5 % , titanium dioxide 2 %;
∙ 2004-01-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Powder | Poudre;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MAKE-UP ART COSMETICS, DIST.;
∙ DIN: 02248338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72680
∙ TEINT LUMIÈRE;
∙ octinoxate 5 % / w/w , titanium dioxide 1.52 % / w/w;
∙ 2015-04-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GROUPE MARCELLE INC;
∙ DIN: 02434016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91835
∙ M.A.C. STUDIO WATERWEIGHT SPF 30 FOUNDATION;
∙ octinoxate 5 % / w/w , titanium dioxide 3.1 % / w/w , zinc oxide 2.1 % / w/w;
∙ 2015-09-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MAKE-UP ART COSMETICS, DIST.;
∙ DIN: 02437376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92171
∙ SUPERDEFENSE CITY BLOCK DAILY ENERGY + FACE PROTECTOR SPF 50;
∙ octinoxate 5 % / w/w , zinc oxide 3.6 % / w/w , titanium dioxide 3.2 % / w/w;
∙ 2020-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02492970
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98295
∙ CLINIQUE EVEN BETTER MAKEUP SPF 15;
∙ octinoxate 5.9 % / w/w , titanium dioxide 3.5 % / w/w , zinc oxide 2.8 % / w/w;
∙ 2012-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02367998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85281
∙ CLINIQUE REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY;
∙ octinoxate 5.90 % / w/w , titanium dioxide 3.70 % / w/w , zinc oxide 2.90 % / w/w;
∙ 2012-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02370425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85558
∙ BRONZ REPAIR SEA AND TROPICS FACE;
∙ octinoxate 6 % , avobenzone 2.6 %;
∙ 2016-09-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS;
∙ DIN: 02455250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94207
∙ BUTTERSTICK;
∙ octinoxate 6 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
∙ 2019-06-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02466716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95506
∙ OLAY AGE DEFYING ADVANCED WITH HYALURONIC ACID HYDRATING MOISTURIZER LOTION WITH SUNSCREEN;
∙ octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
∙ 2018-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02460874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94836
∙ OLAY AGE DEFYING CLASSIC DAILY RENEWAL LOTION WITH SUNSCREEN;
∙ octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
∙ 2017-09-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02460882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94837
∙ OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 15 SENSITIVE;
∙ octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
∙ 2018-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02461242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94873
∙ OLAY COMPLETE UV365* DAILY MOISTURIZING CREAM WITH SUNSCREEN BROAD SPECTRUM SPF 15 SENSITIVE;
∙ octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
∙ 2018-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02461250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94875
∙ OLAY SENSITIVE;
∙ octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
∙ 2020-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02492792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98279
∙ SOOTHING CARE;
∙ octinoxate 6.00 % / w/w , avobenzone 2.50 % / w/w , octocrylene 1.85 % / w/w;
∙ 2014-06-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02416611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90120
∙ SPF 50 CLASSIC FACE SPORT COOLA CLASSIC SUNSCREEN WHITE TEA MOISTURIZER;
∙ octinoxate 6.25 % / w/w , avobenzone 3 % / w/w;
∙ 2018-05-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02464543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95268
∙ MARY KAY CC CREAM;
∙ octinoxate 6.5 % / w/w , homosalate 5.0 % / w/w , oxybenzone 1.2 % / w/w;
∙ 2014-02-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MARY KAY COSMETICS LTD;
∙ DIN: 02414430
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89908
∙ COMPLETE MOISTURE;
∙ octinoxate 6.6 % , octisalate 4.4 %;
∙ 2020-04-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BLISTEX CORPORATION;
∙ DIN: 02475189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96549
∙ SUPERFRUIT SOOTHER;
∙ octinoxate 6.6 % , octisalate 4.4 %;
∙ 2019-05-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BLISTEX CORPORATION;
∙ DIN: 02487160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97729
∙ ULTRA-RICH HYDRATION;
∙ octinoxate 6.6 % / w/w , octisalate 4.4 % / w/w;
∙ 2019-11-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BLISTEX CORPORATION;
∙ DIN: 02487926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97804
∙ SHADE AND ILLUMINATE SOFT RADIANCE FOUNDATION SPF 50;
∙ octinoxate 6.7 % / w/w , octisalate 4.5 % / w/w , zinc oxide 3.8 % / w/w , ensulizole 2.7 % / w/w;
∙ 2020-04-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ TOM FORD BEAUTY DIST.;
∙ DIN: 02491494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98149
∙ FUTURIST HYDRA RESCUE MOISTURIZING MAKEUP FOND DE TEINT HYDRATANT SPF/FPS 45;
∙ octinoxate 6.7 % / w/w , octisalate 4.5 % / w/w , zinc oxide 3.8 % / w/w , ensulizole 2.7 % / w/w;
∙ 2020-02-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ESTEE LAUDER DIST.;
∙ DIN: 02494604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98460
∙ HEALTHY GLOW ALL-IN-ONE TINTED MOISTURIZER BROAD SPECTRUM SPF 25;
∙ octinoxate 6.7 % / w/w , titanium dioxide 3.1 % / w/w , zinc oxide 1.3 % / w/w;
∙ 2020-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SMASHBOX COSMETICS DIST;
∙ DIN: 02496909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98678
∙ CC CREAM CORRECTION COMPLETE COMPLETE CORRECTION FPS 50 / SPF 50;
∙ octinoxate 6.8 % , titanium dioxide 4 % , zinc oxide 15.2 %;
∙ 2019-07-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CHANEL CANADA ULC;
∙ DIN: 02486849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97701
∙ RENEWED HOPE IN A JAR SPF 30;
∙ octinoxate 7 % / w/w , avobenzone 2.7 % / w/w , octocrylene 2 % / w/w;
∙ 2017-10-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ HFC PRESTIGE INTERNATIONAL CANADA INC;
∙ DIN: 02461676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94933
∙ AMOREPACIFIC COLOR CONTROL CUSHION COMPACT;
∙ octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w , zinc oxide 9.8 % / w/w;
∙ 2018-02-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMOREPACIFIC CORPORATION;
∙ DIN: 02462621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95041
∙ IOPE AIR CUSHION;
∙ octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w , zinc oxide 9.8 % / w/w;
∙ 2019-08-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMOREPACIFIC CORPORATION;
∙ DIN: 02488299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97839
∙ SULWHASOO PERFECTING CUSHION;
∙ octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w , zinc oxide 9.8 % / w/w;
∙ 2019-10-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMOREPACIFIC CORPORATION;
∙ DIN: 02491117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98113
∙ ANEW VITALE DAY CREAM;
∙ octinoxate 7.0 % / w/w , octisalate 4.5 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.8 % / w/w;
∙ 2014-09-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02419181
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90373
∙ MAC STUDIO SCULPT SPF 15 FOUNDATION;
∙ octinoxate 7.0 % / w/w , titanium dioxide 2.0 % / w/w;
∙ 2009-02-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MAKE-UP ART COSMETICS, DIST.;
∙ DIN: 02311143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79674
∙ FUTURE SOLUTION LX TOTAL PROTECTIVE EMULSION E;
∙ octinoxate 7.4 % , octocrylene 2 % , avobenzone 1.5 % , oxybenzone 1 %;
∙ 2017-09-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02461951
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94971
∙ FUTURE SOLUTION LX TOTAL PROTECTIVE CREAM E;
∙ octinoxate 7.4 % , octocrylene 3 % , avobenzone 2 % , oxybenzone 1.5 %;
∙ 2017-09-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02461943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94970
∙ COLOR-SMART DAY MOISTURIZER HYDRATANT JOUR CORRECTEUR DE TEINT BROAD SPECTRUM SPF 30 FPS 30 A LARGE SPECTRE;
∙ octinoxate 7.4 % , titanium dioxide 4.5 %;
∙ 2019-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02480565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97111
∙ COLOR-SMART DAY MOISTURIZER OIL-FREE HYDRATANT JOUR CORRECTEUR DE TEINT SANS CORPS GRAS BROAD SPECTRUM SPF 30 FPS;
∙ octinoxate 7.4 % , titanium dioxide 5.3 %;
∙ 2019-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02480573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97112
∙ CLINIQUE FOR MEN SPF 21 MOISTURIZER;
∙ octinoxate 7.4 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , oxybenzone 2.0 % / w/w;
∙ 2006-11-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02271508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75697
∙ UV PROTECTIVE COMPACT FOUNDATION (REFILL);
∙ octinoxate 7.4 % / w/w , octocrylene 5 % / w/w , titanium dioxide 11.8 % / w/w;
∙ 2016-03-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Powder | Poudre;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02424002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90873
∙ ANTI-AGING COMPLEX EYE TREATMENT BROAD SPECTRUM SPF 15;
∙ octinoxate 7.4 % / w/w , zinc oxide 6.5 % / w/w;
∙ 2013-08-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MERLE NORMAN COSMETICS INC;
∙ DIN: 02404842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88967
∙ DORMER 211 FACE CREAM SPF 15;
∙ octinoxate 7.5 % , avobenzone 2 % , oxybenzone 3 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DORMER LABORATORIES INC.;
∙ DIN: 02035472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18554
∙ SUNSCREEN LOTION SPF 30;
∙ octinoxate 7.5 % , avobenzone 2.5 % , ensulizole 2 %;
∙ 2018-08-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VIVIER CANADA INCORPORATED;
∙ DIN: 02473844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96351
∙ DYNAMIC SKIN RECOVERY SPF 50;
∙ octinoxate 7.5 % , avobenzone 3 %;
∙ 2018-05-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DERMALOGICA, LLC;
∙ DIN: 02466007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95427
∙ ULTRA CALMING DAILY MOISTURIZER SPF 15;
∙ octinoxate 7.5 % , avobenzone 3 % , octisalate 2 %;
∙ 2005-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02260255
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74548
∙ MARCELLE/MULTI-DEFENSE CREAM/CRÈME MULTI-DÉFENSE/SPF 15 FPS;
∙ octinoxate 7.5 % , ensulizole 2.0 % , meradimate 4.0 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GROUPE MARCELLE INC;
∙ DIN: 02093014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42377
∙ ADAPTASUN SUN CARE LOTION SEA AND TROPICS BODY / LAIT DE SOIN SOLAIRE MER ET TROPIQUES CORPS SPF/FPS 35;
∙ octinoxate 7.5 % , homosalate 3 % , avobenzone 2.5 %;
∙ 2016-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS;
∙ DIN: 02452642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93901
∙ DRY OIL SUNSCREEN;
∙ octinoxate 7.5 % , homosalate 5.0 % , octisalate 5.0 % , oxybenzone 3.0 %;
∙ 2015-03-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02431041
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91549
∙ SOFTLIPS SLIMS;
∙ octinoxate 7.5 % , octisalate 3 % , oxybenzone 3 %;
∙ 2001-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE MENTHOLATUM COMPANY OF CANADA LTD;
∙ DIN: 02240701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64289
∙ HYDRATANT DÉFENSE FPS 30;
∙ octinoxate 7.5 % , octocrylene 5 % , octisalate 5 % , avobenzone 3 %;
∙ 2018-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GROUPE MARCELLE INC;
∙ DIN: 02468808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95734
∙ AVON SUN LIP BALM SPF 15;
∙ octinoxate 7.5 % , oxybenzone 2 %;
∙ 2000-04-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02240745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64334
∙ DEEP MOISTURE RENEWAL WITH SPF 15;
∙ octinoxate 7.5 % , oxybenzone 2.5 %;
∙ 2008-09-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BLISTEX CORPORATION;
∙ DIN: 02308576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79420
∙ SUN-SHADES LIP BALM SPF 15 – PINA COLADA STK;
∙ octinoxate 7.5 % , oxybenzone 3 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MELALEUCA OF CANADA INC.;
∙ DIN: 02045613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42332
∙ AVON MOISTURE SHIELD-TINTED SPF 15 CRM;
∙ octinoxate 7.5 % , oxybenzone 3.5 %;
∙ 1996-09-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02050773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=32792
∙ REPLENISHING MOISTURE LOTION SPF 15;
∙ octinoxate 7.5 % , oxybenzone 5 % , octisalate 5 %;
∙ 2007-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ H.J. SUTTON INDUSTRIES LTD.;
∙ DIN: 02300605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78589
∙ LIP BALM SPF 30;
∙ octinoxate 7.5 % , oxybenzone 5.5 % , octisalate 3.0 %;
∙ 2008-06-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CROC BLOC PRODUCTS INC.;
∙ DIN: 02305283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79082
∙ REVERSA CRÈME ANTI-RIDES CONTOUR DES YEUX FPS 15;
∙ octinoxate 7.5 % / w/w , avobenzone 2 % / w/w , octisalate 5 % / w/w;
∙ 2002-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DERMTEK PHARMA INC;
∙ DIN: 02241273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64883
∙ DOUBLE-DUTY FACE MOISTURIZER SPF 20;
∙ octinoxate 7.5 % / w/w , avobenzone 2.2 % / w/w;
∙ 2013-07-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JACK BLACK LLC;
∙ DIN: 02381990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86786
∙ CRÈME DE JOUR;
∙ octinoxate 7.5 % / w/w , avobenzone 3 % / w/w;
∙ 1998-01-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC;
∙ DIN: 02232205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51733
∙ MATRIX SUPPORT WITH SUNSCREEN BROAD SPECTRUM SPF 30;
∙ octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
∙ 2018-09-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NEOSTRATA COMPANY, INC;
∙ DIN: 02470527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95951
∙ SHEER HYDRATION SUNSCREEN BROAD SPECTRUM SPF 40;
∙ octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
∙ 2019-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NEOSTRATA COMPANY, INC;
∙ DIN: 02482010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97249
∙ ARTISTRY YOUTH XTEND PROTECTING CREAM;
∙ octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , oxybenzone 1 % / w/w;
∙ 2013-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMWAY CORP.;
∙ DIN: 02391023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87640
∙ ARTISTRY YOUTH XTEND PROTECTING LOTION;
∙ octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , oxybenzone 1 % / w/w;
∙ 2013-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMWAY CORP.;
∙ DIN: 02391031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87641
∙ SUN ULTIMATE SPRAY SPF/FPS 30;
∙ octinoxate 7.5 % / w/w , homosalate 7 % / w/w , octisalate 5 % / w/w , avobenzone 2.5 % / w/w;
∙ 2016-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS CANADA INC.;
∙ DIN: 02450585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93674
∙ OLAY COMPLETE ALL DAY MOISTURE WITH SUNSCREEN BROAD SPECTRUM SPF 30 SENSITIVE;
∙ octinoxate 7.5 % / w/w , octisalate 2.5 % / w/w , octocrylene 2.5 % / w/w , zinc oxide 7.0 % / w/w;
∙ 2015-04-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02422379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90706
∙ BABY LIPS;
∙ octinoxate 7.5 % / w/w , octisalate 3.0 % / w/w;
∙ 2011-12-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MAYBELLINE CANADA;
∙ DIN: 02369486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85441
∙ CLINIQUE REPAIRWEAR UPLIFTING FIRMING CREAM SPF 15 VERY DRY TO DRY;
∙ octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , titanium dioxide 1.7 % / w/w;
∙ 2012-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02384825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87051
∙ CLINIQUE REPAIRWEAR UPLIFTING FIRMING CREAM SPF 15 DRY COMBINATION TO COMBINATION OILY;
∙ octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , titanium dioxide 1.7 % / w/w;
∙ 2012-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02384833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87052
∙ CLINIQUE REPAIRWEAR LASER FOCUS LINE SMOOTHING CREAM SPF 15 VERY DRY TO DRY COMBINATION;
∙ octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , titanium dioxide 1.7 % / w/w;
∙ 2015-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02440547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92492
∙ MAGIX FACE PERFECTOR;
∙ octinoxate 7.5 % / w/w , octisalate 4.0 % / w/w;
∙ 2008-07-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02309068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79466
∙ MATTE MOISTURIZER SPF 15;
∙ octinoxate 7.5 % / w/w , octisalate 4.0 % / w/w , avobenzone 2.5 % / w/w;
∙ 2006-02-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KAMINS DERMATOLOGICS INC;
∙ DIN: 02274345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75980
∙ MOISTURE SURGE SHEERTINT HYDRATOR SPF 25;
∙ octinoxate 7.5 % / w/w , octisalate 4.5 % / w/w , titanium dioxide 3.8 % / w/w , zinc oxide 3.6 % / w/w;
∙ 2020-02-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02492059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98206
∙ ANEW PLATINUM DAY CREAM;
∙ octinoxate 7.5 % / w/w , octisalate 4.75 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.85 % / w/w;
∙ 2011-01-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02353873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83908
∙ FOUNDATION PRIMER PLUS SPF 15;
∙ octinoxate 7.5 % / w/w , octisalate 5 % / w/w;
∙ 2011-07-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MERLE NORMAN COSMETICS INC;
∙ DIN: 02368455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85341
∙ LIP CONDITIONER SPF 15;
∙ octinoxate 7.5 % / w/w , octisalate 5 % / w/w;
∙ 2011-06-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MERLE NORMAN COSMETICS INC;
∙ DIN: 02368463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85343
∙ ESTEE LAUDER DAYWEAR MULTI-PROTECTION SHEER TINT RELEASE MOISTURIZER SPF 15 ALL SKINTYPES;
∙ octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 2.0 % / w/w;
∙ 2003-08-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ESTEE LAUDER DIST.;
∙ DIN: 02246876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71101
∙ CORRECTION CODE (A.M.) DAILY MOISTURIZER BROAD SPECTRUM SPF 25;
∙ octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , oxybenzone 3.0 % / w/w , avobenzone 3.0 % / w/w;
∙ 2013-09-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ALOETTE COSMETICS INC.;
∙ DIN: 02399288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88418
∙ VITAMIN C GLOW-PROTECT LOTION SPF 30;
∙ octinoxate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
∙ 2011-02-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE BODY SHOP CANADA LIMITED;
∙ DIN: 02351498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83677
∙ SPF/FPS 30 ECO-LUX SIZE/FORMAT ÉCOLUX BODY / CORPS;
∙ octinoxate 7.5 % / w/w , octocrylene 7 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w;
∙ 2020-07-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02482169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97263
∙ SPF/FPS 30 BODY/CORPS;
∙ octinoxate 7.5 % / w/w , octocrylene 7 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w;
∙ 2019-07-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02483955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97425
∙ ARTISTRY YOUTH XTEND LIFTING SMOOTHING FOUNDATION;
∙ octinoxate 7.5 % / w/w , oxybenzone 0.5 % / w/w;
∙ 2015-12-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMWAY CORP.;
∙ DIN: 02435829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92017
∙ TIMELESS ILLUMINATING MAKEUP BROAD SPECTRUM SPF 30;
∙ octinoxate 7.5 % / w/w , oxybenzone 2 % / w/w;
∙ 2017-03-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MERLE NORMAN COSMETICS INC;
∙ DIN: 02460327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94764
∙ FLAWLESS EFFECT LIQUID FOUNDATION BROAD SPECTRUM SPF 15;
∙ octinoxate 7.5 % / w/w , oxybenzone 3 % / w/w;
∙ 2008-06-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MERLE NORMAN COSMETICS INC;
∙ DIN: 02306441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79215
∙ MARCELLE SHEER TINT MOISTURIZER HYDRATANT TEINTÉ TRANSLUCIDE SPF 30 FPS;
∙ octinoxate 7.5 % / w/w , oxybenzone 3 % / w/w;
∙ 2019-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GROUPE MARCELLE INC;
∙ DIN: 02464748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95288
∙ CHAPSTICK MOISTURIZER;
∙ octinoxate 7.5 % / w/w , oxybenzone 3.5 % / w/w;
∙ 1997-08-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02229613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47540
∙ SUN AND SNOW SPORT SPF 15;
∙ octinoxate 7.5 % / w/w , oxybenzone 3.5 % / w/w;
∙ 2011-07-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DAVID ASTLEY AND COMPANY INC.;
∙ DIN: 02363909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84886
∙ MARCELLE REVIVAL+ SKIN RENEWAL ANTI-AGING DAY CREAM SPF 15;
∙ octinoxate 7.5 % / w/w , oxybenzone 4 % / w/w , ensulizole 2.5 % / w/w;
∙ 2017-06-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GROUPE MARCELLE INC;
∙ DIN: 02462079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94981
∙ REVERSA CREME FPS30;
∙ octinoxate 7.5 % / w/w , oxybenzone 5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
∙ 2015-05-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DERMTEK PHARMA INC;
∙ DIN: 02435101
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91939
∙ MEANINGFUL BEAUTY CINDY CRAWFORD SKIN BRIGHTENING DÉCOLLETÉ AND NECK TREATMENT SPF 15;
∙ octinoxate 7.5 % / w/w , oxybenzone 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2014-11-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GUTHY-RENKER LLC;
∙ DIN: 02367505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85235
∙ MOISTURIZING ANTIOXIDANT DAY CRÈME SPF 20;
∙ octinoxate 7.5 % / w/w , oxybenzone 5.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w;
∙ 2013-12-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GUTHY-RENKER LLC;
∙ DIN: 02361639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84670
∙ CLINIQUE REPAIRWEAR LASER FOCUS LINE SMOOTHING CREAM SPF 15 COMBINATION OILY TO OILY;
∙ octinoxate 7.5 % / w/w , titanium dioxide 1.5 % / w/w;
∙ 2015-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02440539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92491
∙ RÉNERGIE LIFT MAKEUP;
∙ octinoxate 7.5 % / w/w , titanium dioxide 3.2 % / w/w;
∙ 2020-09-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LANCOME CANADA;
∙ DIN: 02495546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98544
∙ CLINIQUE MOISTURE SURGE CC CREAM HYDRATING COLOUR CORRECTOR SPF 30;
∙ octinoxate 7.5 % / w/w , titanium dioxide 5.2 % / w/w , octisalate 5.0 % / w/w , zinc oxide 3.2 % / w/w;
∙ 2013-05-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02402114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88698
∙ ELTAMD SKINCARE UV FACIAL SPF 30;
∙ octinoxate 7.5 % / w/w , zinc oxide 7 % / w/w;
∙ 2010-01-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELTAMD INC;
∙ DIN: 02322277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80773
∙ INDEFENSE30;
∙ octinoxate 7.5 % / w/w , zinc oxide 7 % / w/w;
∙ 2017-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ INDEED LABORATORIES INC;
∙ DIN: 02461161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94866
∙ ELTAMD SKINCARE UV CLEAR;
∙ octinoxate 7.5 % / w/w , zinc oxide 9 % / w/w;
∙ 2020-06-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELTAMD INC;
∙ DIN: 02496291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98618
∙ PREVENTION + DAILY MATTE MOISTURIZER OIL-FREE;
∙ octinoxate 7.5 % / w/w , zinc oxide 9.0 % / w/w;
∙ 2015-02-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ IMAGE INTERNATIONAL MANUFACTURING LLC;
∙ DIN: 02437554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92188
∙ PREVENTION + DAILY ULTIMATE PROTECTION MOISTURIZER;
∙ octinoxate 7.5 % / w/w , zinc oxide 9.0 % / w/w , octisalate 5.0 % / w/w;
∙ 2015-02-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ IMAGE INTERNATIONAL MANUFACTURING LLC;
∙ DIN: 02437597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92192
∙ DAILY MOISTURIZING CREAM SPF 15;
∙ octinoxate 7.5 g / 100 g , oxybenzone 3 g / 100 g , octisalate 3 g / 100 g;
∙ 2005-09-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VIVIER CANADA INCORPORATED;
∙ DIN: 02246994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71227
∙ OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 30 SENSITIVE;
∙ octisalate 2.5 % , octinoxate 7.5 % , octocrylene 2.5 % , zinc oxide 6.9 %;
∙ 2018-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02461188
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94867
∙ OLAY TOTAL EFFECTS 7 IN ONE TONE CORRECTING MOISTURIZER WITH SUNSCREEN;
∙ octisalate 3 % , avobenzone 2 % , octocrylene 3 %;
∙ 2009-01-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02306972
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79265
∙ MAKEUP SETTING SPRAY PULVÉRISATION POUR FIXER LE MAQUILLAGE;
∙ octisalate 3.94 % / w/w , avobenzone 3 % / w/w , homosalate 3.6 % / w/w;
∙ 2020-07-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02482444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97289
∙ SUN AND SNOW SPORT SPRAY SPF 30;
∙ octisalate 4 % , octocrylene 8 % , octinoxate 6 % , oxybenzone 5 %;
∙ 2004-04-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DAVID ASTLEY AND COMPANY INC.;
∙ DIN: 02247403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71649
∙ OLAY REGENERIST WHIP;
∙ octisalate 4 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w , homosalate 8 % / w/w;
∙ 2018-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02463938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95202
∙ OLAY TOTAL EFFECTS WHIP;
∙ octisalate 4 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w , homosalate 8 % / w/w;
∙ 2018-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02463946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95203
∙ OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 15 COMBINATION/OILY;
∙ octisalate 4.5 % , homosalate 4 % , avobenzone 3 % , octocrylene 2.6 %;
∙ 2017-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02461269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94877
∙ OLAY TOTAL EFFECTS 7IN1 ANTI-AGING MOISTURIZER WITH SUNSCREEN BROAD SPECTRUM SPF 15;
∙ octisalate 4.5 % , homosalate 4.0 % , avobenzone 3.0 % , octocrylene 2.6 %;
∙ 2014-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02424665
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90934
∙ SHEER TOUCH TOUCHER SOYEUX OIL-FREE SUNSCREEN ÉCRAN SOLAIRE SANS HUILE SPF/FPS 50+;
∙ octisalate 4.5 % , homosalate 9 % , octocrylene 6 % , avobenzone 3 %;
∙ 2016-10-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02454572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94128
∙ ESTÉE LAUDER RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME CRÈME TRI-PEPTIDE VISAGE ET COU SPF/FPS 15;
∙ octisalate 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
∙ 2019-03-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ESTEE LAUDER DIST.;
∙ DIN: 02482614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97304
∙ ESTEE LAUDER RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME CRÈME TRI-PEPTIDE VISAGE ET COU SPF/FPS 15 DRY SKIN PEAUX SÈCHES;
∙ octisalate 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
∙ 2020-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ESTEE LAUDER DIST.;
∙ DIN: 02488566
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97865
∙ SHEER TOUCH/TOUCHER SOYEUX OIL-FREE SUNSCREEN/ÉCRAN SOLAIRE SANS HUILE SPF/FPS 15;
∙ octisalate 4.5 % / w/w , homosalate 3 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
∙ 2016-01-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02409461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89417
∙ OLAY TOTAL EFFECTS 7IN1 FEATHERWEIGHT MOISTURIZER WITH SUNSCREEN;
∙ octisalate 4.5 % / w/w , homosalate 4.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 2.6 % / w/w;
∙ 2015-01-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02424517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90920
∙ HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS SUNSCREEN LOTION WITH HYDRATING RIBBONS SPF 30;
∙ octisalate 4.5 % / w/w , homosalate 5.5 % / w/w , octocrylene 4 % / w/w , avobenzone 2 % / w/w;
∙ 2016-01-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02440113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92450
∙ HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS SUNSCREEN LOTION WITH HYDRATING RIBBONS SPF 50;
∙ octisalate 4.5 % / w/w , homosalate 8 % / w/w , octocrylene 5 % / w/w , avobenzone 2.7 % / w/w;
∙ 2016-01-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02440121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92451
∙ COPPERTONE MOUSSE SUNSCREEN SPF 50 WATERBABIES;
∙ octisalate 4.5 % / w/w , homosalate 9 % / w/w , octocrylene 9 % / w/w , avobenzone 3 % / w/w;
∙ 2020-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol, Foam | Aérosol, Mousse;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02479702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97035
∙ PHOTO REGUL CREAM / CRÈME;
∙ octisalate 5 % , octinoxate 4.9 % , homosalate 4 % , avobenzone 3 %;
∙ 2018-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS;
∙ DIN: 02470799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95984
∙ ELTAMD SKINCARE UV SPORT SPF 50;
∙ octisalate 5 % , octinoxate 7.5 % , zinc oxide 9 %;
∙ 2010-03-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELTAMD INC;
∙ DIN: 02314924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80045
∙ SUN AND SNOW SPORT LOTION SPF 30;
∙ octisalate 5 % , octocrylene 2 % , octinoxate 7.5 % , oxybenzone 6 %;
∙ 2004-04-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DAVID ASTLEY AND COMPANY INC.;
∙ DIN: 02247404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71650
∙ SUNSCREEN CONTINUOUS SPRAY SPF 30 SPORT;
∙ octisalate 5 % , octocrylene 5 % , avobenzone 3 % , homosalate 7.5 %;
∙ 2020-02-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02493772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98377
∙ BABY MINERAL SUNSCREEN LOTION;
∙ octisalate 5 % , titanium dioxide 3 % , zinc oxide 6 %;
∙ 2018-03-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02466805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95516
∙ ESTEE LAUDER DAYWEAR MULTI-PROTECTION 24H-MOISTURE CREME SPF 15 FOR NORMAL/ COMBINATION SKIN;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2011-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ESTEE LAUDER DIST.;
∙ DIN: 02352605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83786
∙ CLINIQUE SMART SPF 15 CUSTOM-REPAIR MOISTURIZER VERY DRY TO DRY;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2016-01-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02440067
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92445
∙ CLINIQUE SMART SPF 15 CUSTOM-REPAIR MOISTURIZER DRY COMBINATION;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2016-01-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02440075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92446
∙ SUPERDEFENSE FATIGUE + 1ST SIGNS OF AGE MULTI-CORRECTING CREAM CRÈME MULTI-CORRECTION FATIGUE + 1ERS SIGNES DE L’ÂGE COMBINATION OILY TO OILY / MIXTE À GRASSE SPF 25 FPS;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02492024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98203
∙ SPORT FOR KIDS SUNSCREEN LOTION SPRAY SPF 50+;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 6 % / w/w;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02456044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94289
∙ ALOE SOOTHING MOISTURE LOTION SPF 15;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 2.9 % / w/w , octocrylene 2.2 % / w/w;
∙ 2016-12-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE BODY SHOP CANADA LIMITED;
∙ DIN: 02450739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93688
∙ SEAWEED OIL-CONTROL LOTION SPF 15;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 2.9 % / w/w , octocrylene 2.2 % / w/w;
∙ 2017-02-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE BODY SHOP CANADA LIMITED;
∙ DIN: 02450747
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93689
∙ DAILY MOISTURIZING LOTION SPF 15;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 1.7 % / w/w , oxybenzone 3 % / w/w;
∙ 2010-02-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02317508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80302
∙ ULTRA LIFT ANTI-WRINKLE FIRMING MOISTURIZING CREAM;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 3 % / w/w;
∙ 2014-02-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GARNIER CANADA;
∙ DIN: 02419076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90361
∙ MOISTURE RESCUE SPF 15;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w;
∙ 2016-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GARNIER CANADA;
∙ DIN: 02448351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93405
∙ CETAPHIL PRO DERMACONTROL OIL CONTROL MOISTURIZER;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 7 % / w/w;
∙ 2012-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GALDERMA CANADA INC;
∙ DIN: 02374536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85986
∙ NO7 PROTECT & PERFECT INTENSE ADVANCED DAY CREAM;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 7.5 % / w/w;
∙ 2017-01-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE BOOTS COMPANY PLC;
∙ DIN: 02453541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94010
∙ OLAY COMPLETE ALL DAY MOISTURE CREAM;
∙ octisalate 5 % / w/w , homosalate 3 % / w/w , avobenzone 3 % / w/w , octocrylene 2.6 % / w/w;
∙ 2009-05-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02314800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80034
∙ SUN EXPERT;
∙ octisalate 5 % / w/w , homosalate 4 % / w/w , octinoxate 7.5 % / w/w , avobenzone 2.5 % / w/w;
∙ 2016-06-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NAOS;
∙ DIN: 02455471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94228
∙ PLAY EVERYDAY LOTION;
∙ octisalate 5 % / w/w , octocrylene 7.5 % / w/w , avobenzone 3 % / w/w , homosalate 10 % / w/w;
∙ 2020-06-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ TAYLOR JAMES LLC;
∙ DIN: 02494949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98492
∙ NEUTROGENA MOISTURE OIL-FREE SPF 15;
∙ octisalate 5 % / w/w , oxybenzone 4 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
∙ 2015-08-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02416905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90151
∙ NEUTROGENA HEALTHY SKIN ANTI-WRINKLE CREAM SPF 15;
∙ octisalate 5 % / w/w , oxybenzone 4 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
∙ 2015-04-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02416913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90152
∙ CLINIQUE EVEN BETTER SKIN TONE CORRECTING MOISTURIZER SPF 20;
∙ octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 2.7 % / w/w;
∙ 2009-08-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02322072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80748
∙ CLINIQUE EVEN BETTER LOTION SPF 20;
∙ octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 2.7 % / w/w;
∙ 2012-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02375354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86076
∙ FIRMARINE DAY CREAM SPF 30 CRÈME DE JOUR SPF 30;
∙ octisalate 5.0 % / w/w , octinoxate 7.5 % / w/w , avobenzone 3.0 % / w/w;
∙ 2012-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ERNO LASZLO;
∙ DIN: 02389681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87518
∙ NEUTROGENA HEALTHY SKIN FACE LOTION SPF 15;
∙ octisalate 5.0 % / w/w , oxybenzone 4.0 % / w/w , octocrylene 3.0 % / w/w , avobenzone 1.5 % / w/w;
∙ 2015-04-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02404753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88954
∙ HAWAIIAN TROPIC SUNSCREEN LOTION ÉCRAN SOLAIRE 4;
∙ octocrylene 1 % / w/w , oxybenzone 0.5 % / w/w;
∙ 2010-01-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02329212
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81490
∙ DRY-TOUCH SUNSCREEN SPF 45;
∙ octocrylene 10 % , homosalate 10 % , octisalate 5 % , avobenzone 3 %;
∙ 2020-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02487780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97794
∙ REVERSA URBAN PROTECTION HYDRATING CARE SPF 30 SOIN HYDRATANT PROTECTION URBAINE FPS 30;
∙ octocrylene 10 % , octinoxate 7.5 % , octisalate 5 % , avobenzone 2 %;
∙ 2018-04-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DERMTEK PHARMA INC;
∙ DIN: 02473178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96253
∙ OMBRELLE SPORT SPRAY;
∙ octocrylene 10 % , oxybenzone 6 % , octisalate 5 % , avobenzone 3 %;
∙ 2007-03-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02290472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77578
∙ OMBRELLE STICK SPF 60;
∙ octocrylene 10 % , titanium dioxide 6.25 % , avobenzone 3 % , drometrizole trisiloxane 2 %;
∙ 2007-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02285738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77122
∙ ULTRA PROTECTION SUNSCREEN STICK SPF 60;
∙ octocrylene 10 % , titanium dioxide 6.25 % , avobenzone 3 % , drometrizole trisiloxane 2 %;
∙ 2007-04-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02285746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77123
∙ GLOWSCREEN;
∙ octocrylene 10 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
∙ 2021-01-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ TAYLOR JAMES LLC;
∙ DIN: 02503107
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99261
∙ FACE SUNSCREEN SPF 45;
∙ octocrylene 10 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02487764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97790
∙ WATER DRENCH;
∙ octocrylene 10 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ -;
∙ Otc | En Vente Libre;
∙ PETER THOMAS ROTH LABS LLC;
∙ DIN: 02506971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99639
∙ COOLZONE INSTANTLY COOLS & REFRESHES RAFRAÎCHIT INSTANTANÉMENT SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 50;
∙ octocrylene 10 % / w/w , oxybenzone 5 % / w/w , avobenzone 3 % / w/w;
∙ 2013-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02387050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87262
∙ SUNSCREEN STICK ÉCRAN SOLAIRE EN BÂTONNET WITH ALOE VERA/AVEC ALOÈS;
∙ octocrylene 10 % / w/w , oxybenzone 6 % / w/w , avobenzone 2 % / w/w;
∙ 2009-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02317990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80350
∙ COPPERTONE SUNSCREEN STICK WATERBABIES;
∙ octocrylene 10 % / w/w , zinc oxide 15 % / w/w , octinoxate 7.5 % / w/w;
∙ 2018-01-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02467100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95550
∙ REVERSA CRÈME RADIANCE FPS 30;
∙ octocrylene 10.0 % / w/w , octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 2.0 % / w/w;
∙ 2015-07-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DERMTEK PHARMA INC;
∙ DIN: 02435802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92015
∙ NOURISHING DAY CREAM;
∙ octocrylene 2 % / w/w , ensulizole 2 % / w/w , avobenzone 1.5 % / w/w;
∙ 2018-04-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02466570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95491
∙ SUN LOGIC 20 FPS UVA UVB SPF MOYENNE MEDIUM PROTECTION LARGE SPECTRE BROAD SPECTRUM LAIT SOLAIRE CORPS SUNSCREEN LOTION BODY;
∙ octocrylene 2.7 % , avobenzone 2.9 % , homosalate 12 %;
∙ 2019-04-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GUINOT;
∙ DIN: 02480484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97100
∙ SHISEIDO BENEFIANCE NUTRIPERFECT DAY CREAM SPF 15;
∙ octocrylene 3 % , octinoxate 5 % , ensulizole 2 %;
∙ 2009-02-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICA INC;
∙ DIN: 02306468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79216
∙ REFRESHING DAY CREAM;
∙ octocrylene 3 % / w/w , ensulizole 2 % / w/w , avobenzone 2 % / w/w;
∙ 2018-04-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02466589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95492
∙ MATTIFYING DAY CREAM;
∙ octocrylene 3 % / w/w , ensulizole 2 % / w/w , avobenzone 2 % / w/w;
∙ 2018-04-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02466597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95493
∙ URBAN ENVIRONMENT UV PROTECTION CREAM;
∙ octocrylene 3.0 % / w/w , octinoxate 2.9 % / w/w , zinc oxide 10.6 % / w/w;
∙ 2014-12-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02423901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90864
∙ URBAN ENVIRONMENT OIL-FREE UV PROTECTOR;
∙ octocrylene 3.0 % / w/w , octinoxate 4.9 % / w/w , zinc oxide 12.5 % / w/w;
∙ 2014-12-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02423928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90865
∙ HIGH PERFORMANCE SUNSCREEN SPRAY SPF 15;
∙ octocrylene 3.5 % / w/w , homosalate 5 % / w/w , avobenzone 1.5 % / w/w;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02454564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94127
∙ ROSALIAC UV LEGERE;
∙ octocrylene 4.6 % / w/w , octisalate 3.3 % / w/w , avobenzone 2.0 % / w/w , drometrizole trisiloxane 1.0 % / w/w;
∙ 2010-06-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02330792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81654
∙ ROSALIAC UV RICHE;
∙ octocrylene 4.6 % / w/w , octisalate 3.3 % / w/w , avobenzone 2.0 % / w/w , drometrizole trisiloxane 1.0 % / w/w;
∙ 2009-11-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02330857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81660
∙ BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN LOTION SPF 30;
∙ octocrylene 5 % / w/w , avobenzone 1.8 % / w/w , homosalate 7 % / w/w;
∙ 2014-12-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02423545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90826
∙ DRY BALANCE SUNSCREEN LOTION SPF 50+;
∙ octocrylene 5 % / w/w , homosalate 9 % / w/w , octisalate 4 % / w/w , avobenzone 3 % / w/w;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02456028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94287
∙ ULTRA SUN PROTECTION LOTION TI;
∙ octocrylene 5 % / w/w , octinoxate 4.9 % / w/w , oxybenzone 3 % / w/w , avobenzone 2.5 % / w/w;
∙ 2017-11-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02463660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95176
∙ ESTEE LAUDER REVITALIZING SUPREME+ GLOBAL ANTI-AGING CREME SPF 15;
∙ octocrylene 5 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2018-10-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ESTEE LAUDER DIST.;
∙ DIN: 02473828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96345
∙ ISLAND SPORT SUNSCREEN LOTION SPF 30;
∙ octocrylene 5 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w;
∙ 2017-07-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02449269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93509
∙ VITA LIFT SPF 15 DAILY MOISTURIZER;
∙ octocrylene 5.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , homosalate 2.0 % / w/w;
∙ 2014-06-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ L’ OREAL CANADA;
∙ DIN: 02419068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90360
∙ FACIAL FUEL;
∙ octocrylene 5.9 % / w/w , homosalate 8.8 % / w/w , octisalate 4.9 % / w/w , avobenzone 3 % / w/w;
∙ 2019-03-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02483777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97412
∙ BANANA BOAT ULTRA SPORT CLEAR SUNSCREEN SPRAY SPF 30;
∙ octocrylene 6 % / w/w , avobenzone 2 % / w/w , homosalate 6 % / w/w;
∙ 2019-10-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02477548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96859
∙ HAWAIIAN TROPIC DUO DEFENCE REFRESH SUNSCREEN MIST SPF 30;
∙ octocrylene 6 % / w/w , avobenzone 2.7 % / w/w , homosalate 6 % / w/w;
∙ 2019-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02477866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96871
∙ BRIGHT BOOST MOISTURIZER SPF 30;
∙ octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w;
∙ 2020-01-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02488116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97821
∙ CLEAR COMPLEXION SHEER DAILY MOISTURIZER;
∙ octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w;
∙ 2020-03-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02491842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98184
∙ PROTECT + HYDRATE MOISTURIZING SUNSCREEN SPF 30;
∙ octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w;
∙ 2021-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02496798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98664
∙ HYDRO BOOST WATER GEL LOTION SUNSCREEN SPF 30;
∙ octocrylene 6 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w , homosalate 5 % / w/w;
∙ 2019-01-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02463172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95108
∙ BANANA BOAT ULTRA SPORT CLEAR SUNSCREEN SPRAY SPF 50 PLUS;
∙ octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w , homosalate 9 % / w/w;
∙ 2019-10-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02477556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96860
∙ HAWAIIAN TROPIC KIDS SUNSCREEN LOTION SPF/FPS 50+;
∙ octocrylene 6 % / w/w , oxybenzone 4 % / w/w , avobenzone 3 % / w/w;
∙ 2015-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02423219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90795
∙ BIENFAIT MULTI-VITAL SPF 30;
∙ octocrylene 7 % , octisalate 5 % , avobenzone 3 %;
∙ 2005-12-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LANCOME CANADA;
∙ DIN: 02270161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75557
∙ CRÈME RAJEUNISSANTE HAUTE FERMETÉ JOUR;
∙ octocrylene 7 % , oxybenzone 3 % , avobenzone 3 %;
∙ 2014-04-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GROUPE MARCELLE INC;
∙ DIN: 02418088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90267
∙ OMBRELLE SPORT LOTION SPF 30;
∙ octocrylene 7 % , titanium dioxide 2.5 % , avobenzone 1.5 % , terephthalylidene dicamphor sulfonic acid 0.5 %;
∙ 2006-04-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02269902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75527
∙ OMBRELLE SPORT LOTION SPF 45;
∙ octocrylene 7 % , titanium dioxide 3.3 % , avobenzone 1.5 % , terephthalylidene dicamphor sulfonic acid 0.5 %;
∙ 2006-04-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02269910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75528
∙ FUTUR E SPF 15 MOISTURIZING LOTION;
∙ octocrylene 7 % / w/w , ensulizole 2 % / w/w;
∙ 2013-06-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ L’ OREAL CANADA;
∙ DIN: 02390671
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87609
∙ TOLERIANE SENSITIVE CRÈME UV;
∙ octocrylene 7 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-06-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02492458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98246
∙ ABSOLUE VELVET CREAM WITH BROAD SPECTRUM SPF 15;
∙ octocrylene 7 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-09-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LANCOME CANADA;
∙ DIN: 02495252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98518
∙ ULTRA FACIAL CREAM/CRÈME SPF 30;
∙ octocrylene 7 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-07-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02495694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98558
∙ COPPERTONE SPRAY SUNSCREEN SPF 30 SUN GUARD;
∙ octocrylene 7 % / w/w , homosalate 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w;
∙ 2020-02-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02478285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96904
∙ CHAPSTICK ACTIVE SPF 30;
∙ octocrylene 7 % / w/w , octinoxate 7.5 % / w/w , octisalate 5 % / w/w , oxybenzone 5 % / w/w;
∙ 2003-03-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02245381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69420
∙ RENERGIE LIFT MULTI-ACTION SPF 15 FIRMING MOISTURIZING CREAM ALL SKIN TYPES;
∙ octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2015-06-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LANCOME CANADA;
∙ DIN: 02438232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92260
∙ REVITALIFT ANTI-WRINKLE + FIRMING DAY CREAM;
∙ octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2018-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ L’ OREAL CANADA;
∙ DIN: 02466724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95508
∙ RÉNERGIE LIFT MULTI-ACTION ULTRA SPF30;
∙ octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2019-12-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LANCOME CANADA;
∙ DIN: 02492962
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98294
∙ RODAN+FIELDS REDEFINE;
∙ octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Kit , Cream | Trousse , Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02513838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100303
∙ AGE PERFECT ROSY TONE DAY CREAM;
∙ octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 2.7 % / w/w;
∙ 2020-03-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ L’ OREAL CANADA;
∙ DIN: 02490501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98055
∙ MULTI-ACTION CREAM SPF 30;
∙ octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 5 % / w/w;
∙ 2016-10-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02446979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93254
∙ RÉNERGIE LIFT MULTI-ACTION ULTRA;
∙ octocrylene 7 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2019-08-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LANCOME CANADA;
∙ DIN: 02484005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97434
∙ REVITALIFT TRIPLE POWER LZR DAY LOTION;
∙ octocrylene 7 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-02-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ L’ OREAL CANADA;
∙ DIN: 02491141
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98116
∙ AQUALIA THERMAL UV DEFENSE MOISTURIZING CREAM SPF30;
∙ octocrylene 7 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-01-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ -;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02491265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98127
∙ BIENFAIT MULTI-VITAL (SPF 30);
∙ octocrylene 7.0 % , octisalate 5.0 % , avobenzone 3.0 %;
∙ 2007-01-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LANCOME CANADA;
∙ DIN: 02283379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76898
∙ SPF 30 IDEAL SOLEIL LIP PROTECTION STICK;
∙ octocrylene 7.0 % / w/w , avobenzone 2.5 % / w/w , drometrizole trisiloxane 4.0 % / w/w;
∙ 2013-06-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02393956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87913
∙ SPF 30 WRINKLE REDUCING CREAM;
∙ octocrylene 7.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , homosalate 2.7 % / w/w;
∙ 2013-07-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02404214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88900
∙ WRINKLE EXPERT AGE DEFENSE UV LOTION;
∙ octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-03-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ L’ OREAL CANADA;
∙ DIN: 02498324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98810
∙ HYALU-MELON WITH CONDITIONING (HYALURONIC ACID + WATERMELON);
∙ octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-02-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GARNIER CANADA;
∙ DIN: 02507048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99645
∙ PINEA-C;
∙ octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-02-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GARNIER CANADA;
∙ DIN: 02507056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99646
∙ NIACINA-B;
∙ octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2021-02-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GARNIER CANADA;
∙ DIN: 02508982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99830
∙ COOLZONE INSTANTLY COOLS & REFRESHES RAFRAÎCHIT INSTANTANÉMENT SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 30;
∙ octocrylene 7.4 % / w/w , oxybenzone 3 % / w/w , avobenzone 1 % / w/w;
∙ 2013-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02387042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87261
∙ SPF/FPS 30 BROAD SPECTRUM ALCOHOL FREE SUNSCREEN;
∙ octocrylene 7.5 % , octinoxate 7.5 % , octisalate 5 % , avobenzone 2.5 %;
∙ 2018-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BU BRANDS, LLC;
∙ DIN: 02462184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94991
∙ NO7 EARLY DEFENCE GLOW ACTIVATING DAY CREAM;
∙ octocrylene 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2016-09-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE BOOTS COMPANY PLC;
∙ DIN: 02444429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92947
∙ SPF 50+ FPS ULTRA LOTION;
∙ octocrylene 7.5 % / w/w , octisalate 5 % / w/w , octinoxate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2016-07-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EMPACK SPRAYTECH INC;
∙ DIN: 02449617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93545
∙ COOLA CLASSIC SPF 30 SUNSCREEN SPRAY TROPICAL COCONUT SCENT;
∙ octocrylene 7.6 % / w/w , octisalate 4.9 % / w/w , avobenzone 2.8 % / w/w;
∙ 2021-03-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02510065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99932
∙ COOLA CLASSIC SPF 30 SUNSCREEN SPRAY PINA COLADA SCENT;
∙ octocrylene 7.6 % / w/w , octisalate 4.9 % / w/w , avobenzone 2.8 % / w/w;
∙ 2021-03-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ COOLA LLC;
∙ DIN: 02510332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99956
∙ HYDRANCE OPTIMALE SPF 25;
∙ octocrylene 8 % , octinoxate 7.5 % , titanium dioxide 3.2 %;
∙ 2005-09-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES DERMATOLOGIQUES AVÈNE;
∙ DIN: 02270269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75565
∙ COPPERTONE LOTION SUNSCREEN SPF 50 DEFEND & CARE FACE;
∙ octocrylene 8 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2019-01-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02467070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95547
∙ COPPERTONE LOTION SUNSCREEN SPF 50 SPORT;
∙ octocrylene 8 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , oxybenzone 3 % / w/w;
∙ 2020-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02475413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96580
∙ ULTRA SHEER DRY-TOUCH SUNSCREEN SPF 30;
∙ octocrylene 8 % / w/w , homosalate 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.5 % / w/w;
∙ 2020-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02486407
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97662
∙ CLEAR FACE SUNSCREEN LOTION;
∙ octocrylene 8 % / w/w , homosalate 8 % / w/w , octisalate 5 % / w/w , avobenzone 2.5 % / w/w;
∙ 2020-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02487845
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97800
∙ FACE & NECK MULTI ACTION VISAGE ET COU MULTI ACTION DAY CREAM / CRÈME DE JOUR SPF 30 / FPS 30;
∙ octocrylene 8 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2019-05-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE BOOTS COMPANY PLC;
∙ DIN: 02476118
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96704
∙ COPPERTONE CLEAR SUNSCREEN SPF 30 SPORT;
∙ octocrylene 9 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-02-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02488345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97844
∙ URBAN SKIN DEFENCE;
∙ octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.75 % / w/w;
∙ 2019-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02478471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96925
∙ CLINOLEIC 20%;
∙ olive oil 16 % / w/w , soybean oil 4 % / w/w;
∙ 2012-03-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02344327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82981
∙ OLMETEC PLUS;
∙ olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2008-12-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02319616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80508
∙ ACT OLMESARTAN HCT;
∙ olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2017-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02443112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92768
∙ APO-OLMESARTAN/HCTZ;
∙ olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2017-06-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02453606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94016
∙ GLN-OLMESARTAN HCTZ;
∙ olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2020-02-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ GLENMARK PHARMACEUTICALS CANADA INC.;
∙ DIN: 02475707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96608
∙ AURO-OLMESARTAN HCTZ;
∙ olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2019-01-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02476487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96741
∙ OLMETEC PLUS;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
∙ 2008-12-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02319624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80509
∙ ACT OLMESARTAN HCT;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
∙ 2017-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02443120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92771
∙ APO-OLMESARTAN/HCTZ;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
∙ 2017-05-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02453614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94017
∙ GLN-OLMESARTAN HCTZ;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
∙ 2020-02-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ GLENMARK PHARMACEUTICALS CANADA INC.;
∙ DIN: 02475715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96609
∙ AURO-OLMESARTAN HCTZ;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
∙ 2019-01-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02476495
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96742
∙ OLMETEC PLUS;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
∙ 2008-12-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02319632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80510
∙ ACT OLMESARTAN HCT;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
∙ 2017-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02443139
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92772
∙ APO-OLMESARTAN/HCTZ;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
∙ 2017-05-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02453622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94018
∙ GLN-OLMESARTAN HCTZ;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
∙ 2020-02-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ GLENMARK PHARMACEUTICALS CANADA INC.;
∙ DIN: 02475723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96610
∙ AURO-OLMESARTAN HCTZ;
∙ olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
∙ 2019-01-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02476509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96743
∙ CHOLEDYL EXPECTORANT ELIXIR;
∙ oxtriphylline 100 mg / 5 ml , guaifenesin 50 mg / 5 ml;
∙ 1981-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Elixir | Élixir;
∙ 48:16.00 – EXPECTORANTS , 86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ ERFA CANADA 2012 INC;
∙ DIN: 00476374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4258
∙ COPPERTONE SUNSCREEN LOTION SPF 8 DEFEND & GLOW;
∙ oxybenzone 2 % / w/w , octinoxate 7 % / w/w;
∙ 1970-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 01931199
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41935
∙ SUN-SHADES LIP BALM SPF 15 – VANILLA STK;
∙ oxybenzone 3 % , octinoxate 7.5 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MELALEUCA OF CANADA INC.;
∙ DIN: 02045672
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42329
∙ MARCELLE FLAWLESS AIR SERUM FOUNDATION SÉRUM DE TEINT PEAU PARFAITE SPF 15 FPS;
∙ oxybenzone 3 % / w/w , octinoxate 7.5 % / w/w;
∙ 2017-06-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GROUPE MARCELLE INC;
∙ DIN: 02461080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94858
∙ DAY CREAM SPF 15;
∙ oxybenzone 5 % , octinoxate 7 % , avobenzone 2 %;
∙ 2003-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KAMINS DERMATOLOGICS INC;
∙ DIN: 02246708
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70903
∙ TARGIN;
∙ oxycodone hydrochloride 10 mg , naloxone hydrochloride 5 mg;
∙ 2010-10-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PURDUE PHARMA;
∙ DIN: 02339609
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82520
∙ TARGIN;
∙ oxycodone hydrochloride 20 mg , naloxone hydrochloride 10 mg;
∙ 2010-10-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PURDUE PHARMA;
∙ DIN: 02339617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82521
∙ TARGIN;
∙ oxycodone hydrochloride 40 mg , naloxone hydrochloride 20 mg;
∙ 2010-10-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PURDUE PHARMA;
∙ DIN: 02339625
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82522
∙ TEVA-OXYCOCET;
∙ oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
∙ 1984-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 00608165
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5778
∙ RIVACOCET;
∙ oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
∙ 2001-12-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02242468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66193
∙ SANDOZ OXYCODONE/ACETAMINOPHEN;
∙ oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
∙ 2008-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02307898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79356
∙ APO-OXYCODONE/ACET;
∙ oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
∙ 2009-04-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ APOTEX INC;
∙ DIN: 02324628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81005
∙ TARGIN;
∙ oxycodone hydrochloride 5.00 mg , naloxone hydrochloride 2.50 mg;
∙ 2012-10-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PURDUE PHARMA;
∙ DIN: 02387425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87301
∙ AIR USP;
∙ oxygen 19.5 % , nitrogen 80.5 %;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 02014483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13885
∙ HELIUM OXYGEN MIXTURE;
∙ oxygen 20 % , helium 80 %;
∙ 1911-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ AIR LIQUIDE CANADA INC.;
∙ DIN: 00572896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5689
∙ MEDICAL AIR U.S.P.;
∙ oxygen 23.5 % / v/v , nitrogen 76.5 % / v/v;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ MESSER CANADA INC.;
∙ DIN: 02154781
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19291
∙ OXYGEN USP, HELIUM USP, MEDICAL GAS MIXTURE;
∙ oxygen 24 % , helium 76 %;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 02014440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13890
∙ HELIOX;
∙ oxygen 50 % , helium 50 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ LINDE CANADA LIMITED;
∙ DIN: 02154846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19290
∙ HELIUM-OXYGEN MIX GAS;
∙ oxygen 50 % , helium 50 %;
∙ 1997-05-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 01906801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46353
∙ ENTONOX;
∙ oxygen 50 % , nitrous oxide 50 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 28:04.16 – INHALATION ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ LINDE CANADA LIMITED;
∙ DIN: 02154757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19102
∙ OXYGEN CARBON DIOXIDE MIXTURE;
∙ oxygen 95 % , carbon dioxide 5 %;
∙ 1911-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ AIR LIQUIDE CANADA INC.;
∙ DIN: 00572853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5686
∙ ZEPOSIA;
∙ ozanimod (ozanimod hydrochloride) 0.23 mg , ozanimod (ozanimod hydrochloride) 0.46 mg;
∙ 2020-11-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ CELGENE INC;
∙ DIN: 02506009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99536
∙ BLISTEX LIP BALM;
∙ padimate o 6.6 % , oxybenzone 2.5 % , dimethicone 2 %;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BLISTEX CORPORATION;
∙ DIN: 02013878
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42159
∙ ELIZABETH ARDEN LIP PROTECTANT STICK SPF 15;
∙ padimate o 8 % , oxybenzone 3 %;
∙ 2005-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELIZABETH ARDEN (CANADA) LIMITED;
∙ DIN: 02250071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73489
∙ AKYNZEO;
∙ palonosetron (palonosetron hydrochloride) 0.5 mg , netupitant 300 mg;
∙ 2017-11-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:22.00 – ANTIEMETICS;
∙ Prescription | Prescription;
∙ ELVIUM LIFE SCIENCES;
∙ DIN: 02468735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95721
∙ PLEGRIDY;
∙ peginterferon beta-1a 63 mcg / 0.5 ml , peginterferon beta-1a 94 mcg / 0.5 ml;
∙ 2015-09-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Kit , Liquid | Trousse , Liquide;
∙ 08:18.20 – INTERFERONS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BIOGEN CANADA INC;
∙ DIN: 02444402
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92944
∙ VIACORAM;
∙ perindopril arginine 14 mg , amlodipine (amlodipine besylate) 10 mg;
∙ 2016-04-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02451557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93784
∙ APO-PERINDOPRIL/AMLODIPINE;
∙ perindopril arginine 14 mg , amlodipine (amlodipine besylate) 10 mg;
∙ 2019-06-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02468581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95701
∙ VIACORAM;
∙ perindopril arginine 3.5 mg , amlodipine (amlodipine besylate) 2.5 mg;
∙ 2016-04-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02451530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93782
∙ APO-PERINDOPRIL/AMLODIPINE;
∙ perindopril arginine 3.5 mg , amlodipine (amlodipine besylate) 2.5 mg;
∙ 2019-06-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02468565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95699
∙ APO-PERINDOPRIL/AMLODIPINE;
∙ perindopril arginine 7 mg , amlodipine (amlodipine besylate) 5 mg;
∙ 2019-06-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02468573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95700
∙ COVERSYL PLUS LD;
∙ perindopril erbumine 2 mg , indapamide 0.625 mg;
∙ 2003-05-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02246568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70751
∙ SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD;
∙ perindopril erbumine 2 mg , indapamide 0.625 mg;
∙ 2018-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02470411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95939
∙ COVERSYL PLUS;
∙ perindopril erbumine 4 mg , indapamide 1.25 mg;
∙ 2002-12-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02246569
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70752
∙ APO-PERINDOPRIL-INDAPAMIDE;
∙ perindopril erbumine 4 mg , indapamide 1.25 mg;
∙ 2021-02-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02297574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78291
∙ TEVA-PERINDOPRIL/INDAPAMIDE;
∙ perindopril erbumine 4 mg , indapamide 1.25 mg;
∙ 2018-03-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02464020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95216
∙ SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE;
∙ perindopril erbumine 4 mg , indapamide 1.25 mg;
∙ 2018-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02470438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95940
∙ COVERSYL PLUS HD;
∙ perindopril erbumine 8 mg , indapamide 2.5 mg;
∙ 2009-05-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02321653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80705
∙ TEVA-PERINDOPRIL/INDAPAMIDE;
∙ perindopril erbumine 8 mg , indapamide 2.5 mg;
∙ 2018-03-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02464039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95215
∙ SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD;
∙ perindopril erbumine 8 mg , indapamide 2.5 mg;
∙ 2018-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02470446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95941
∙ PERJETA-HERCEPTIN;
∙ pertuzumab 420 mg / 14 ml , trastuzumab 440 mg / vial;
∙ 2013-05-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution , Kit , Powder For Solution | Solution , Trousse , Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02405024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88985
∙ SEBAMED DIAPER RASH CREAM;
∙ petrolatum 10.00 % , mineral oil 7.00 %;
∙ 2000-04-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ LOFCO CANADA INC.;
∙ DIN: 02240541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64111
∙ SOOTHE NIGHT TIME;
∙ petrolatum 80 % , mineral oil 20 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Ointment | Pommade;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ BAUSCH & LOMB INC;
∙ DIN: 02125706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16777
∙ VISINE FOR ALLERGY WITH ANTIHISTAMINE;
∙ pheniramine maleate 0.3 % / w/v , naphazoline hydrochloride 0.025 % / w/v;
∙ 2003-12-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02242764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66582
∙ HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU EXTRA STRENGTH;
∙ pheniramine maleate 20 mg / sachet , ascorbic acid 50 mg / sachet , acetaminophen 650 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
∙ 2001-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02238890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62330
∙ HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU REGULAR STRENGTH;
∙ pheniramine maleate 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet , ascorbic acid 50 mg / sachet , acetaminophen 325 mg / sachet;
∙ 1999-01-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02047349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=32780
∙ ROBITUSSIN AC;
∙ pheniramine maleate 7.5 mg / 5 ml , guaifenesin 100 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 01934740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13494
∙ PREPARATION H-PE GEL;
∙ phenylephrine hydrochloride 0.25 % / w/w , hamamelis virginiana 50 % / w/w;
∙ 1997-05-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal , Topical | Rectale , Topique;
∙ Gel | Gel;
∙ 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02209594
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36788
∙ DRISTAN NASAL MIST;
∙ phenylephrine hydrochloride 0.5 % / w/v , pheniramine maleate 0.2 % / w/v;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Nasal | Nasale;
∙ Spray | Pulvérisation;
∙ 52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ FOUNDATION CONSUMER BRANDS, LLC;
∙ DIN: 01929313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41952
∙ DIMETAPP-C;
∙ phenylephrine hydrochloride 1 mg / ml , brompheniramine maleate 0.4 mg / ml , codeine phosphate 2 mg / ml;
∙ 2001-09-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ FOUNDATION CONSUMER BRANDS, LLC;
∙ DIN: 02244078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68031
∙ DIMETANE EXPECTORANT C;
∙ phenylephrine hydrochloride 1 mg / ml , brompheniramine maleate 0.4 mg / ml , codeine phosphate 2 mg / ml , guaifenesin 20 mg / ml;
∙ 2001-09-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ FOUNDATION CONSUMER BRANDS, LLC;
∙ DIN: 02244079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68034
∙ NEOCITRAN COLD & SORE THROAT NIGHT;
∙ phenylephrine hydrochloride 10 mg / sachet , acetaminophen 325 mg / sachet , pheniramine maleate 20 mg / sachet;
∙ 2003-06-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02246602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70790
∙ NEOCITRAN EXTRA STRENGTH COLD & CONGESTION;
∙ phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 00843792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10188
∙ DAYTIME COLD;
∙ phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet;
∙ 2020-01-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02487276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97743
∙ NIGHTTIME COLD;
∙ phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet;
∙ 2020-01-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02487233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97739
∙ NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT;
∙ phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , pheniramine maleate 20 mg / sachet;
∙ 1996-09-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02215403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37051
∙ NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT – APPLE CINNAMON;
∙ phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , pheniramine maleate 20 mg / sachet;
∙ 2017-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02456982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94410
∙ DIMETAPP EXTRA STRENGTH;
∙ phenylephrine hydrochloride 10 mg / 5 ml , brompheniramine maleate 4 mg / 5 ml;
∙ 2002-08-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 04:04.20 – PROPYLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ FOUNDATION CONSUMER BRANDS, LLC;
∙ DIN: 02245075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69079
∙ EXTRA STRENGTH TYLENOL COLD DAYTIME;
∙ phenylephrine hydrochloride 5 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 10 mg;
∙ 2006-07-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02276186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76185
∙ DIMETAPP;
∙ phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml;
∙ 2001-07-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 04:04.20 – PROPYLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ FOUNDATION CONSUMER BRANDS, LLC;
∙ DIN: 02243980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67924
∙ ROBITUSSIN CHILDREN’S COLD;
∙ phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml;
∙ 2013-07-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 04:04.20 – PROPYLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02394693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87984
∙ DIMETAPP DM COUGH & COLD;
∙ phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml , dextromethorphan hydrobromide 10 mg / 5 ml;
∙ 2001-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ FOUNDATION CONSUMER BRANDS, LLC;
∙ DIN: 02243969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67912
∙ DIMETANE EXPECTORANT DC;
∙ phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml , guaifenesin 100 mg / 5 ml , hydrocodone bitartrate 1.8 mg / 5 ml;
∙ 2001-09-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ FOUNDATION CONSUMER BRANDS, LLC;
∙ DIN: 02244080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68035
∙ BLES;
∙ phospholipid 27 mg / ml , surfactant-associated proteins sp-b and sp-c 500 mcg / ml;
∙ 2002-02-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intratracheal | Intratrachéale;
∙ Suspension | Suspension;
∙ 48:36.00 – PULMONARY SURFACTANTS;
∙ Ethical | Spécialité Médicale;
∙ BLES BIOCHEMICALS INC;
∙ DIN: 02245464
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69524
∙ MAVIRET;
∙ pibrentasvir 40 mg , glecaprevir 100 mg;
∙ 2017-09-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.40.20 – HCV Protease Inhibitors , 08:18.40.24 – HCV Replication Complex Inhibitors;
∙ Prescription | Prescription;
∙ ABBVIE CORPORATION;
∙ DIN: 02467550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95591
∙ VISKAZIDE;
∙ pindolol 10 mg , hydrochlorothiazide 25 mg;
∙ 1983-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ XEDITON PHARMACEUTICALS INC;
∙ DIN: 00568627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5156
∙ VISKAZIDE;
∙ pindolol 10 mg , hydrochlorothiazide 50 mg;
∙ 1983-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ XEDITON PHARMACEUTICALS INC;
∙ DIN: 00568635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5157
∙ PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION;
∙ piperacillin (piperacillin sodium) 12 g / vial , tazobactam (tazobactam sodium) 1.5 g / vial;
∙ 2010-03-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02330547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81627
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 12 g / vial , tazobactam (tazobactam sodium) 1.5 g / vial;
∙ 2012-03-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02377748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86356
∙ PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION;
∙ piperacillin (piperacillin sodium) 2 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
∙ 2007-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02299623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78500
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 2 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
∙ 2015-03-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02401312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88623
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 2 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
∙ 2021-06-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02402068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88693
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 2.00 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
∙ 2011-08-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02362619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84762
∙ PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION;
∙ piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
∙ 2007-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02299631
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78501
∙ PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION;
∙ piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
∙ 2013-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85518
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
∙ 2015-03-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02401320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88624
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
∙ 2021-06-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02402076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88694
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 3.000 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
∙ 2011-08-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02362627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84763
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 36 g / vial , tazobactam (tazobactam sodium) 4.5 g / vial;
∙ 2015-09-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02439131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92352
∙ PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION;
∙ piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
∙ 2007-11-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02299658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78502
∙ PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION;
∙ piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
∙ 2013-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85519
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
∙ 2015-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02401339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88625
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
∙ 2021-06-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02402084
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88695
∙ PIPERACILLIN AND TAZOBACTAM FOR INJECTION;
∙ piperacillin (piperacillin sodium) 4.0 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
∙ 2011-08-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02362635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84764
∙ PREVNAR 13;
∙ pneumococcal polysaccharide serotype 1 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 3 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 4 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6a 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b 4.4 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 18c 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19a 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19f 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f 2.2 mcg / 0.5 ml , corynebacterium diphtheriae crm-197 protein 34 mcg / 0.5 ml;
∙ 2010-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 14.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02335204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82074
∙ PNEUMOVAX 23;
∙ pneumococcal polysaccharide serotype 1 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 2 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 3 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 4 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 8 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9n 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 10a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 11a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 12f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 15b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 17f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 18c 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 20 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 22f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 33f 25 mcg / 0.5 ml;
∙ 1978-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 23.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Solution | Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 00431648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2969
∙ PNEUMOVAX 23;
∙ pneumococcal polysaccharide serotype 1 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 2 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 3 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 4 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 8 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9n 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 10a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 11a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 12f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 15b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 17f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 18c 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 20 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 22f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 33f 25 mcg / 0.5 ml;
∙ 2021-04-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 23.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Solution | Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 02436442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92078
∙ SYSTANE LUBRICANT EYE DROPS;
∙ polyethylene glycol 400 0.4 % / w/v , propylene glycol 0.3 % / w/v;
∙ 2004-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Otc | En Vente Libre;
∙ ALCON CANADA INC;
∙ DIN: 02248967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73342
∙ TRIPLE ANTIBIOTIC OINTMENT;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin (bacitracin zinc) 500 unit / g , gramicidin .25 mg / g;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ MELALEUCA OF CANADA INC.;
∙ DIN: 02088339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16171
∙ BIODERM OINTMENT;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin 500 unit / g;
∙ 1987-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ ODAN LABORATORIES LTD;
∙ DIN: 00621366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8398
∙ POLYSPORIN ANTIBIOTIC OINTMENT;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g;
∙ 1998-08-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02237227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60546
∙ POLYSPORIN TRIPLE ANTIBIOTIC OINTMENT;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g , gramicidin 0.25 mg / g;
∙ 1998-08-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02237226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60545
∙ TRIPLE ANTIBIOTIC OINTMENT;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g , gramicidin 0.25 mg / g;
∙ 2003-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02246693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70888
∙ POLYSPORIN COMPLETE;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g , gramicidin 0.25 mg / g , lidocaine 50 mg / g;
∙ 2005-05-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02240568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64139
∙ POLYSPORIN ANTIBIOTIC CREAM;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / g , gramicidin 0.25 mg / g;
∙ 1997-08-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02230844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50105
∙ POLYSPORIN PLUS PAIN RELIEF;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
∙ 1999-06-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02239201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62658
∙ POLYSPORIN FOR KIDS;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
∙ 2004-04-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02248189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72525
∙ POLYSPORIN EYE AND EAR DROPS STERILE;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / ml , gramicidin 0.025 mg / ml;
∙ 2000-02-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic , Otic | Ophtalmique , Otique;
∙ Drops | Gouttes;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02239156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62612
∙ POLYSPORIN PLUS PAIN RELIEF EAR DROPS;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / ml , lidocaine hydrochloride 50 mg / ml;
∙ 1999-12-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Otic | Otique;
∙ Drops | Gouttes;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02239155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62611
∙ POLYTRIM OPHTHALMIC SOLUTION;
∙ polymyxin b (polymyxin b sulfate) 10000 unit / ml , trimethoprim (trimethoprim sulfate) 1 mg / ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02011956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13628
∙ BAND-AID BRAND ADHESIVE BANDAGES PLUS ANTIBIOTIC;
∙ polymyxin b sulfate 10000 unit / g , bacitracin zinc 500 unit / g;
∙ 1998-04-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment , Pad | Pommade , Compresse;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02236954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60248
∙ ANTIBIOTIC OINTMENT;
∙ polymyxin b sulfate 10000 unit / g , bacitracin zinc 500 unit / g;
∙ 2012-05-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ CANADIAN CUSTOM PACKAGING COMPANY;
∙ DIN: 02372037
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85716
∙ POLYSPORIN SINGLES;
∙ polymyxin b sulfate 10000 unit / g , bacitracin zinc 500 unit / g;
∙ 2019-10-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02481618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97207
∙ ORIGINAL ANTIBIOTIC CREAM;
∙ polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g;
∙ 2010-10-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02317656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80317
∙ ANTIBIOTIC CREAM;
∙ polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g;
∙ 2012-03-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ CANADIAN CUSTOM PACKAGING COMPANY;
∙ DIN: 02372029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85715
∙ COMPLETE ANTIBIOTIC OINTMENT;
∙ polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine 50 mg / g , bacitracin zinc 500 unit / g;
∙ 2009-01-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02304465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78975
∙ ANTIBIOTIC CREAM PLUS PAIN RELIEF;
∙ polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 40 mg / g;
∙ 2012-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ CANADIAN CUSTOM PACKAGING COMPANY;
∙ DIN: 02372045
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85717
∙ ANTIBIOTIC CREAM PLUS PAIN RELIEF FOR KIDS;
∙ polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 40 mg / g;
∙ 2012-07-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ CANADIAN CUSTOM PACKAGING COMPANY;
∙ DIN: 02377187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86278
∙ ANTIBIOTIC PLUS PAIN RELIEF CREAM;
∙ polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
∙ 2009-07-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02304457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78974
∙ ANTIBIOTIC CREAM FOR KIDS;
∙ polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
∙ 2009-07-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02315033
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80057
∙ SANDOZ POLYTRIMETHOPRIM;
∙ polymyxin b sulfate 10000 unit / ml , trimethoprim (trimethoprim sulfate) 1 mg / ml;
∙ 2012-08-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02239234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62695
∙ CLEAR EYES TRIPLE ACTION RELIEF;
∙ polyvinyl alcohol 0.5 % , povidone 0.6 % , tetrahydrozoline hydrochloride 0.05 %;
∙ 2008-03-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS;
∙ Otc | En Vente Libre;
∙ PRESTIGE BRANDS INC;
∙ DIN: 02301687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78699
∙ MURINE;
∙ polyvinyl alcohol 5 mg / ml , povidone 6 mg / ml;
∙ 2004-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ PRESTIGE BRANDS INC;
∙ DIN: 02247538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71788
∙ POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE;
∙ potassium chloride 0.15 g / 100 ml , sodium chloride 0.9 g / 100 ml;
∙ 2008-04-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 02299100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78450
∙ POTASSIUM PHOSPHATES;
∙ potassium phosphate monobasic 224 mg / ml , potassium phosphate dibasic 236 mg / ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00804789
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10509
∙ POTASSIUM PHOSPHATES INJECTION, USP;
∙ potassium phosphate monobasic 224 mg / ml , potassium phosphate dibasic 236 mg / ml;
∙ 1984-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02139545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19442
∙ POLYSPORIN POLY TO GO;
∙ pramoxine hydrochloride 1 % , benzalkonium chloride 0.13 %;
∙ 2009-03-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02318946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80442
∙ PROCTODAN-HC OINTMENT;
∙ pramoxine hydrochloride 1 % , hydrocortisone acetate 0.5 % , zinc sulfate 0.5 %;
∙ 1998-01-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Rectal , Topical | Rectale , Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02234466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55837
∙ ANUSOL PLUS OINTMENT;
∙ pramoxine hydrochloride 1 % , zinc sulfate 0.5 %;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal , Topical | Rectale , Topique;
∙ Ointment | Pommade;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 01945912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12764
∙ POLYSPORIN ITCH RELIEF;
∙ pramoxine hydrochloride 1.0 % , zinc acetate 0.1 %;
∙ 2003-04-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02246156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70300
∙ PROCTODAN-HC SUPPOSITORIES;
∙ pramoxine hydrochloride 20 mg , hydrocortisone acetate 10 mg , zinc sulfate 10 mg;
∙ 2000-03-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02240851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64442
∙ ANUSOL PLUS SUPPOSITORIES;
∙ pramoxine hydrochloride 20 mg , zinc sulfate 10 mg;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 01945904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12763
∙ EMLA CREAM;
∙ prilocaine 2.5 % , lidocaine 2.5 %;
∙ 1991-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 00886858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11440
∙ ORAQIX;
∙ prilocaine 2.5 % , lidocaine 2.5 %;
∙ 2010-02-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 52:16.00 – LOCAL ANESTHETICS;
∙ Otc | En Vente Libre;
∙ DENTSPLY CANADA LIMITED;
∙ DIN: 02325993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81134
∙ PRILOCAINE HCL 4% EPINEPH 1:200000INJ;
∙ prilocaine hydrochloride 40 mg / ml , epinephrine 0.005 mg / ml;
∙ 1977-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ NOVOCOL PHARMACEUTICAL OF CANADA INC;
∙ DIN: 00393746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2828
∙ 4% CITANEST FORTE DENTAL WITH EPINEPHRINE 1:200,000;
∙ prilocaine hydrochloride 40 mg / ml , epinephrine 0.005 mg / ml;
∙ 2011-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ DENTSPLY CANADA LIMITED;
∙ DIN: 02347695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83307
∙ SECARIS;
∙ propylene glycol 20 % / w/w , macrogol 15 % / w/w;
∙ 1982-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Nasal | Nasale;
∙ Gel | Gel;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 00551805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4885
∙ RHINARIS NASAL MIST;
∙ propylene glycol 5 % / w/w , macrogol 15 % / w/w;
∙ 2012-01-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02354551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83972
∙ VIOKACE;
∙ protease 112500 unit , amylase 113400 unit , lipase 20880 unit;
∙ 2000-06-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ NESTLE ENTERPRISES S.A.;
∙ DIN: 02241933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65603
∙ VIOKACE;
∙ protease 57100 unit , lipase 10440 unit , amylase 56400 unit;
∙ 1997-01-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:16.00 – DIGESTANTS;
∙ Prescription | Prescription;
∙ NESTLE ENTERPRISES S.A.;
∙ DIN: 02230019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48551
∙ DAYTIME COLD MEDICATION LIQUID FASTGELS;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 250 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
∙ 2011-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02330822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81657
∙ BUCKLEY’S COMPLETE + MUCUS RELIEF;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 250 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
∙ 2010-08-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02335948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82152
∙ COMPLETE DAYTIME LIQUID CAPSULES;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 250 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
∙ 2015-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02428113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91260
∙ BUCKLEYS COLD & SINUS;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 325 mg , dextromethorphan hydrobromide 15 mg;
∙ 2008-07-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02307111
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79278
∙ EXTRA STRENGTH SINUS RELIEF DAYTIME;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
∙ 1996-10-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02050242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27225
∙ COLD AND FLU-IN-ONE EXTRA STRENGTH;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg;
∙ 2007-04-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02281147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76681
∙ TOTAL COLD AND FLU;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg;
∙ 2007-01-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02286394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77185
∙ EXTRA STRENGTH SINUTAB SINUS NIGHTTIME;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , diphenhydramine hydrochloride 25 mg;
∙ 1998-03-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02215241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37037
∙ BUCKLEY’S NIGHTTIME COLD AND SINUS;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , doxylamine succinate 6.25 mg;
∙ 2008-07-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02307014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79269
∙ BUCKLEY’S COMPLETE NIGHTTIME SOFTGELS;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , doxylamine succinate 6.25 mg;
∙ 2010-08-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02335239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82084
∙ EXTRA STRENGTH COLD MEDICATION DAYTIME RELIEF;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02083736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17880
∙ BUCKLEY’S COMPLETE EXTRA STRENGTH COUGH, COLD & FLU DAY;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
∙ 2000-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02241593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65250
∙ EXTRA STRENGTH FLU RELIEF DAYTIME;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
∙ 2004-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02248580
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72935
∙ COMPLETE DAYTIME;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
∙ 2018-02-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02427540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91206
∙ NIGHTTIME COLD & FLU LIQUID CAPSULES;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg , acetaminophen 325 mg;
∙ 2005-01-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02258927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74415
∙ COMPLETE LIQUID CAPSULES NIGHTTIME RELIEF;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg , acetaminophen 325 mg;
∙ 2017-05-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02427923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91242
∙ COLD + SINUS NIGHTTIME;
∙ pseudoephedrine hydrochloride 30 mg , ibuprofen 200 mg , chlorpheniramine maleate 2 mg;
∙ 2015-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02369559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85448
∙ EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF;
∙ pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml;
∙ 2011-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 4.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02365774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85065
∙ COUGH & COLD RELIEF;
∙ pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
∙ 2013-08-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ TRILLIUM HEALTH CARE PRODUCTS INC;
∙ DIN: 02405873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89064
∙ COUGH & COLD RELIEF EXTRA STRENGTH;
∙ pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
∙ 2013-07-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ TRILLIUM HEALTH CARE PRODUCTS INC;
∙ DIN: 02405881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89065
∙ COLD + SINUS PLUS;
∙ pseudoephedrine hydrochloride 30.0 mg , ibuprofen 200.0 mg , chlorpheniramine maleate 2.0 mg;
∙ 2011-04-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 3.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02359243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84427
∙ EXTRA STRENGTH SUDAFED HEAD COLD & SINUS;
∙ pseudoephedrine hydrochloride 60 mg , acetaminophen 500 mg;
∙ 2000-08-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02239159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62615
∙ EXTRA STRENGTH HEAD COLD AND SINUS;
∙ pseudoephedrine hydrochloride 60 mg , acetaminophen 500 mg;
∙ 2004-04-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02248646
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73003
∙ EXTRA STRENGTH TYLENOL SINUS PRESSURE & PAIN;
∙ pseudoephedrine hydrochloride 60 mg , acetaminophen 500 mg;
∙ 2019-06-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02478110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96884
∙ CLARITIN ALLERGY + SINUS EXTRA STRENGTH;
∙ pseudoephedrine sulfate 240 mg , loratadine 10 mg;
∙ 2005-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet (Immediate And Extended Release) | Comprimé(À Libération Immédiate Et Prolongée);
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02260557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74601
∙ R & C SHAMPOO WITH CONDITIONER;
∙ pyrethrins 0.33 % , piperonyl butoxide 3 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Shampoo | Shampoing;
∙ 84:04.12 – SCABICIDES AND PEDICULICIDES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 02125447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18634
∙ Z-PLUS SHAMPOO;
∙ pyrithione zinc 2 % , menthol 0.3 %;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Topical | Topique;
∙ Shampoo | Shampoing;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ DORMER LABORATORIES INC.;
∙ DIN: 00800686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10999
∙ ACCURETIC;
∙ quinapril (quinapril hydrochloride) 10 mg , hydrochlorothiazide 12.5 mg;
∙ 1998-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02237367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60690
∙ APO-QUINAPRIL/HCTZ;
∙ quinapril (quinapril hydrochloride) 10 mg , hydrochlorothiazide 12.5 mg;
∙ 2013-08-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02408767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89352
∙ AURO-QUINAPRIL HCTZ;
∙ quinapril (quinapril hydrochloride) 10 mg , hydrochlorothiazide 12.5 mg;
∙ 2019-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02473291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96270
∙ ACCURETIC;
∙ quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 12.5 mg;
∙ 1998-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02237368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60691
∙ APO-QUINAPRIL/HCTZ;
∙ quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2013-08-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02408775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89353
∙ AURO-QUINAPRIL HCTZ;
∙ quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 12.5 mg;
∙ 2019-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02473305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96271
∙ ACCURETIC;
∙ quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 25 mg;
∙ 2003-06-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02237369
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60692
∙ APO-QUINAPRIL/HCTZ;
∙ quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 25 mg;
∙ 2013-08-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02408783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89354
∙ AURO-QUINAPRIL HCTZ;
∙ quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 25 mg;
∙ 2019-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02473321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96273
∙ ALTACE HCT;
∙ ramipril 10 mg , hydrochlorothiazide 12.5 mg;
∙ 2006-11-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 2.00;